Abstract is: Optic neuritis describes any condition that causes inflammation of the optic nerve; it may be associated with demyelinating diseases, or infectious or inflammatory processes. It is also known as optic papillitis (when the head of the optic nerve is involved), neuroretinitis (when there is a combined involvement of the optic disc and surrounding retina in the macular area) and retrobulbar neuritis (when the posterior part of the nerve is involved). Prelaminar optic neuritis describes involvement of the non-myelinated axons in the retina. It is most often associated with multiple sclerosis, and it may lead to complete or partial loss of vision in one or both eyes. Other causes include: 1. * Leber's hereditary optic neuropathy 2. * Parainfectious optic neuritis (associated with viral infections such as measles, mumps, chickenpox, whooping cough and glandular fever) 3. * Infectious optic neuritis (sinus related or associated with cat-scratch fever, tuberculosis, Lyme disease and cryptococcal meningitis in AIDS patients 4. * Autoimmune causes (sarcoidosis, systemic lupus erythematosus, polyarteritis nodosa, MOG antibody disease, granulomatosis with polyangiitis) 5. * Diabetes mellitus 6. * Low phosphorus levels 7. * Hyperkalaemia Partial, transient vision loss (lasting less than one hour) can be an indication of early onset multiple sclerosis.
| class of disease | Q112193867 |
| disease | Q12136 |
| encephalomyelitis | Q1634879 |
| optic nerve disease | Q2879095 |
| eye disease | Q3041498 |
| P2176 | drug or therapy used for treatment | methylprednisolone | Q417222 |
| P6532 | has phenotype | acute visual loss | Q11789224 |
| P1995 | health specialty | neurology | Q83042 |
| ophthalmology | Q161437 | ||
| P5008 | on focus list of Wikimedia project | WikiProject Medicine | Q4099686 |
| Q61974967 | A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) |
| Q65381436 | A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON) |
| Q65536701 | A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon) |
| Q63813329 | A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide (MTP-131) Topical Ophthalmic Solution for the Treatment of Leber's Hereditary Optic Neuropathy |
| Q64715348 | A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION |
| Q63835717 | A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors |
| Q66343711 | A Trial of Neuroprotection With ACTH in Acute Optic Neuritis |
| Q65368206 | Amiloride Clinical Trial In Optic Neuritis |
| Q65363161 | Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve |
| Q63335142 | Ampyra for Optic Neuritis in MS |
| Q65339313 | Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER) |
| Q63843290 | Assessment of Visual Field-related Endpoints in Patients With Non-arteritic Ischemic Optic Neuropathy |
| Q63592363 | Assessment of Visual Function With a Portable Brain-computer Interface |
| Q64722352 | Atacicept in Subjects With Optic Neuritis |
| Q64638381 | BIIB033 In Acute Optic Neuritis (AON) |
| Q64835578 | BIOtinidase Test In Optic-Neuropathy |
| Q63394978 | BN201 SAD MAD Study in Healthy Subjects |
| Q61924626 | Biobank For MS And Other Demyelinating Diseases |
| Q63011263 | Biomechanics of Optic Neuropathy |
| Q65335249 | CHRONIC OPTIC NEUROPATHY IN MULTIPLE SCLEROSIS |
| Q63397479 | Can Diffusion Tensor Imaging (DTI) of the Optic Ways Contributes to Predict the 6 Months Prognosis of Optic Neuritis (ON)? |
| Q64398136 | Choroidal Thickness in Optic Neuropathy |
| Q66073827 | Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) |
| Q63593118 | Citicoline in Non-Arteritic Ischemic Optic Neuropathy |
| Q67129872 | Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players |
| Q63337957 | Comparison of Intravitreal Bevacizumab and Triamcinolone With Placebo |
| Q64351983 | Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis |
| Q74275103 | Diagnosis of ON With or Without MS or NMOSD |
| Q63597994 | EAP_GS010_single Patient |
| Q65346856 | ENDOTHELION Study Group: Effect of Bosentan in NAION Patients |
| Q63844644 | Effect of EECP on Anterior Ischemic Optic Neuropathy |
| Q65384062 | Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy |
| Q64604395 | Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis |
| Q66393281 | Effect of Phenytoin on the Ganglion Cell Inner Plexiform Layer and Visual Field in Patients With an Acute Optic Neuritis |
| Q66388709 | Effect of Transorbital Electrical STIMulation of Optic Nerve on Remyelination After an Acute Optic Neuritis |
| Q61956460 | Effect of Vitamin D on Retinal Changes in Patient With Optic Neuritis by Optic Coherence Tomography |
| Q63600639 | Effectiveness of Plasma Exchange in Treating With Severe Acute AQP4-Ab Positive Optic Neuritis |
| Q64816964 | Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year |
| Q63811712 | Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) |
| Q64350404 | Electric Stimulation of the Eye to Improve Vision After Trauma |
| Q64599160 | Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON] |
| Q86252661 | Epidemiologic and Clinical Characteristics of Optic Neuritis in China |
| Q63817521 | Epidemiology Study of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) |
| Q65346914 | Erythropoietin in Methanol Associated Optic Neuropathy: A Phase-2 Clinical Trial (EPO-MAON Study) |
| Q63535078 | Evaluation of Visual and Task Performance |
| Q74273621 | Fampridine-SR and Optic Neuritis Recovery |
| Q63837937 | Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON) |
| Q66394020 | Gypenosides Treatment for Optic Neuritis |
| Q64790410 | High-Dose Vitamin D Induction in Optic Neuritis |
| Q66402226 | Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON) |
| Q87078867 | Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS) |
| Q66038618 | Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event. |
| Q63335413 | Influence of Oral Treatment With Citicoline for the Prevention of Radiation Optic Neuropathy in Patients Treated for Uveal Melanomas With Proton Beam Therapy |
| Q64789158 | Initial Clinical Presentation of Inflammatory Optic Neuritis Associated or Not With Autoantibodies Anti-Myelin-oligodendrocyte-glycoprotein |
| Q64351688 | Interest of Dynamic Measures of the Pupil in Optic Neuritis |
| Q61921082 | Intraocular Pressure During Abdominal Aortic Aneurysm (AAA) Repair |
| Q62030773 | Intravenous Immunoglobulin Therapy in Optic Neuritis |
| Q61865568 | Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy |
| Q64697056 | Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy |
| Q66062166 | Ischemic Optic Neuropathy Decompression Trial (IONDT) |
| Q66062169 | Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup) |
| Q66343096 | Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey |
| Q62025349 | Linking Optic Nerve MRI and the Retinal Axonal Loss After Optic Neuritis |
| Q63339417 | Lipoic Acid as a Treatment for Acute Optic Neuritis |
| Q66026078 | Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis |
| Q65466223 | Long-Term Assessment of Remyelinating Therapy |
| Q66024536 | Longitudinal Optic Neuritis Study (LONS) |
| Q63839827 | MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study) |
| Q65365960 | Macular Retinoschisis and Detachment Associated With Glaucomatous Optic Neuropathy |
| Q61864919 | Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis |
| Q62040891 | NAION Treatment With Oral Prednisolone and Erythropoietin Injection |
| Q64660475 | NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement |
| Q62813977 | Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis |
| Q65364648 | Natural History of Optic Neuritis |
| Q64681141 | Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy |
| Q64650358 | Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON) |
| Q65473631 | Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases |
| Q61967227 | Neuroprotection With Phenytoin in Optic Neuritis |
| Q61938418 | Neuroprotection and Repair in Optic Neuritis |
| Q65389088 | Neurotomy of Optic Nerve in Non-Arthritic Anterior Ischemic Optic Neuropathy |
| Q62814127 | New Non-invasive Modalities for Assessing Retinal Structure and Function |
| Q63594751 | Ocular Manifestations in Rheumatic Diseases |
| Q63811823 | Optic Neuritis Differential Diagnosis Study |
| Q63319317 | Optic Neuritis Recovery After Oral or IV Corticosteroids |
| Q66024538 | Optic Neuritis Treatment Trial (ONTT) |
| Q66396709 | Optic Neuritis and Ganglion Cell Layer |
| Q63337557 | Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab |
| Q65317983 | Optical Coherence Tomography and Optic Neuritis (OCTON) |
| Q66066389 | Optical Coherence Tomography and Optic Neuritis Not Related to Multiple Sclerosis |
| Q66345951 | Optical Coherence Tomography in Multiple Sclerosis Patients |
| Q64396916 | Outcomes of Steroid and Oxygen Therapy Versus Placebo Therapy in Non-arteritic Anterior Ischemic Optic Neuropathy |
| Q61980863 | PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) |
| Q65375611 | Paraorbital-Occipital Alternating Current Stimulation Therapy for Optic Neuropathy (MCT_optnerve) |
| Q65375181 | Paraorbital-Occipital Electric Stimulation in Patients With Optic Neuropathy (BCT_optnerve) |
| Q66397715 | Pharmacokinetics, Safety and Tolerability of Single Doses of BIIB033 (Opicinumab) Produced by 2 Manufacturing Processes |
| Q65349297 | Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) |
| Q66403804 | Post Authorisation Safety Study With Raxone in LHON Patients |
| Q66083154 | Pupillometry Dynamic Measures in Patients Without Ocular or Neurological Disease |
| Q63572643 | REALITY LHON Registry |
| Q63404528 | RESCUE and REVERSE Long-term Follow-up |
| Q105493654 | RESting-state Functional MRI in Patients With Optic Neuritis for ANticipation of reCovEry |
| Q63322104 | RHODOS Follow-up Single-visit Study |
| Q65379548 | Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy |
| Q63577993 | Repetitive Transorbital Alternating Current Stimulation in Acute Autoimmune Optic Neuritis |
| Q63405484 | Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis |
| Q63405482 | Retinal Neuro-vascular Coupling in Patients With Non-arteritic Anterior Ischemic Optic Neuropathy |
| Q107974187 | Retrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis Trial |
| Q67133451 | Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION |
| Q66069984 | Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy |
| Q64223160 | Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients |
| Q65535711 | Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients |
| Q63813493 | Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy |
| Q65387165 | Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis |
| Q61909836 | Safety and Efficacy Study of Gene Therapy for The Treatment of Leber's Hereditary Optic Neuropathy |
| Q64348598 | Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION). |
| Q63816453 | Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON) |
| Q66408701 | Safety and Efficacy of Using SightSaver Visual Evoked Potential (VEP) for VEP Monitoring in Prone Spine Surgery |
| Q65539483 | Simvastatin Treatment of Patients With Acute Optic Neuritis |
| Q66392703 | Stem Cell Ophthalmology Treatment Study II |
| Q63319340 | Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON) |
| Q64717127 | Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy |
| Q66403426 | Study to Assess the Efficacy and Safety of Raxone in LHON Patients |
| Q65392524 | Surgery for Traumatic Optic Neuropathy |
| Q63320805 | TLR-9 Antagonism in Steroid Resistant Optic Neuritis |
| Q66084346 | The Correlation Between AQP-4 Ab and the Visual Function of Patients With Demyelinating ON at Onset |
| Q63400744 | The Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CIS |
| Q64644499 | The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders |
| Q74283496 | The Therapeutic Effect of Dysthyroid Optic Neuropathy |
| Q64708801 | Transcorneal Electrical Stimulation Therapy for Retinal Disease |
| Q63571579 | Traumatic Optic Neuropathy Treatment Trial (TONTT) |
| Q63572525 | Traumatic Optic Neuropathy Treatment Trial 2 |
| Q64645299 | Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5% |
| Q64352949 | Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial |
| Q66409526 | Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells |
| Q63816022 | Trial of Alternating Current Stimulation in Optic Neuropathy |
| Q64611188 | Trial of Cyclosporine in the Acute Phase of Leber Hereditary Optic Neuropathy |
| Q64600566 | Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses |
| Q63832810 | Use of Bevacizumab in Trabeculectomy Surgery |
| Q66028473 | Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy |
| Q63815347 | Visual Reconstitution Therapy After Optic Neuritis |
| Q17080979 | Autoimmune optic neuropathy |
| Q25312936 | Chronic relapsing inflammatory optic neuropathy |
| Q18554699 | acute retrobulbar neuritis |
| Q55009186 | autoimmune optic neuritis |
| Q18975032 | meningococcal optic neuritis |
| Q7830375 | nutritional optic neuropathy |
| Q7098800 | optic papillitis |
| Q27675244 | toxic optic neuropathy |
| Q96617486 | "NMDA receptor spectrum disorder" in the differential diagnosis of demyelinating disorders of the CNS: optic neuritis and myelitis |
| Q39328479 | 'The worm that got away': parainfectious atypical optic neuritis associated with schistosomiasis infection. |
| Q69452272 | 2 cases of rhinogenic retrobulbar optic neuritis and a case of odontogenic retrobulbar optic neuritis with abducent palsy |
| Q39545800 | 20/40 or Better Visual Acuity After Optic Neuritis: Not as Good as We Once Thought? |
| Q53521192 | 25-Hydroxyvitamin D levels in acute monosymptomatic optic neuritis: relation to clinical severity, paraclinical findings and risk of multiple sclerosis. |
| Q36022754 | 25-hydroxyvitamin D Concentrations in Patients with Optic Neuritis as a Clinically Isolated Syndrome and Healthy Controls |
| Q28327113 | 4 cases of bilateral optic neuritis in the course of ethambutol treatment |
| Q46450456 | 7 cases of Leber's disease in an African family of the Wolof people. (Problem of their possible relation to so-called nutritional tropical optic neuritis said to be nutritional |
| Q84895319 | A CASE OF BILATERAL OPTIC NEURITIS DUE TO SPHENOIDAL SINUSITIS |
| Q40738776 | A CASE OF DACRYO-CYSTITIS LEADING TO ORBITAL PHLEGMON, OPTIC NEURITIS AND ATROPHY. |
| Q76869016 | A CASE OF OPTIC NEURITIS CAUSED BY THERMAL BURNS OF THE FACE, TRUNK AND UPPER AND LOWER EXTREMITIES |
| Q58738351 | A Case of Carcinomatous Tumour Occupying the Right Postero-Parietal Lobule of the Cerebrum: Blindness from Double Optic Neuritis |
| Q50236173 | A Case of Optic Neuritis Concomitant with Pituitary Tumor During Pregnancy. |
| Q90501278 | A Case of Optic Neuritis Secondary to Lyme Disease |
| Q54222900 | A Case of Post Encephalitic Optic Neuritis: Clinical Spectrum, Differential Diagnosis and Management. |
| Q55692461 | A Case of Suppuration in the Mastoid with Optic Neuritis on the Same Side: Operation: Recovery |
| Q64045957 | A Case of Vogt-Koyanagi-Harada Syndrome Mimicking Optic Neuritis |
| Q91168119 | A Comparison of Optic Neuritis in Asian and in Western Countries |
| Q40321408 | A Rare Case of Bilateral Optic Neuritis and Guillain-Barré Syndrome Post Mycoplasma pneumoniae Infection. |
| Q90718950 | A Rare Presentation of Myelin Oligodendrocyte Glycoprotein IgG-Associated Optic Neuritis |
| Q90324336 | A Stereotyped Syndrome with Retro-Ocular Pain, Photophobia, and Visual Disturbance Masquerading as Optic Neuritis: Case Series |
| Q85356475 | A blurry differential. Optic neuritis leads down a treacherous slope |
| Q40435584 | A case of Adamantiades-Behçet disease with ischemic optic neuritis (posterior optic neuropathy). |
| Q45325909 | A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection |
| Q40625613 | A case of Sjögren's syndrome with retrobulbar optic neuritis and cutaneous vasculitis |
| Q103835075 | A case of anti-aquaporin-4 antibody-positive optic neuritis treated by selective immunoadsorption |
| Q80081064 | A case of branch retinal artery occlusion associated with presumed optic neuritis |
| Q64070129 | A case of cancer-associated retinopathy with chorioretinitis and optic neuritis associated with occult small cell lung cancer |
| Q40871189 | A case of double traumatic optic neuritis, followed by absolute blindness and recovery |
| Q78175073 | A case of isolated acute optic neuritis |
| Q36768506 | A case of multiple evanescent white dot syndrome misdiagnosed as optic neuritis: Differential diagnosis for the neurologist |
| Q71396732 | A case of myasthenia gravis associated with optic neuritis |
| Q51577087 | A case of optic neuritis and transverse myelitis in a postpartum Ghanaian female. |
| Q68202877 | A case of optic neuritis associated with anticardiolipin antibodies |
| Q33774777 | A case of optic neuritis complicating herpes zoster ophthalmicus in a child |
| Q44126053 | A case of optic neuritis due to Treponema pallidum and treatment with megadoses of corticosteroids |
| Q73023083 | A case of optic neuritis in a qat addict |
| Q45347790 | A case of optic neuritis incidentally detected by somatostatin receptor scintigraphy. |
| Q42344143 | A case of post-vaccination optic neuritis: coincidence or causative? |
| Q90837170 | A case of recurrent MOG antibody positive bilateral optic neuritis and anti-NMDAR encephalitis: Different biological evolution of the two associated antibodies |
| Q28274353 | A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy |
| Q50804089 | A case of retrobulbar optic neuritis caused by duloxetine. |
| Q83026922 | A case of secondary syphilis presenting as optic neuritis |
| Q40776188 | A case of systemic lupus erythematosus associated with meningitis, myelitis, and bilateral optic neuritis |
| Q64242597 | A case report of hepatitis B related optic neuritis treated with plasma exchange |
| Q80000634 | A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis |
| Q91736007 | A comparative study on clinical features of anterior ischemic optic neuropathy and idiopathic optic neuritis |
| Q86566727 | A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin |
| Q81489543 | A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis |
| Q38094403 | A literature review on optic neuritis following vaccination against virus infections |
| Q68816442 | A long-term prospective study of optic neuritis: evaluation of risk factors |
| Q57911842 | A longitudinal conventional and magnetization transfer magnetic resonance imaging study of optic neuritis |
| Q91565664 | A new association: acute macular neuroretinopathy in acute optic neuritis |
| Q28331310 | A new case of optic neuritis induced by chloramphenicol in a child |
| Q50508368 | A new color vep procedure discloses asymptomatic visual impairments in optic neuritis and glaucoma suspects. |
| Q44282083 | A new etiology of toxic optic neuritis: amoproxan |
| Q104079192 | A novel decision tree approach to predict the probability of conversion to multiple sclerosis in Iranian patients with optic neuritis |
| Q58723440 | A novel method of inducing endogenous pupil oscillations to detect patients with unilateral optic neuritis |
| Q58741638 | A prospective case-control study comparing optical coherence tomography characteristics in neuromyelitis optica spectrum disorder- optic neuritis and idiopathic optic neuritis |
| Q39870622 | A prospective cohort study of vitamin D in optic neuritis recovery |
| Q33618968 | A prospective study of the risk of developing multiple sclerosis in optic neuritis in a tropical and sub-tropical area |
| Q57746395 | A prospective study of the risk of developing multiple sclerosis in uncomplicated optic neuritis |
| Q33599375 | A putative role for calpain in demyelination associated with optic neuritis |
| Q74009730 | A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis |
| Q43800957 | A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group |
| Q41266398 | A rare case of odontogenic parainfectious intraorbital optic neuritis with the absence of clinical manifestation of orbital cellulitis |
| Q89618728 | A rare complication of combined oral contraceptives (COCs): optic neuritis |
| Q125770574 | A rare ocular manifestation of mycoplasma pneumoniae infection. |
| Q104610190 | A rare pediatric case of neurobrucellosis with bilateral optic neuritis |
| Q33628639 | A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up |
| Q81250618 | A role for calpain in optic neuritis |
| Q61861971 | A serial MRI study following optic nerve mean area in acute optic neuritis |
| Q43010508 | A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials |
| Q71396404 | A simple psychophysical technique provides early diagnosis in optic neuritis |
| Q74517214 | A toxic ocular manifestation of chloramphenicol therapy; report of a case of optic neuritis |
| Q90672454 | A-scan ultrasonography as a supportive diagnostic tool in case of acute optic neuritis |
| Q74528684 | A.C.T.H. in optic neuritis |
| Q34983220 | AIDS and optic neuritis in a rhesus monkey infected with the R5 clade C SHIV-1157ipd3N4 |
| Q84883114 | AN INVESTIGATION INTO THE FREQUENCY AND SIGNIFICANCE OF OPTIC NEURITIS AND OTHER VASCULAR CHANGES IN THE RETINAE OF PATIENTS SUFFERING FROM PURULENT DISEASE OF THE MIDDLE EAR WITH THE RESULTS OF THE EXAMINATION OF THE EYES AND EARS IN 100 CONSECUTIV |
| Q79954246 | Abducens nerve palsy and optic neuritis as initial manifestation in brucellosis |
| Q74480505 | Acquired combined hamartoma of the retina and pigment epithelium following parainfectious meningoencephalitis with optic neuritis |
| Q36531930 | Acute Bilateral Optic Neuritis in Active Ankylosing Spondylitis |
| Q92629611 | Acute Disseminated Encephalomyelitis followed by Optic Neuritis: A Rare Syndrome of Uncertain Treatment and Prognosis |
| Q94570048 | Acute Inflammatory Optic Neuritis Associated with a Self-Taper of Oral Prednisone in a Patient Taking Adalimumab |
| Q90939651 | Acute Management of Optic Neuritis: An Evolving Paradigm |
| Q104102175 | Acute Myelitis, Recurrent Optic Neuritis, and Seizures Over 17 Years |
| Q73238350 | Acute Optic Neuritis |
| Q92958242 | Acute Optic Neuritis Diagnosed by Bedside Ultrasound in an Emergency Department |
| Q84511432 | Acute anterior uveitis and optic neuritis as ocular complications of influenza A infection in an 11-year-old boy |
| Q67580225 | Acute axial optic neuritis and herpes simplex virus in the cerebral spinal fluid. (discussion of a case) |
| Q69470754 | Acute bilateral optic neuritis |
| Q48924088 | Acute cerebellar ataxia of childhood and optic neuritis with retrochiasmal involvement. |
| Q92759483 | Acute changes in ganglion cell layer thickness in ischemic optic neuropathy compared to optic neuritis using optical coherence tomography |
| Q30747566 | Acute demyelinating optic neuritis |
| Q31135355 | Acute demyelinating optic neuritis: a review |
| Q43007290 | Acute disseminated encephalomyelitis associated with optic neuritis and marked peri-papillary hemorrhages |
| Q43828887 | Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients |
| Q33415160 | Acute disseminated encephalomyelitis presenting as optic neuritis in a case of idiopathic thrombocytopaenic purpura |
| Q42258909 | Acute disseminated encephalomyelitis without optic neuritis followed by optic neuritis in a child due to the sudden cessation of steroid therapy |
| Q46588194 | Acute generalized exanthematous pustulosis induced by high-dose prednisolone in a young woman with optic neuritis owing to disseminated encephalomyelitis |
| Q90029507 | Acute idiopathic optic neuritis: not always benign |
| Q36274409 | Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management |
| Q37212716 | Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations |
| Q67944525 | Acute monocular disturbances mimicking optic neuritis in pituitary apoplexy |
| Q38972247 | Acute onset blindness: a case of optic neuritis and review of childhood optic neuritis. |
| Q100501547 | Acute optic nerve lesions in first-ever NMOSD-related optic neuritis using conventional brain MRI: A Latin American multicenter study |
| Q72104789 | Acute optic neuritis |
| Q93937190 | Acute optic neuritis |
| Q70671781 | Acute optic neuritis and multiple sclerosis |
| Q70963762 | Acute optic neuritis and multiple sclerosis (author's transl) |
| Q37042177 | Acute optic neuritis and the prognosis for multiple sclerosis |
| Q67895868 | Acute optic neuritis associated with immunization with the CNS myelin proteolipid protein |
| Q40341488 | Acute optic neuritis following infection with chikungunya virus in southern rural India |
| Q43071996 | Acute optic neuritis in Australia: a 13 year prospective study |
| Q42734209 | Acute optic neuritis in multiple sclerosis |
| Q88384662 | Acute optic neuritis with diffusion restriction on MRI |
| Q33416327 | Acute optic neuritis with normal visual acuity. Comparison of symptoms and signs with psychophysiological, electrophysiological and magnetic resonance imaging data. |
| Q41378876 | Acute optic neuritis: A virological study in relation to multiple sclerosis |
| Q26799784 | Acute optic neuritis: Unmet clinical needs and model for new therapies |
| Q43154346 | Acute optic neuritis: a clinical paradigm for evaluation of neuroprotective and restorative strategies? |
| Q33622683 | Acute optic neuritis: a prospective study of risk factors for multiple sclerosis |
| Q49103881 | Acute optic neuritis: association with paranasal sinus inflammatory changes on magnetic resonance imaging. |
| Q74485808 | Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The Optic Neuritis Study Group |
| Q37129397 | Acute optic neuritis: its clinical features and their relation to prognosis for recovery of vision |
| Q70799327 | Acute optic neuritis: myelin basic protein and proteolipid protein antibodies, affinity, and the HLA system |
| Q37130376 | Acute optic neuritis: prognosis for development of multiple sclerosis |
| Q67007636 | Acute optic neuritis: prognosis for the development of multiple sclerosis |
| Q85776632 | Acute optic neuritis: retinal ganglion cell loss precedes retinal nerve fiber thinning |
| Q86000261 | Acute optic neuritis: retinal ganglion cell loss precedes retinal nerve fiber thinning |
| Q43627945 | Acute posterior multifocal pigment epitheliopathy and optic neuritis in a family. |
| Q43106605 | Acute retrobulbar optic neuritis and macular detachment associated with morning glory optic disc anomaly |
| Q72255910 | Acute retrobulbar optic neuritis during herpes zoster oticus with paralysis of the facial nerve and cochleo-vestibular disorders |
| Q58124013 | Acute vision loss in multiple sclerosis: Optic neuritis or central serous chorioretinopathy? |
| Q58112960 | Acute visual loss and optic disc edema followed by optic atrophy in two cases with deeply buried optic disc drusen: a mimicker of atypical optic neuritis |
| Q101040167 | Acute zonal occult outer retinopathy presenting as optic neuritis |
| Q36015674 | Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple Sclerosis |
| Q36802175 | Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis |
| Q92369982 | Adherence to Clinical Trial Supported Evaluation of Optic Neuritis |
| Q57462962 | Adipokines in Multiple Sclerosis Patients with and without Optic Neuritis as the First Clinical Presentation |
| Q50124174 | Advanced diffusion-weighted imaging in patients with optic neuritis deficit - value of reduced field of view DWI and readout-segmented DWI. |
| Q30392316 | Adverse neurologic reactions after both doses of pandemic H1N1 influenza vaccine with optic neuritis and demyelination. |
| Q79923723 | Adverse reactions to anthrax vaccine (eg, optic neuritis) may be more complex or delayed than reported initially by Payne et al (2006) |
| Q39646557 | Allergic encephalomyelitis - a model of allergic optic neuritis |
| Q72117255 | Allergic granulomatosis and angiitis (Churg-Strauss syndrome) presenting as prominent neurologic lesions and optic neuritis |
| Q69022871 | Alteration of the visual evoked potential by macular holes: comparison with optic neuritis |
| Q60943262 | Altered Brain Structure and Functional Connectivity of Primary Visual Cortex in Optic Neuritis |
| Q36390994 | Altered intrinsic regional spontaneous brain activity in patients with optic neuritis: a resting-state functional magnetic resonance imaging study |
| Q42359453 | Alveolar rhabdomyosarcoma of the sphenoid sinus mimicking optic neuritis presenting with intermittent visual loss in an adult. |
| Q35836853 | Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial |
| Q47417640 | Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial |
| Q100694879 | Amnion-Derived Multipotent Progenitor Cells Suppress Experimental Optic Neuritis and Myelitis |
| Q35560008 | An Eye on Brain Integrity: Acute Optic Neuritis Affects Resting State Functional Connectivity |
| Q75439133 | An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis |
| Q99555226 | An adult case of parainfectious optic neuritis associated with genital herpes simplex virus type 2 infection |
| Q72313965 | An analysis of VEP components in optic neuritis |
| Q37736903 | An interesting case of wrongly diagnosed optic neuritis |
| Q42782672 | An overview of idiopathic optic neuritis in eastern Nepal. |
| Q38260711 | An unusual case of bilateral multifocal retinal pigment epithelial detachment with methanol-induced optic neuritis |
| Q33844406 | An unusual case of optic neuritis |
| Q41874224 | An unusual presentation of optic neuritis and the Pulfrich phenomenon |
| Q42765851 | An unusual presentation of optic neuritis and the Pulfrich phenomenon |
| Q37136875 | Analysis of Fundus Photography and Fluorescein Angiography in Nonarteritic Anterior Ischemic Optic Neuropathy and Optic Neuritis |
| Q86366933 | Analysis of macular and nerve fiber layer thickness in multiple sclerosis patients according to severity level and optic neuritis episodes |
| Q46442627 | Analysis of spectral domain optical coherence tomography measurements in optic neuritis: differences in neuromyelitis optica, multiple sclerosis, isolated optic neuritis and normal healthy controls. |
| Q85217483 | Animal model of human disease with optic neuritis: neuropapillitis in a rat model infected with Angiostrongylus cantonensis |
| Q83686991 | Ankylosing spondylitis presented as unilateral optic neuritis in a young woman |
| Q28325767 | Anterior optic neuritis caused by ethambutol toxicity |
| Q44170010 | Anthrax vaccination and risk of optic neuritis in the United States military, 1998-2003. |
| Q40419331 | Anti-MOG (Myelin Oligodendrocyte Glycoprotein)-Positive Severe Optic Neuritis with Optic Disc Ischaemia and Macular Star |
| Q35833865 | Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis |
| Q91412241 | Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis Presenting with Dense Premacular Hemorrhage |
| Q57488252 | Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis or Neuroretinitis? |
| Q42922440 | Anti-NMDA receptor antibody encephalitis with recurrent optic neuritis and epilepsy |
| Q50025496 | Anti-NMDA-receptor optic neuritis in a patient with a history of encephalitis. |
| Q58084210 | Anti-aquaporin-4 Antibody Positive Optic Neuritis Following Scrub Typhus in an Elderly Female |
| Q36242655 | Anti-aquaporin-4 IgG in Patients Presenting with Unilateral Optic Neuritis: A Cohort Study |
| Q84711972 | Anti-aquaporin-4 antibody-positive optic neuritis treated with double-filtration plasmapheresis |
| Q83428603 | Anti-aquaporin-4 antibody-positive recurrent isolated optic neuritis and primary Sjögren's syndrome |
| Q48735313 | Anti-myelin Oligodendrocyte Glycoprotein Antibodies in a Patient with Recurrent Optic Neuritis Involving the Cerebral White Matter and Brainstem. |
| Q91141980 | Anti-myelin Oligodendrocyte Glycoprotein Antibody-positive Optic Neuritis in a Girl With Ulcerative Colitis |
| Q71653857 | Anti-myelin basic protein and anti-proteolipid protein antibody-secreting cells in the cerebrospinal fluid of patients with acute optic neuritis |
| Q68935474 | Anti-myelin basic protein antibody in experimental allergic optic neuritis and encephalomyelitis |
| Q87384377 | Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis |
| Q52639773 | Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with optic neuritis and seizures. |
| Q100990682 | Anti-myelin oligodendrocyte glycoprotein antibody-positive coursing with optic neuritis: Imaging and clinical implications |
| Q97588830 | Antibodies to Epstein-Barr virus and neurotropic viruses in multiple sclerosis and optic neuritis |
| Q34453889 | Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis |
| Q101331224 | Antibody Testing in Atypical Optic Neuritis |
| Q72185360 | Antirabic vaccine optic neuritis |
| Q59273786 | Anti–Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Patients With Optic Neuritis |
| Q57807234 | Apo E in multiple sclerosis and optic neuritis: the Apo E-o4 allele is associated with progression of multiple sclerosis |
| Q85252638 | Application of immunosuppressant facilitates the therapy of optic neuritis combined with Sjögren's syndrome |
| Q79206585 | Apropos of a case of optic neuritis in the course of sphenoid sinusitis |
| Q72856835 | Apropos of the late recovery of certain alcohol-nicotinic optic neuritis |
| Q88414691 | Aquaporin 4 Antibody in the Korean Patient with New-Onset Optic Neuritis |
| Q51055303 | Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India. |
| Q92305627 | Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning |
| Q90035497 | Aquaporin-4 Serostatus and Visual Outcomes in Clinically Isolated Acute Optic Neuritis |
| Q88536681 | Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis |
| Q92225540 | Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up |
| Q43666453 | Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneity |
| Q50473348 | Aquaporin-4 autoimmunity in a child without optic neuritis and myelitis. |
| Q47337655 | Are VEP abnormalities in optic neuritis (ON) dependent on plaque size? A reappraisal of the physiopathology of ON based on improved MRI and multiple-lead recordings |
| Q36479607 | Argon laser coagulation of the retina in optic neuritis |
| Q34601120 | Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS. |
| Q53568752 | Aspergillosis causing bilateral optic neuritis and later orbital apex syndrome. |
| Q91266600 | Assessing the anterior visual pathway in optic neuritis: recent experimental and clinical aspects |
| Q91864455 | Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential |
| Q100562191 | Assessment of Pediatric Optic Neuritis Visual Acuity Outcomes at 6 Months |
| Q80857624 | Assessment of blood flow velocity in eyeball arteries in multiple sclerosis patients with past retrobulbar optic neuritis in color Doppler ultrasonography |
| Q91706750 | Association Between BDNF Val66Met Polymorphism and Optic Neuritis Damage in Neuromyelitis Optica Spectrum Disorder |
| Q57825618 | Association of Gene Polymorphism with Predisposition to Optic Neuritis and Optic Neuritis Together with Multiple Sclerosis |
| Q94604427 | Association of Individual-Level Factors With Visual Outcomes in Optic Neuritis: Secondary Analysis of a Randomized Clinical Trial |
| Q54936193 | Association of Optic Neuritis with CYP4F2 Gene Single Nucleotide Polymorphism and IL-17A Concentration. |
| Q61804337 | Association of Optic Neuritis with Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Korea |
| Q101118480 | Association of VEGFA, TIMP-3, and IL-6 gene polymorphisms with predisposition to optic neuritis and optic neuritis with multiple sclerosis |
| Q33970576 | Association of race/ethnicity with visual outcomes following acute optic neuritis: an analysis of the Optic Neuritis Treatment Trial |
| Q87120290 | Association of vitamin D deficiency with RNFL thickness in MS individuals without history of optic neuritis |
| Q95657815 | Associations between IL1RAP rs4624606, IL1RL1 rs1041973, IL-6 rs1800795, and HTRA1 rs11200638 gene polymorphisms and development of optic neuritis with or without multiple sclerosis |
| Q73469970 | Asymmetric myopia developing after optic neuritis |
| Q80608726 | Asymptomatic visual field disturbances in multiple sclerosis patients without a history of optic neuritis |
| Q83101270 | Atopic optic neuritis |
| Q33649389 | Atrophy of myelinated nerve fibres in the retina in optic neuritis |
| Q54251255 | Atypical Optic Neuritis After Inactivated Influenza Vaccination. |
| Q90637889 | Atypical Optic Neuritis: Neuromyelitis Optica and Other Causes |
| Q86012083 | Atypical optic neuritis |
| Q91744398 | Atypical optic neuritis - a case with a new surprise every visit |
| Q97692451 | Atypical optic neuritis as the presenting feature of testicular malignancy: Rare case report with review of literature |
| Q43165146 | Atypical optic neuritis due to tuberculosis |
| Q104479343 | Atypical optic neuritis: An overview |
| Q92243160 | Atypical presentation of primary Sjögren's syndrome as optic neuritis |
| Q92334884 | Author response: Optical coherence tomography for diagnosing optic neuritis: Are we there yet? |
| Q81244222 | Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis |
| Q33732430 | Autoimmune T cell repertoire in optic neuritis and multiple sclerosis: T cells recognising multiple myelin proteins are accumulated in cerebrospinal fluid |
| Q97076281 | Autoimmune and demyelinating optic neuritis |
| Q53837202 | Autoimmune and immunogenetic profile of patients with optic neuritis in a population-based cohort. |
| Q68082282 | Autoimmune optic neuritis |
| Q69190783 | Autoimmune retrobulbar optic neuritis |
| Q72004502 | Autopsy case of demyelinating optic neuritis (a subtype of neuromyelitis optica) |
| Q71127148 | Availability of frequency-selective fat-saturation pulse (Fat-Sat) MRI in childhood optic neuritis |
| Q84435774 | Axonal loss in a rat model of optic neuritis is closely correlated with visual evoked potential amplitudes using electroencephalogram-based scaling |
| Q34066839 | Axonal transport rate decreased at the onset of optic neuritis in EAE mice |
| Q40692399 | B and T lymphocytes in cerebrospinal fluid and blood in multiple sclerosis, optic neuritis and mumps meningitis |
| Q90641362 | B-cell related biomarkers associated with severity of the first demyelinating event of acute optic neuritis |
| Q47242758 | B-lymphocyte and plasma cell clonal expansion in monosymptomatic optic neuritis cerebrospinal fluid |
| Q40943134 | B.A.L. IN OPTIC NEURITIS CAUSED BY ARSENICALS. |
| Q80272653 | BAL in arsenical optic neuritis |
| Q78560694 | BILATERAL OPTIC NEURITIS CAUSED BY THE PROLONGED THERAPEUTIC USE OF CHLORAMPHENICOL |
| Q34571946 | Basal ganglia and brainstem encephalitis, optic neuritis, and radiculomyelitis in Epstein-Barr virus infection. |
| Q43975811 | Basedowien optic neuritis, cured by Ogura's operation |
| Q77788464 | Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG) |
| Q35032107 | Baseline magnetic resonance imaging of the optic nerve provides limited predictive information on short-term recovery after acute optic neuritis |
| Q44573384 | Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group |
| Q84566115 | Baseline, one and three month changes in the peripapillary retinal nerve fiber layer in acute optic neuritis: relation to baseline vision and MRI |
| Q91820053 | Bedside Ocular Ultrasound Evaluation of Pediatric Optic Neuritis |
| Q96430707 | Bedside Ophthalmic Ultrasonography to Diagnose Acute Optic Neuritis |
| Q91466512 | Bedside Transorbital Ultrasound in the Clinical Evaluation of Pediatric Optic Neuritis in the Emergency Department |
| Q38654464 | Bevacizumab for Radiation Induced Optic Neuritis Among Aggressive Residual/Recurrent Suprasellar Tumors: More Than a Mere Antineoplastic Effect |
| Q97677613 | Bilateral Atypical Retrobulbar Optic Neuritis Associated With Tuberculosis in an Immunocompetent Patient |
| Q33545831 | Bilateral Choroidal Osteoma Associated with Optic Neuritis in Behçet's Disease |
| Q41351773 | Bilateral Multifocal Chorioretinitis and Optic Neuritis due to Epstein-Barr Virus: A Case Report |
| Q59238970 | Bilateral Optic Neuritis After Influenza Vaccination |
| Q100380830 | Bilateral Optic Neuritis After Vero Cell-Derived Antirabies Vaccination |
| Q71970583 | Bilateral Optic Neuritis Following Herpes Zoster Ophthalmicus |
| Q99636836 | Bilateral Optic Neuritis Secondary to Immune Etiology by anti-PD-L1 Antibody |
| Q58608018 | Bilateral Optic Neuritis Secondary to Nivolumab Therapy: A Case Report |
| Q58866617 | Bilateral Optic Neuritis in Wegener Granulomatosis |
| Q95934791 | Bilateral Optic Neuritis: A Rare Complication of Mumps |
| Q36424598 | Bilateral Retrobulbar Optic Neuritis Caused by Varicella Zoster Virus in a Patient with AIDS. |
| Q100751688 | Bilateral Retrobulbar Optic Neuritis as the First Manifestation of Neuro-Behçet Disease |
| Q84457439 | Bilateral and recurrent optic neuritis in multiple sclerosis |
| Q44214621 | Bilateral anterior optic neuritis in adult measles infection without encephalomyelitis |
| Q36719824 | Bilateral atypical optic neuritis associated with tuberculosis in an immunocompromised patient |
| Q41000067 | Bilateral axial optic neuritis caused by Q fever |
| Q69612830 | Bilateral chorioretinitis, centripetal optic neuritis, and encephalitis in a llama |
| Q53466903 | Bilateral cytomegalovirus retinitis with unilateral optic neuritis in Good syndrome. |
| Q43495145 | Bilateral idiopathic optic neuritis in pregnancy |
| Q46723023 | Bilateral isolated acute optic neuritis in a child after acute rubella infection |
| Q38227427 | Bilateral monosymptomatic optic neuritis following Mycoplasma pneumoniae infection: a case report and literature review |
| Q51350732 | Bilateral occipital-lobe infarction simulating retrobulbar optic neuritis; report of case terminating fatally during use of corticotropin. |
| Q83321997 | Bilateral optic neuritis |
| Q52543497 | Bilateral optic neuritis after a bee sting. |
| Q81498600 | Bilateral optic neuritis after dengue viral infection |
| Q40356457 | Bilateral optic neuritis after dengue viral infection: case report |
| Q40870193 | Bilateral optic neuritis after ethmoiditis |
| Q33734040 | Bilateral optic neuritis after hepatitis A |
| Q85652809 | Bilateral optic neuritis after inactivated influenza vaccination |
| Q42239592 | Bilateral optic neuritis after treatment with chloramphenicol. A case and a survey |
| Q78646617 | Bilateral optic neuritis after virus pneumonia |
| Q44971515 | Bilateral optic neuritis and Guillain-Barré syndrome following an acute Mycoplasma pneumoniae infection |
| Q41010797 | Bilateral optic neuritis and encephalitis complicating typhoid fever |
| Q71245080 | Bilateral optic neuritis and occlusion of the superior mucular arteriole in a 24-year-old woman |
| Q92237500 | Bilateral optic neuritis as a complication of successive Flaviviridae virus infections |
| Q44089794 | Bilateral optic neuritis as first manifestation of systemic lupus erythematosus |
| Q79699959 | Bilateral optic neuritis as initial manifestation of neurosyphilis in a HIV-positive patient |
| Q54342590 | Bilateral optic neuritis associated with scrub typhus. |
| Q41904838 | Bilateral optic neuritis associated with the use of infliximab |
| Q42239203 | Bilateral optic neuritis caused by ethambutol in a patient with renal insufficiency |
| Q44839154 | Bilateral optic neuritis complicating rabies vaccination |
| Q42973391 | Bilateral optic neuritis due to isoniazid (INH). |
| Q38936600 | Bilateral optic neuritis due to malaria |
| Q42221174 | Bilateral optic neuritis evolved during tamoxifen treatment |
| Q43126302 | Bilateral optic neuritis following Mycoplasma pneumoniae infection |
| Q48613677 | Bilateral optic neuritis following bacille Calmette-Guérin (BCG) vaccination |
| Q39739237 | Bilateral optic neuritis following cataract extraction |
| Q38489887 | Bilateral optic neuritis following chicken pox; report of case with apparently complete recovery |
| Q73099952 | Bilateral optic neuritis following chloramphenicol therapy |
| Q42247328 | Bilateral optic neuritis following minoxidil administration |
| Q52463056 | Bilateral optic neuritis following multiple wasp stings. |
| Q73318392 | Bilateral optic neuritis following smallpox vaccination and diphtheria-tetanus toxoid |
| Q70588196 | Bilateral optic neuritis following snake bite--a case report |
| Q92157410 | Bilateral optic neuritis from acute HIV infection |
| Q42855426 | Bilateral optic neuritis in a 26-year-old man with common variable immunodeficiency: a case report |
| Q44358417 | Bilateral optic neuritis in a 9-year-old girl |
| Q95421882 | Bilateral optic neuritis in a boy - More than the eyes |
| Q77831374 | Bilateral optic neuritis in a child diagnosed with Gd-enhanced MR imaging using fat-suppression technique |
| Q45423619 | Bilateral optic neuritis in a child following Epstein-Barr virus infection. |
| Q43197496 | Bilateral optic neuritis in a patient with Behçet's disease who respond to therapeutic plasma exchange |
| Q50334260 | Bilateral optic neuritis in acute hepatitis C. |
| Q45751897 | Bilateral optic neuritis in acute human immunodeficiency virus infection |
| Q73140840 | Bilateral optic neuritis in ankylosing spondylitis |
| Q44414247 | Bilateral optic neuritis in childhood |
| Q45984963 | Bilateral optic neuritis in leprosy. |
| Q41358189 | Bilateral optic neuritis in occupational exposure to trichloroethylene |
| Q83149759 | Bilateral optic neuritis in pediatric systemic lupus erythematosus associated with antiphospholipid antibodies and neuromyelitis optica immunoglobulin |
| Q33392088 | Bilateral optic neuritis in pediatric systemic lupus erythematosus with antiphospholipid antibody syndrome |
| Q50998890 | Bilateral optic neuritis in pregnancy. |
| Q42238086 | Bilateral optic neuritis in the course of ethambutol treatment |
| Q36837702 | Bilateral optic neuritis originating in a single chiasmal lesion. A case report. |
| Q42360112 | Bilateral optic neuritis related to chronic inflammatory demyelinating polyneuropathy |
| Q73042777 | Bilateral optic neuritis simulating papilledema |
| Q43971140 | Bilateral optic neuritis with branch retinal artery occlusion associated with vaccination |
| Q38914513 | Bilateral optic neuritis with maculopathy: A rare manifestation of dengue fever |
| Q80299250 | Bilateral optic neuritis with partial internal ophthalmoplegia following administration of diphtheria toxoid, alum precipitated, refined |
| Q104577312 | Bilateral optic neuritis with spine demyelination associated with influenza A H1N1 infection |
| Q72555775 | Bilateral optic neuritis with sudden onset occurring in an atherosclerotic subject, a heavy smoker, poisoned by an monoamine oxidase inhibitor (MAOI) |
| Q52862987 | Bilateral optic neuritis: A new twist on immune reconstitution inflammatory syndrome. |
| Q81271398 | Bilateral panuveitis and optic neuritis following Bacillus Calmette-Guérin (BCG) vaccination |
| Q68777271 | Bilateral postinfectious optic neuritis and intravenous steroid therapy in children |
| Q81723447 | Bilateral retrobulbar optic neuritis as first signs of Lyme disease |
| Q43750348 | Bilateral retrobulbar optic neuritis with hepatitis B vaccination |
| Q83407433 | Bilateral retrobulbar optic neuritis, Guillain-Barré syndrome and asymptomatic central white matter lesions following adult measles infection |
| Q72696520 | Bilateral segmental edematous optic neuritis |
| Q43197622 | Bilateral sequential optic neuritis in Behçet's syndrome. |
| Q72783607 | Bilateral simultaneous optic neuritis in childhood systemic lupus erythematosus. A case report |
| Q69439367 | Bilateral syphilitic optic neuritis in a patient with a positive test for HIV. Case report |
| Q75819463 | Bilateral transverse optic neuritis; report of two cases with cortisone therapy |
| Q79748611 | Bilateral uraemic optic neuritis complicating acute nephrocalcinosis |
| Q98471076 | Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study |
| Q48266450 | Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice |
| Q86420712 | Blood plasma levels of microelements in patients with history of optic neuritis |
| Q91316501 | Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype |
| Q57912074 | Brain MRI follow-up of patients with persistent isolated optic neuritis |
| Q48161060 | Brain MRI lesions characteristic of neuromyelitis optica and positive anti-aquaporin 4-antibody may predict longitudinal extensive myelitis and optic neuritis in Sjögren's syndrome |
| Q34793304 | Brain Tissue Volumes and Perfusion Change with the Number of Optic Neuritis Attacks in Relapsing Neuromyelitis Optica: A Voxel-Based Correlation Study. |
| Q48238551 | Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group |
| Q72589056 | Brain stem encephalitis and optic neuritis in acquired toxoplasmosis |
| Q68207394 | C wave of electroretinogram and visual evoked response in optic neuritis due to demyelinating diseases |
| Q44689507 | C wave study in optic neuritis due to demyelinating disease |
| Q76820964 | CEREBROSPINAL FLUID ELECTROPHORETIGRAMS IN OPTIC NEURITIS |
| Q45166561 | CNS MR and CT findings associated with a clinical presentation of herpetic acute retinal necrosis and herpetic retrobulbar optic neuritis: five HIV-infected and one non-infected patients |
| Q76861949 | CONSIDERATIONS ON A CASE OF POST-MEASLES OPTIC NEURITIS ASSOCIATED WITH THE MARCUS GUNN PUPILLARY PHENOMENON |
| Q102386881 | COVID-19-Induced Acute Bilateral Optic Neuritis |
| Q79719088 | CRMP-5-IgG in patient with paraneoplastic optic neuritis with lung adenocarcinoma |
| Q72719887 | CSF Myelin Basic Protein Levels in Acute Optic Neuritis and Multiple Sclerosis |
| Q59811444 | CSF macrophage migration inhibitory factor levels did not predict steroid treatment response after optic neuritis in patients with multiple sclerosis |
| Q71351429 | CT findings in acute optic neuritis |
| Q36603573 | Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats |
| Q42425257 | Capreomycin-induced optic neuritis in a case of multidrug resistant pulmonary tuberculosis. |
| Q41832716 | Carotid artery thrombosis, encephalitis, myelitis and optic neuritis associated with rubella virus infections |
| Q33622178 | Carotid-ophthalmic artery aneurysm masquerading as optic neuritis |
| Q91328901 | Case for a new corticosteroid treatment trial in optic neuritis: review of updated evidence |
| Q68568704 | Case notes. Value of ACTH in nonspecific optic neuritis |
| Q42158926 | Case of Right Optic Neuritis caused by Suppuration in the Right Posterior Ethmoidal Cells and Sphenoidal Sinus. |
| Q40875519 | Case of acute double retro-bulbar optic neuritis hereditary in origin |
| Q44839145 | Case-centered Analysis of Optic Neuritis After Vaccines |
| Q38940839 | Celastrol Attenuates Multiple Sclerosis and Optic Neuritis in an Experimental Autoimmune Encephalomyelitis Model |
| Q72101267 | Cell-mediated immunity in acute idiopathic optic neuritis and multiple sclerosis |
| Q59798786 | Central Nervous System Involvement in Common Variable Immunodeficiency: A Case of Acute Unilateral Optic Neuritis in a 26-Year-Old Italian Patient |
| Q87127114 | Central adaptation after optic neuritis: is the whole greater than the sum of its parts? |
| Q68658314 | Central fiber contribution to W-shaped visual evoked potentials in patients with optic neuritis |
| Q33619513 | Central nervous system involvement in optic neuritis |
| Q91624171 | Cerebral venous thrombosis presenting with isolated vision loss misdiagnosed as optic neuritis |
| Q64108144 | Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study |
| Q70275143 | Cerebrospinal fluid findings in isolated optic neuritis |
| Q71041582 | Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial |
| Q86777868 | Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis |
| Q71841624 | Cerebrospinal fluid myelin basic protein-like material in acute monosymptomatic optic neuritis |
| Q85920984 | Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis |
| Q91208417 | Change in visual acuity and retinal structures following Repository Corticotropin Injection (RCI) therapy in patients with acute demyelinating optic neuritis: Improvement in low contrast visual acuity in both affected and contralateral eyes in a sin |
| Q35897848 | Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis |
| Q94172601 | Change of visual acuity and related factors in idiopathic optic neuritis |
| Q47865998 | Changes in oxygen saturation and the retinal nerve fibre layer in patients with optic neuritis - a pilot study. |
| Q94582637 | Changes in oxygen saturation and the retinal nerve fibre layer in patients with optic neuritis associated with multiple sclerosis in a 6-month follow-up |
| Q78111742 | Changes in the retinal veins in acute optic neuritis |
| Q41452273 | Changes of CXCL12, CXCL14 and PDGF levels in the brain of patients with idiopathic demyelinating optic neuritis and neuromyelitis optica |
| Q77377312 | Characterization of the mitochondrial genome in childhood multiple sclerosis. I. Optic neuritis and LHON mutations |
| Q74462568 | Characterization of the mitochondrial genome in childhood multiple sclerosis. II. Multiple sclerosis without optic neuritis and LHON-associated genes |
| Q74462569 | Characterization of the mitochondrial genome in childhood multiple sclerosis. III. Multiple sclerosis without optic neuritis and the non-LHON-associated genes |
| Q57704130 | Charcot–Marie–Tooth disease associated with recurrent optic neuritis |
| Q57025250 | Chemical shift selective magnetic resonance imaging of the optic nerve in patients with acute optic neuritis |
| Q46744614 | Chiasmal optic neuritis following mumps parotitis |
| Q73421878 | Chiasmal optic neuritis in Lyme disease |
| Q30565647 | Chiasmal optic neuritis in a 4-year-old girl: a case report and review of the literature. |
| Q52149902 | Chiasmal optic neuritis may be secondary to pneumococcal meningitis: a child with acute monocular vision loss. |
| Q92897440 | Chiasmitis Secondary to Neuromyelitis Optica 25 Years After Initial Optic Neuritis |
| Q81097218 | Childhood optic neuritis associated with premacular epiretinal membrane |
| Q48162750 | Childhood optic neuritis clinical features and outcome |
| Q46302231 | Childhood optic neuritis: the pediatric neurologist's perspective |
| Q87983909 | Chloramphenicol-induced acute bilateral optic neuritis in cystic fibrosis |
| Q88151657 | Chloride imbalance is involved in the pathogenesis of optic neuritis in neuromyelitis optica |
| Q99583128 | Choroidal changes in eyes treated with high-dose systemic corticosteroids for optic neuritis |
| Q50489893 | Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise. |
| Q50458216 | Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test. |
| Q90316270 | Chronic demyelination exacerbates neuroaxonal loss in patients with MS with unilateral optic neuritis |
| Q74310510 | Chronic inflammatory demyelinating polyradiculoneuropathy with histologically proven optic neuritis |
| Q102071936 | Chronobiotic effect of melatonin in experimental optic neuritis |
| Q54062688 | Classification of optic neuritis |
| Q91480447 | Clinical Characteristics and Treatment of MOG-IgG-Associated Optic Neuritis |
| Q91939275 | Clinical Characteristics of Anti-aquaporin 4 Antibody Positive Optic Neuritis in Japan |
| Q102142232 | Clinical Characteristics of HIV-Associated Optic Neuritis |
| Q88736726 | Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study |
| Q58780353 | Clinical Characteristics, Treatment Outcomes and Predictive Factors in Optic Neuritis |
| Q90361348 | Clinical Features and Outcomes of Pediatric Monophasic and Recurrent Idiopathic Optic Neuritis |
| Q37306713 | Clinical Features and Visual Outcomes of Optic Neuritis in Chinese Children |
| Q53074045 | Clinical Features of Toxocara-Seropositive Optic Neuritis in Korea. |
| Q47094035 | Clinical Profile and Outcomes of Optic Neuritis in an HIV Prevalent Urban Community in South Africa |
| Q46660009 | Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma |
| Q84329608 | Clinical analysis of the etiology of optic neuritis in patients at different ages in china |
| Q68177877 | Clinical and magnetic resonance imaging in optic neuritis |
| Q50855897 | Clinical and pathological features of acute optic neuritis in Chinese patients. |
| Q90017113 | Clinical and radiologic approach to 'typical' versus antibody-related optic neuritis |
| Q35018442 | Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis |
| Q47749660 | Clinical characteristics and long-term visual outcome of optic neuritis in neuromyelitis optica spectrum disorder: A comparison between Thai and American-Caucasian cohorts |
| Q92574204 | Clinical characteristics and outcomes of myelin oligodendrocyte glycoprotein antibody-seropositive optic neuritis in varying age groups: A cohort study in China |
| Q90520676 | Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China |
| Q80321758 | Clinical characteristics of Japanese children with optic neuritis |
| Q51739584 | Clinical characteristics of multiple sclerosis and associated optic neuritis in Korean children. |
| Q47987707 | Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China |
| Q39177030 | Clinical characteristics of optic neuritis in Hong Kong population: 10-year review |
| Q34236538 | Clinical characteristics of optic neuritis in Koreans greater than 50 years of age. |
| Q35542701 | Clinical characteristics of optic neuritis in Taiwanese children |
| Q45848951 | Clinical characteristics of optic neuritis in Taiwanese children. |
| Q83796793 | Clinical characteristics, therapeutic outcomes of isolated atypical optic neuritis in China |
| Q45263495 | Clinical course of optic neuritis in patients with relapsing neuromyelitis optica |
| Q50996606 | Clinical features and outcome of childhood optic neuritis at Queen Sirikit National Institute of Child Health. |
| Q48177700 | Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients. |
| Q40402099 | Clinical features of neurosyphilis with optic neuritis as an initial finding |
| Q71008008 | Clinical features of optic neuritis standard examination techniques |
| Q91338290 | Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis |
| Q72219397 | Clinical picture of a bilateral retrobulbar optic neuritis due to overdosage of digitalis |
| Q31034879 | Clinical practice. Optic neuritis |
| Q102074666 | Clinical predictive factors for diagnosis of MOG-IgG and AQP4-IgG related paediatric optic neuritis: a Chinese cohort study |
| Q89416451 | Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein |
| Q38028499 | Clinical profile and aetiology of optic neuritis in Hospital Universiti Sains Malaysia--5 years review. |
| Q33660893 | Clinical profile and neuroimaging in pediatric optic neuritis in Indian population: A case series |
| Q30436444 | Clinical profile and short-term outcomes of optic neuritis patients in India |
| Q35761837 | Clinical profile of simultaneous bilateral optic neuritis in adults |
| Q37121567 | Clinical update on optic neuritis and multiple sclerosis. |
| Q90161952 | Clinical, imaging and follow-up study of optic neuritis associated with myelin oligodendrocyte glycoprotein antibody: a multicentre study of 62 adult patients |
| Q73929329 | Clinically definite multiple sclerosis following optic neuritis |
| Q71211134 | Clinically pupillary signs in optic neuritis |
| Q73934680 | Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children |
| Q80514261 | Clinics in diagnostic imaging (120). Right rhinogenic optic neuritis secondary to mucocoele of the Onodi cell |
| Q58585578 | Color Doppler imaging evaluation of blood flow parameters in ophthalmic and posterior ciliary arteries and optic nerve diameter in chronic optic neuritis in multiple sclerosis patients |
| Q45183914 | Color Doppler imaging in optic neuritis with multiple sclerosis |
| Q91784956 | Color perception impairment following optic neuritis and its association with retinal atrophy |
| Q67827546 | Color vision and visually evoked response (VECP) in the recovery period of optic neuritis |
| Q46848268 | Color vision defect type and spatial vision in the optic neuritis treatment trial. |
| Q86093348 | Color-code agreement among stratus, cirrus, and spectralis optical coherence tomography in relapsing-remitting multiple sclerosis with and without prior optic neuritis |
| Q81615933 | Colour Doppler imaging evaluation of blood flow parameters in the ophthalmic artery in acute and chronic phases of optic neuritis in multiple sclerosis |
| Q90993117 | Combined Left Central Retinal Artery Occlusion and Bilateral Anterior Ischemic Optic Neuritis: A Rare Presentation of Giant Cell Arteritis |
| Q92224882 | Combined central and peripheral demyelination with tumefactive demyelinating lesions in the brainstem and longitudinally extensive optic neuritis: a case report |
| Q85640264 | Comment on multiphasic disseminated encephalomyelitis followed by optic neuritis in a child with gluten sensitivity |
| Q83623341 | Comment on: Optic neuritis in Singapore |
| Q64075130 | Commentary: Ganglion cell complex of retinal layer thickness by optical coherence tomography in cases of multiple sclerosis without optic neuritis compared to healthy eyes |
| Q48215253 | Comments on "Neuroplasticity predicts outcome of optic neuritis independent of tissue damage". |
| Q87328856 | Comments on "first-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis" |
| Q37084100 | Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis |
| Q74319341 | Comparative studies on pattern VECP between patients with ischemic optic neuropathy and optic neuritis |
| Q58121108 | Comparing myelin oligodendrocyte glycoprotein antibody (MOG-Ab) and non MOG-Ab associated optic neuritis: Clinical course and treatment outcome |
| Q91818858 | Comparison between optic neuritis associated with antibody against myelin oligodendrocyte glycoprotein and presumed idiopathic optic perineuritis |
| Q72754145 | Comparison between the flicker test procedures of Aulhorn and of Dölle in the diagnosis of optic neuritis |
| Q87642309 | Comparison of 3D double inversion recovery and 2D STIR FLAIR MR sequences for the imaging of optic neuritis: pilot study |
| Q70214137 | Comparison of automated perimetry and pattern visually evoked cortical potentials in optic neuritis |
| Q41704522 | Comparison of central and peripheral visual field properties in the optic neuritis treatment trial |
| Q80822382 | Comparison of pupil responses to luminance and colour in severe optic neuritis |
| Q47097135 | Comparison of spontaneous brain activity revealed by regional homogeneity in AQP4-IgG neuromyelitis optica-optic neuritis versus MOG-IgG optic neuritis patients: a resting-state functional MRI study |
| Q68825986 | Comparison of the Aulhorn flicker test with visual evoked potentials in the diagnosis of optic neuritis |
| Q37563132 | Comprehensive review of ocular angiostrongyliasis with special reference to optic neuritis. |
| Q72584188 | Computerized tomography of the orbits in optic neuritis |
| Q69550936 | Concurrence of myasthenia gravis and optic neuritis |
| Q48099765 | Concurrent intramedullary spinal cord and multiple intracranial tuberculomas with tuberculous optic neuritis: A rare case report |
| Q42645369 | Concurrent macular oedema and optic neuritis in Crohn's disease with varied response to steroids |
| Q67729189 | Considerations on a case of optic neuritis |
| Q74586143 | Continuing optic nerve atrophy following optic neuritis: a serial MRI study |
| Q71025480 | Contrast sensitivity and other vision tests in the optic neuritis treatment trial |
| Q68544507 | Contrast sensitivity in multiple sclerosis. A study in 35 patients with and without optic neuritis |
| Q33643627 | Contrast sensitivity measurements in acute and resolved optic neuritis |
| Q39280763 | Contrast vision and optic neuritis: neural blurring |
| Q48651352 | Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. |
| Q54677154 | Contribution to the differential diagnosis of isolated visual field defects under special consideration of optic neuritis (author's transl) |
| Q69420649 | Contributions of magnetic resonance imaging to the diagnosis of MS in isolated optic neuritis |
| Q36145471 | Controversies in optic neuritis pain diagnosis. |
| Q97636061 | Conversion of Optic Neuritis to Relapsing Remitting Multiple Sclerosis: A Retrospective Comorbidity Cohort Study |
| Q92239885 | Corneal Refractive Surgery in Patients with History of Optic Neuritis |
| Q78111748 | Coronaviruses in spinal fluid of patients with acute monosymptomatic optic neuritis |
| Q42580850 | Correction to Imidazol-1-ylethylindazole Voltage-Gated Sodium Channel Ligands Are Neuroprotective during Optic Neuritis in a Mouse Model of Multiple Sclerosis. |
| Q90806036 | Correction to: Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis |
| Q28709442 | Correction: Optic Nerve Magnetisation Transfer Ratio after Acute Optic Neuritis Predicts Axonal and Visual Outcomes |
| Q94015788 | Correction: Optic Neuritis Is Associated with Inner Nuclear Layer Thickening and Microcystic Macular Edema Independently of Multiple Sclerosis |
| Q80751883 | Correlation between full-field and multifocal VEPs in optic neuritis |
| Q35563013 | Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer’s disease |
| Q71347478 | Correlation between the ERG the EOG and the electrical excitability, especially in acute optic neuritis |
| Q91771122 | Correlation of Peripapillary Retinal Nerve Fibre Layer Thickness and Visual Evoked Potential in Optic Neuritis in a Tertiary Eye Care Centre |
| Q70713240 | Correlation of visual evoked potentials, ophthalmological and neurological findings after unilateral optic neuritis |
| Q41523649 | Cortical blindness and not optic neuritis as a cause of vision loss in a Sjögren's syndrome (SS) patient with the neuromyelitis optica spectrum disorder (NMOSD): Challenges of ascribing demyelinating syndromes to SS: a case report |
| Q89982826 | Cortical topological network changes following optic neuritis |
| Q67739186 | Corticosteroid Treatment of Acute Optic Neuritis |
| Q71578682 | Corticosteroid therapy for the treatment of optic neuritis |
| Q49128487 | Corticosteroid therapy in optic neuritis (optic neuropathy). |
| Q67489767 | Corticosteroid treatment of optic neuritis: a need to change treatment practices. The Optic Neuritis Study Group |
| Q70603778 | Corticosteroids and optic neuritis |
| Q93879151 | Corticosteroids and optic neuritis |
| Q93880060 | Corticosteroids and optic neuritis |
| Q35475456 | Corticosteroids do not prevent optic nerve atrophy following optic neuritis |
| Q24187865 | Corticosteroids for treating optic neuritis |
| Q24200239 | Corticosteroids for treating optic neuritis |
| Q24246536 | Corticosteroids for treating optic neuritis |
| Q68175797 | Corticosteroids in the treatment of optic neuritis |
| Q72319821 | Corticosteroids, optic neuritis, and multiple sclerosis |
| Q41577995 | Cosaldon retard in the treatment of optic neuritis and macular degeneration |
| Q77397643 | Costimulatory molecules B7-1 and B7-2 on CSF cells in multiple sclerosis and optic neuritis |
| Q58744324 | Craniectomy for Double Optic Neuritis with Microcephaly |
| Q91681672 | Critical Role of Monocyte Recruitment in Optic Nerve Damage Induced by Experimental Optic Neuritis |
| Q72581172 | Critical flicker frequency in acute and recovered optic neuritis |
| Q92959437 | Critical review: Typical and atypical optic neuritis |
| Q74481448 | Cross-scotomas in optic neuritis |
| Q102136403 | Current Recommendations on Optic Neuritis |
| Q72925122 | Current aspects of optic neuritis of the alcoholic |
| Q39538559 | Current concepts of the pathogenesis of optic neuritis associated with multiple sclerosis |
| Q39365315 | Cutaneous larva migrans, sacroileitis, and optic neuritis caused by an unidentified organism acquired in Thailand |
| Q77729932 | Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: an open trial |
| Q86857246 | Cytokines and soluble IL-4 in patients with acute optic neuritis and multiple sclerosis |
| Q33575984 | Cytomegalovirus optic neuritis |
| Q44409623 | Cytomegalovirus optic neuritis: characteristics, therapy and survival |
| Q45942371 | Cytomegalovirus retinitis and optic neuritis in a child with severe combined immunodeficiency syndrome. |
| Q44228143 | Cytomegalovirus retinitis and optic neuritis in acquired immune deficiency syndrome. Report of a case |
| Q79436437 | Data vs conclusions in the optic neuritis vaccination investigation |
| Q100417100 | Deaf and Mute Patient Developing Recurrent Idiopathic Bilateral Optic Neuritis: A Case for Early Treatment With Plasmapheresis? |
| Q41633811 | Decreased visual acuity without optic neuritis: an unusual presentation of SLE |
| Q69407343 | Deficits in visual function after resolution of optic neuritis |
| Q80174522 | Delayed and pseudodelayed visual evoked potentials in optic neuritis compared with long time echo-short tau inversion recovery magnetic resonance imaging of optic nerve |
| Q69051455 | Delayed pattern-evoked responses in optic neuritis in relation to visual acuity |
| Q47612724 | Demographic pattern and clinical characteristics of optic neuritis in a tertiary eye care centre |
| Q92983257 | Demyelinating Optic Neuritis and its Subtypes |
| Q37073183 | Demyelinating optic neuritis in children |
| Q48792532 | Demyelinating optic neuritis presenting as a clinically isolated syndrome. |
| Q37779346 | Demyelinating optic neuritis: clinical features and differential diagnosis. |
| Q83742338 | Demyelination affects temporal aspects of perception: an optic neuritis study |
| Q71182559 | Demyelination in optic neuritis and its effects on the visual evoked potential |
| Q70733217 | Design, methods, and conduct of the Optic Neuritis Treatment Trial |
| Q51384709 | Detection of Thyroid Abnormalities in Aquaporin-4 Antibody-Seropositive Optic Neuritis Patients. |
| Q46710171 | Detection of autoantibodies against NMDA-type glutamate receptor in a patient with recurrent optic neuritis and transient cerebral lesions |
| Q62601707 | Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence |
| Q70562269 | Detection of optic nerve lesions in optic neuritis using frequency-selective fat-saturation sequences |
| Q69883361 | Detection of optic nerve lesions in optic neuritis with magnetic resonance imaging |
| Q47660882 | Devic's disease before Devic: Bilateral optic neuritis and simultaneous myelitis in a young woman (1874). |
| Q92577571 | Dexras1 Deletion and Iron Chelation Promote Neuroprotection in Experimental Optic Neuritis |
| Q66855299 | Diagnosis and management of optic neuritis |
| Q47693137 | Diagnostic accuracy of optical coherence tomography inter-eye percentage difference for optic neuritis in multiple sclerosis. |
| Q84192056 | Diagnostic and therapeutic challenges: panuveitis and optic neuritis |
| Q90967816 | Diagnostic implications of MOG/AQP4 antibodies in recurrent optic neuritis |
| Q55465927 | Diagnostic pitfall: optic neuritis mimicking optic nerve glioma. |
| Q82344444 | Diagnostic pitfalls: posterior ischemic optic neuropathy mimicking optic neuritis |
| Q33551861 | Diagnostic validity of optic disc and retinal nerve fiber layer evaluations in detecting structural changes after optic neuritis |
| Q74549487 | Diameter of the optic nerve in idiopathic optic neuritis and in anterior ischemic optic neuropathy |
| Q36155011 | Dichoptic Metacontrast Masking Functions to Infer Transmission Delay in Optic Neuritis |
| Q97588579 | Differences in Clinical Features of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in White and Asian Race |
| Q58788487 | Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis |
| Q98391026 | Differences in morphology and visual function of myelin oligodendrocyte glycoprotein antibody and multiple sclerosis associated optic neuritis |
| Q46083745 | Differences in pupillary light reflex between optic neuritis and ischemic optic neuropathy. |
| Q64095345 | Different Characteristics of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Seropositive Male Optic Neuritis in China |
| Q97537631 | Different alteration patterns of sub-macular choroidal thicknesses in aquaporin-4 immunoglobulin G antibodies sero-positive neuromyelitis optica spectrum diseases and isolated optic neuritis |
| Q47984702 | Different etiologies and prognoses of optic neuritis in demyelinating diseases |
| Q57183013 | Differential Diagnosis for Multiple Sclerosis-related Optic Neuritis |
| Q42243032 | Differential diagnoses to MS: experiences from an optic neuritis clinic. |
| Q71211145 | Differential diagnosis of optic neuritis |
| Q78629313 | Differential diagnosis of optic neuritis |
| Q44626480 | Differential diagnosis of optic neuritis and congested optic disk |
| Q44165887 | Differential diagnosis of optic neuritis in a patient with ankylosing spondylitis |
| Q88772023 | Differentiating Neuromyelitis Optica-Related and Multiple Sclerosis-Related Acute Optic Neuritis Using Conventional Magnetic Resonance Imaging Combined With Readout-Segmented Echo-Planar Diffusion-Weighted Imaging |
| Q59605128 | Differentiating Vogt-Koyanagi-Harada syndrome from recurrent optic neuritis: a case report and review of the literature concerning Hispanic patients |
| Q58397530 | Differentiation Between Recently Resolved Optic Neuritis and Central Serous Retinopathy |
| Q30778741 | Diffusion fMRI detects white-matter dysfunction in mice with acute optic neuritis |
| Q37289547 | Diffusion tensor imaging of occult injury of optic radiation following optic neuritis in multiple sclerosis |
| Q88126380 | Diffusion-Weighted Imaging and Post-contrast Enhancement in Differentiating Optic Neuritis and Non-arteritic Anterior Optic Neuropathy |
| Q91232428 | Diffusion-weighted imaging hyperintensity and low apparent diffusion coefficient of the optic nerve in myelin oligodendrocyte glycoprotein-IgG optic neuritis |
| Q73809330 | Diffusion-weighted imaging of the human optic nerve: a new approach to evaluate optic neuritis in multiple sclerosis |
| Q80304209 | Digitoxin intoxication resulting in retrobulbar optic neuritis |
| Q90115095 | Dimethyl fumarate mitigates optic neuritis |
| Q36324055 | Directional diffusivity changes in the optic nerve and optic radiation in optic neuritis |
| Q37168634 | Disability in optic neuritis correlates with diffusion tensor-derived directional diffusivities |
| Q41524593 | Discoid spot of the central region of the retina in optic neuritis and atrophy (a preliminary report) |
| Q41613510 | Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin |
| Q46537360 | Disruption of the blood-brain barrier in experimental optic neuritis: immunocytochemical co-localization of H2O2 and extravasated serum albumin. |
| Q48491625 | Dissecting structure-function interactions in acute optic neuritis to investigate neuroplasticity. |
| Q33621909 | Disseminated lesions at presentation in patients with optic neuritis |
| Q68495448 | Disseminated sclerosis in optic neuritis |
| Q47795266 | Distinct clinical characteristics of atypical optic neuritis with seronegative aquaporin-4 antibody among Chinese patients |
| Q70587983 | Distinct patterns of spatial frequency response by normal, recovered optic neuritis, and normal fellow eyes to a new linearly variable neutral density device |
| Q53075425 | Distinguishing ischaemic optic neuropathy from optic neuritis by ganglion cell analysis. |
| Q86641582 | Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: a novel magnetic resonance imaging scoring system |
| Q71740369 | Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity |
| Q36399096 | Disturbed spontaneous brain-activity pattern in patients with optic neuritis using amplitude of low-frequency fluctuation: a functional magnetic resonance imaging study |
| Q58763064 | Do eyes with and without optic neuritis in multiple sclerosis age equally? |
| Q86016439 | Do patients with non-arteritic ischemic optic neuritis have increased risk for cardiovascular and cerebrovascular events? |
| Q92745735 | Does CETP rs5882, rs708272, SIRT1 rs12778366, FGFR2 rs2981582, STAT3 rs744166, VEGFA rs833068, IL6 rs1800795 polymorphisms play a role in optic neuritis development? |
| Q28339158 | Does a correlation exist between Myambutol dosage and occurrence of optic neuritis |
| Q66987935 | Does diabetic axial optic neuritis exist? Apropos of a case |
| Q36181836 | Double Optic Neuritis (Choked Discs), with Changes in the Maculae, in a Case of Cerebral Tumour |
| Q85147323 | Double Optic Neuritis (Choked Discs), with Changes in the Maculæ, in a Case of Cerebral Tumour |
| Q41022223 | Double Optic Neuritis and Ophthalmoplegia from Lead Poisoning; Complicated by Typhoid Fever |
| Q58783481 | Double Optic Neuritis in Enteric Fever |
| Q48561153 | Doyne memorial lecture (1969). Retrobulbar and optic neuritis in childhood and adolescence. |
| Q66838450 | Drug induced optic neuritis |
| Q82799996 | Drug-induced optic neuritis and uveitis secondary to bisphosphonates |
| Q73792888 | Dry cough and optic neuritis: two rare complications of interferon alpha treatment in chronic viral hepatitis |
| Q34211912 | Dynamic visual tests to identify and quantify visual damage and repair following demyelination in optic neuritis patients |
| Q60461877 | Dynamics of retinal injury after acute optic neuritis |
| Q67906621 | Dysgammaglobulinemia in steroid-dependent optic neuritis: response to gammaglobulin treatment |
| Q84909607 | EMPYEMA OF THE LEFT SPHENOIDAL SINUS WITH OPTIC NEURITIS AND SUBSEQUENT POST-PAPILLITIC ATROPHY |
| Q89432510 | Early Diagnosis of Recurrent Optic Neuritis Using Contrast-Enhanced T2 Fluid-attenuated Inversion Recovery Imaging: a Case Report |
| Q48340179 | Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis |
| Q40004080 | Early MRI in optic neuritis: the risk for disability |
| Q81221611 | Early anisotropy changes in the corpus callosum of patients with optic neuritis |
| Q34118375 | Early diagnosis, monitoring, and treatment of optic neuritis |
| Q83099852 | Early factors associated with axonal loss after optic neuritis |
| Q92435366 | Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritis |
| Q90191802 | Early neuroaxonal injury is seen in the acute phase of pediatric optic neuritis |
| Q48466897 | Early observations on optic neuritis and Uhthoff's sign. |
| Q36659524 | Early onset optic neuritis following measles-rubella vaccination |
| Q60815722 | Early pericalcarine atrophy in acute optic neuritis is associated with conversion to multiple sclerosis |
| Q79443212 | Early relapse in multiple sclerosis-associated optic neuritis following the use of interferon beta-1a in Chinese patients |
| Q48003574 | Echovirus type 4 as a probable cause of meningitis associated with bilateral optic neuritis: a case report |
| Q66955303 | Editorial: Aetiology of optic neuritis |
| Q69742993 | Editorial: Implications of optic neuritis |
| Q69121277 | Editorial: Optic neuritis and multiple sclerosis |
| Q48506415 | Editorial: Optic neuritis of obscure origin. |
| Q87972565 | Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical Trial |
| Q34205854 | Effect of diphenylhydantoin in ischemic optic neuritis |
| Q45926046 | Effect of geranylgeranylacetone on optic neuritis in experimental autoimmune encephalomyelitis. |
| Q33814175 | Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients. |
| Q90647830 | Effect of phenytoin on retinal ganglion cells in acute isolated optic neuritis |
| Q91980057 | Effects of Optic Neuritis, T2 Lesions, and Microstructural Diffusion Integrity in the Visual Pathway on Cortical Thickness in Pediatric-Onset Multiple Sclerosis |
| Q101053099 | Effects of Retinal Transcription Regulation After GB20 Needling Treatment in Retina With Optic Neuritis |
| Q36321846 | Effects of albendazole combined with TSII-A (a Chinese herb compound) on optic neuritis caused by Angiostrongylus cantonensis in BALB/c mice |
| Q33346346 | Effects of high-dose prednisolone on optic nerve head blood flow in patients with acute optic neuritis |
| Q77568513 | Effects of i.v. methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis |
| Q74093734 | Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis |
| Q35745304 | Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial. |
| Q36127706 | Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial |
| Q73073688 | Ehrlichiosis optic neuritis |
| Q67234694 | Electrophysiological and immunological studies in optic neuritis |
| Q81358074 | Electrophysiological evidence for heterogeneity of lesions in optic neuritis |
| Q71781929 | Electrophysiological tests and CSF examination in patients with optic neuritis |
| Q82262897 | Electroretinogram findings in unilateral optic neuritis |
| Q62065027 | Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis |
| Q36511714 | Elevation of AQP4 and selective cytokines in experimental autoimmune encephalitis mice provides some potential biomarkers in optic neuritis and demyelinating diseases |
| Q48405575 | Eleven episodes of recurrent optic neuritis of the same eye for 22 years eventually diagnosed as neuromyelitis optica spectrum disorder |
| Q64059466 | Empowering Mesenchymal Stem Cells for Ocular Degenerative Disorders |
| Q59238425 | Encephalitis followed by optic neuritis: A case report and review of literature |
| Q38172508 | Encephalitis followed by optic neuritis: a case report and review of literature |
| Q43067194 | Enhancing Brain Lesions during Acute Optic Neuritis and/or Longitudinally Extensive Transverse Myelitis May Portend a Higher Relapse Rate in Neuromyelitis Optica Spectrum Disorders |
| Q79566832 | Enlargement of optic nerve resembling orbital mass in case of optic neuritis |
| Q86252661 | Epidemiologic and Clinical Characteristics of Optic Neuritis in China |
| Q92730826 | Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan |
| Q43314231 | Epidemiologic and clinical features of optic neuritis in the 20th and 21st sanitary districts of the Sardinia (Italy). |
| Q72283663 | Epidemiological Survey of Optic Neuritis in Italy in the Years from 1958 to 1962 |
| Q81102305 | Epidemiology of monosymptomatic optic neuritis in Rijeka County, Croatia: meteorological aspects |
| Q91537596 | Epidemiology of pediatric multiple sclerosis, neuromyelitis optica, and optic neuritis in Taiwan |
| Q71887992 | Epiretinal membrane: an unusual complication of childhood optic neuritis |
| Q40212463 | Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice |
| Q45386269 | Epstein-Barr virus-related optic neuritis as a precursor to the development of posttransplant lymphoproliferative disease |
| Q88271295 | Erratum to: Plasma exchange response in 34 patients with severe optic neuritis |
| Q39578504 | Erythrocyte unsaturated fatty acid test (E-UFA test): A biological test to detect optic neuritis as initial feature of multiple sclerosis |
| Q90979576 | Erythropoietin for Optic Neuritis |
| Q50954049 | Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event. |
| Q33644874 | Estimation of visual function after optic neuritis: a comparison of clinical tests |
| Q66968844 | Estimation of work capacity in subjects with optic neuritis and its sequelae |
| Q42235994 | Ethambutol induced severe optic neuritis |
| Q85034512 | Ethambutol-induced optic neuritis and multiple sclerosis: is there an association? |
| Q35852480 | Ethambutol-induced optic neuritis in patients with end stage renal disease on hemodialysis: two case reports and literature review |
| Q48862573 | Etiological profile of presumptive optic neuritis in China. |
| Q100639874 | Etiologies of Acute Optic Neuritis in Thailand: An Observational Study of 171 Patients |
| Q48182524 | Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients. |
| Q80298593 | Etiology and treatment of optic neuritis |
| Q91709518 | Evaluating the Utility of a Postprocessing Algorithm for MRI Evaluation of Optic Neuritis |
| Q36327952 | Evaluation of Retinal Nerve Fiber Layer and Ganglion Cell Complex in Patients with Optic Neuritis or Neuromyelitis Optica Spectrum Disorders Using Optical Coherence Tomography in a Chinese Cohort |
| Q48225567 | Evaluation of central nervous system involvement in uncomplicated optic neuritis after prolonged follow-up |
| Q37369148 | Evaluation of changes in retinal nerve fiber layer thickness and visual functions in cases of optic neuritis and multiple sclerosis |
| Q37670349 | Evaluation of contrast sensitivity measurements after retrobulbar optic neuritis in Multiple Sclerosis. |
| Q57584766 | Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases |
| Q57584769 | Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases |
| Q38809091 | Evaluation of optic neuritis following human papillomavirus vaccination |
| Q101040156 | Evaluation of retinal nerve fiber layer thickness and optic nerve functions in fellow eye of neuromyelitis optica with unilateral optic neuritis |
| Q51360570 | Evaluation of retinal nerve fibre layer thickness and visual evoked potentials in optic neuritis associated with multiple sclerosis. |
| Q28344773 | Evaluation of the management of optic neuritis: audit on the neurological and ophthalmological practice in the north west of England |
| Q73072708 | Evidence favoring the involvement of CC chemokine receptor (CCR) 5 in T-lymphocyte accumulation in optic neuritis |
| Q66982140 | Evolution and prognosis of retrobulbar optic neuritis as the initial symptom of multiple sclerosis |
| Q67999049 | Evolution of visual evoked potentials in optic neuritis |
| Q36161619 | Evolving management of optic neuritis and multiple sclerosis |
| Q67353625 | Examination of the fundus oculi in the acute phase of Leber's hereditary optic neuritis |
| Q101225787 | Expanding the phenotype of MOG antibody-associated disease (MOGAD): half a century of epilepsy and relapsing optic neuritis |
| Q45026772 | Experience of the optic neuritis treatment trial |
| Q70447745 | Experimental Hartmannella optic neuritis and uveitis |
| Q39314552 | Experimental allergic optic neuritis (EAON) in the rabbit. A new model to study primary demyelinating diseases |
| Q46984897 | Experimental allergic optic neuritis in guinea pigs: preliminary report |
| Q37539041 | Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G. |
| Q36845899 | Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus. |
| Q50217423 | Experimental optic neuritis induced by the microinjection of lipopolysaccharide into the optic nerve. |
| Q76894562 | FLUORIDE AND OPTIC NEURITIS |
| Q101153871 | Facial Nerve Involvement Accompanying Optic Neuritis Secondary to Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder |
| Q103824037 | Factors Associated with Changes in Retinal Layers Following Acute Optic Neuritis: A Longitudinal Study Using Optical Coherence Tomography |
| Q33961774 | Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis |
| Q39159405 | Factors likely to affect the development of multiple sclerosis in patients presenting with optic neuritis in a tropical and subtropical area |
| Q100294898 | Failure of painful eye movements to respond to topical anesthetics supports the diagnosis of optic neuritis |
| Q40124944 | Familial Mediterranean fever associated with optic neuritis, successfully treated with anti-interleukin 1 agents. |
| Q66930855 | Favorable effect of procaine administration in retrobulbar optic neuritis |
| Q28330838 | Favorable outcome, under treatment, of retrobulbar optic neuritis attributed to ethambutol |
| Q48289958 | Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial |
| Q48585927 | Fellow eye changes in optic neuritis correlate with the risk of multiple sclerosis. |
| Q90003258 | Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial |
| Q89859782 | First Clinical Experience with Anti-myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis |
| Q51164142 | First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis. |
| Q90748353 | Focal Thickness Reduction of the Ganglion Cell-Inner Plexiform Layer Best Discriminates Prior Optic Neuritis in Patients With Multiple Sclerosis |
| Q48444455 | Focal demyelinative damage and neighboring white matter integrity: an optic neuritis study. |
| Q35209875 | Focal macular photopic negative response in patients with optic neuritis |
| Q78933444 | Follow-up on patients with a history of optic neuritis |
| Q72749374 | Four cases of optic neuritis favorably treated with an intraspinal administration of dexamethasone (decadron) solution |
| Q45911899 | Fractal analysis of fluoroangiographic patterns in anterior ischaemic optic neuropathy and optic neuritis: a pilot study. |
| Q93209632 | Frequency and immunophenotype of IL10-producing regulatory B cells in optic neuritis |
| Q74150862 | Frequency doubling perimetry in resolved optic neuritis |
| Q33783819 | Frequency of autoantibodies and connective tissue diseases in Chinese patients with optic neuritis |
| Q52200805 | Functional coupling between the central-autonomic and the cognitive systems is enhanced in states after optic neuritis and early multiple sclerosis. |
| Q95518920 | Functional magnetic resonace imaging in patients with optic neuritis |
| Q48482359 | Functional magnetic resonance imaging of the cortical response to photic stimulation in humans following optic neuritis recovery. |
| Q66968125 | Functional prognosis of acute optic neuritis in relation to the general treatment used |
| Q90785821 | Functional-structural assessment of the optic pathways in patients with optic neuritis |
| Q57297134 | Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis |
| Q92781993 | Gadolinium leakage in ocular structures in optic neuritis |
| Q68791915 | Gadolinium-DTPA-enhanced magnetic resonance imaging in experimental optic neuritis |
| Q101120143 | Gadolinium-Enhanced 3D T1-Weighted Black-Blood MR Imaging for the Detection of Acute Optic Neuritis |
| Q71086116 | Genetic counseling in Leber's hereditary optic neuritis |
| Q94581141 | Glioblastoma multiforme mimicking optic neuritis |
| Q33782066 | Global visual field involvement in acute unilateral optic neuritis |
| Q30659123 | Glucocorticosteroid therapy in optic neuritis and multiple sclerosis. Evidence from clinical studies and practical recommendations |
| Q100760144 | Granulomatosis with polyangiitis complicated with refractory optic neuritis and maxillary osteomyelitis |
| Q48310690 | Guillain-Barré syndrome (GBS) with bilateral optic neuritis and central white matter disease |
| Q77427551 | Guillain-Barré syndrome and optic neuritis after Mycoplasma pneumoniae infection |
| Q50076609 | Guillain-Barré syndrome and optic neuritis after Mycoplasma pneumoniae infection. |
| Q34596403 | Guillain-Barré syndrome with optic neuritis and a focal lesion in the central white matter following Epstein-Barr virus infection |
| Q81343977 | Guillain-Barré syndrome with optic neuritis and cytomegalovirus infection |
| Q52646311 | Gypenosides attenuate lipopolysaccharide-induced optic neuritis in rats. |
| Q87443015 | Gypenosides might have neuroprotective and immunomodulatory effects on optic neuritis |
| Q34166691 | HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis |
| Q66936611 | HL-A antigens in optic neuritis (author's transl) |
| Q94570054 | Herpes Simplex Virus 2 Meningoencephalitis-Associated Bilateral Optic Neuritis and Radiculitis |
| Q91246721 | Herpes viruses in optic neuritis: Similar to Bell's palsy |
| Q84230179 | Herpes zoster optic neuritis |
| Q45850323 | Herpes zoster optic neuritis in human immunodeficiency virus infection |
| Q44352556 | Herpetic optic neuritis associated with herpetic keratitis |
| Q93194244 | High association of MOG-IgG antibodies in children with bilateral optic neuritis |
| Q47295551 | High resolution retinal scanning reveals regional structural differences between MS and NMOSD optic neuritis regardless of antibody status |
| Q37110838 | High sensitivity of diffusion tensor imaging in discriminating idiopathic demyelinating optic neuritis |
| Q43693130 | High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial |
| Q72718707 | High-dose corticosteroid regimen retards development of multiple sclerosis in optic neuritis treatment trial |
| Q67941013 | High-pass resolution perimetry in optic neuritis |
| Q96635051 | Highly sensitive quantification of optic neuritis intrathecal biomarker CXCL13 |
| Q37097154 | Historical Issues of Optic neuritis and Sensory Disorder in Persian Traditional Medicine |
| Q37019990 | Historical perspective and future prospective for retinal nerve fiber loss in optic neuritis and multiple sclerosis |
| Q70809904 | History and aetiology of Leber's optic neuritis |
| Q48160697 | Human herpesvirus 6-associated retrobulbar optic neuritis in an HIV-infected patient: response to anti-herpesvirus therapy and long-term outcome |
| Q28244834 | Human herpesvirus 6-associated uveitis with optic neuritis diagnosed by multiplex PCR |
| Q40558451 | Human herpesvirus 7-associated meningitis and optic neuritis in a patient after allogeneic stem cell transplantation |
| Q79148714 | Human herpesvirus-6B active infection associated with relapsing bilateral anterior optic neuritis |
| Q45196681 | Human vision with a lesion of the parvocellular pathway: an optic neuritis model for selective contrast sensitivity deficits with severe loss of midget ganglion cell function |
| Q35412184 | Hyperacute corticosteroid treatment of optic neuritis at the onset of pain may prevent visual loss: a case series |
| Q37980152 | Hyperbaric oxygen therapy and optic neuritis: case report and literature review |
| Q93262675 | Hyponatremia Associated with Prophylactic Low-Dose Trimethoprim during Systemic Corticosteroid Therapy for AQP4-Positive Optic Neuritis in a Diabetic Patient |
| Q85021544 | Hypopituitarism, Dystrophia Adiposo-genitalis, Polyuria and Polydipsia; Bilateral Cortico-spinal Interference; Optic Neuritis and Ptosis on Left Side; No Changes in Sella Turcica; Positive Wassermann Reaction in Serum |
| Q42846319 | INFECTION OF SPHENOIDAL SINUSES WITH SECONDARY AFFECTION OF THE EYES : Causing in one detachment of the retinae in both eyes, and in the other acute optic neuritis of one eye |
| Q78311489 | INTRAOCULAR OPTIC NEURITIS WITH NORMAL VISUAL ACUITY |
| Q87433953 | Ibuprofen-induced unilateral optic neuritis |
| Q52639762 | Identification and treatment of the visual processing asymmetry in MS patients with optic neuritis: The Pulfrich phenomenon. |
| Q91138963 | Identifying optic neuritis and transverse myelitis using administrative data |
| Q91308657 | Idiopathic Bilateral Optic Neuritis |
| Q70878827 | Idiopathic Optic Neuritis of Childhood |
| Q86876052 | Idiopathic optic perineuritis: disguised as recurrent optic neuritis |
| Q68200435 | Image interpretation session. Viral optic neuritis |
| Q75230754 | Images in clinical medicine. Optic neuritis due to Bartonella henselae infection |
| Q33259704 | Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis |
| Q80101748 | Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia |
| Q33568213 | Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis. |
| Q74357462 | Immune-mediated optic neuritis after unrelated allogeneic bone marrow transplantation |
| Q67516200 | Immunogenetics of multiple sclerosis and optic neuritis: DNA polymorphism of HLA class II genes |
| Q64382846 | Immunoglobulins and measles antibodies in optic neuritis |
| Q79917924 | Immunohistochemical evidence of inducible nitric oxide synthase and nitrotyrosine in a case of clinically isolated optic neuritis |
| Q73968722 | Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis |
| Q69614360 | Immunological studies on patients with optic neuritis without evidence of multiple sclerosis |
| Q36281303 | Impact of the anti-aquaporin-4 autoantibody on inner retinal structure, function and structure-function associations in Japanese patients with optic neuritis |
| Q74215907 | Impaired VEP after photostress response in multiple sclerosis patients previously affected by optic neuritis |
| Q67973687 | Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis |
| Q64904314 | Improvement in conduction velocity after optic neuritis measured with the multifocal VEP. |
| Q101130734 | In Reply to Vitiello et al.: Acute Optic Neuritis Diagnosed by Bedside Ultrasound in an Emergency Department: Follow-Up and Clarification |
| Q91054307 | Incidence and Causes of Overdiagnosis of Optic Neuritis: Physician Insecurity |
| Q91054288 | Incidence and Causes of Overdiagnosis of Optic Neuritis: Physician Insecurity-Reply |
| Q90440940 | Incidence and Mimickers of Acute Idiopathic Optic Neuritis: Analysis of 291 Consecutive Patients from Southern Finland |
| Q90905287 | Incidence and timing of recurrence of optic neuritis |
| Q91211419 | Incidence of optic neuritis in Korean children and adolescents: A Nationwide survey and National Registry Analysis |
| Q39473089 | Incidence of optic neuritis in Stockholm, Sweden 1990-1995: I. Age, sex, birth and ethnic-group related patterns |
| Q50650766 | Incidence of optic neuritis in Stockholm, Sweden, 1990-1995: II. Time and space patterns. |
| Q73341523 | Increase of manganese superoxide dismutase, but not of Cu/Zn-SOD, in experimental optic neuritis |
| Q90469591 | Increased Levels of Endothelin-1 in Cerebrospinal Fluid Are a Marker of Poor Visual Recovery after Optic Neuritis in Multiple Sclerosis Patients |
| Q48481151 | Increased calpain expression in experimental demyelinating optic neuritis: an immunocytochemical study. |
| Q43233583 | Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin |
| Q71674891 | Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis |
| Q62129166 | Independent patterns of damage to retinocortical pathways in multiple sclerosis without a previous episode of optic neuritis |
| Q31160004 | Inflammatory Optic Neuritis: From Multiple Sclerosis to Neuromyelitis Optica |
| Q91342007 | Inflammatory optic neuropathy in granulomatosis with polyangiitis can mimick isolated idiopathic optic neuritis |
| Q104608037 | Infliximab-induced optic neuritis |
| Q80547891 | Infliximab-induced retrobulbar optic neuritis |
| Q46367825 | Influence of HLA on progression of optic neuritis to multiple sclerosis: results of a four-year follow-up study |
| Q90868338 | Initial Impairment and Recovery of Vision-Related Functioning in Participants With Acute Optic Neuritis From the RENEW Trial of Opicinumab |
| Q87120372 | Initiation of anti-TNF therapy and the risk of optic neuritis: from the Safety Assessment of Biologic ThERapy (SABER) Study |
| Q34081364 | Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study |
| Q73191328 | Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS |
| Q41735010 | Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group |
| Q48762317 | Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis. |
| Q70441792 | Interferon-alpha and interferon-gamma production capacity of idiopathic isolated optic neuritis patients |
| Q57267898 | Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis |
| Q101233734 | Interocular Difference in Retinal Nerve Fiber Layer Thickness Predicts Optic Neuritis in Pediatric-Onset Multiple Sclerosis |
| Q44147228 | Interpretation of RNFLT values in multiple sclerosis-associated acute optic neuritis using high-resolution SD-OCT device |
| Q58764662 | Intracranial Inoculation Is More Potent Than Intranasal Inoculation for Inducing Optic Neuritis in the Mouse Hepatitis Virus-Induced Model of Multiple Sclerosis |
| Q86780330 | Intractable vomiting antecedent to optic neuritis: an early clinical clue to neuromyelitis optica |
| Q80158240 | Intravenous immunoglobin treatment in acute optic neuritis |
| Q81160056 | Intravenous immunoglobulin and interferon: successful treatment of optic neuritis in pediatric multiple sclerosis |
| Q41028513 | Intravenous treatment of optic neuritis; comparison of corticotropin and typhoid bacilli. |
| Q73087370 | Intravenous use of corticotropin in optic neuritis |
| Q37581931 | In vivo detection of experimental optic neuritis by pupillometry |
| Q36425142 | Ipsilateral uveitis and optic neuritis in multiple sclerosis |
| Q48099880 | Irreversible optic neuritis after infliximab treatment in a patient with ulcerative colitis |
| Q72780366 | Is optic neuritis in alcoholics caused by formic acid? |
| Q49116493 | Is optic neuritis more benign than other first attacks in multiple sclerosis? |
| Q36143086 | Is the frequency of abnormalities on magnetic resonance imaging in isolated optic neuritis related to the prevalence of multiple sclerosis? A global comparison |
| Q45970017 | Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012. |
| Q73534616 | Ischemic optic neuritis in Churg-Strauss syndrome |
| Q26764774 | Isolated CNS Blast Crises in Chronic Myeloid Leukaemia Presenting as Hypertrophic Pachymeningitis and Bilateral Optic Neuritis: A Case Report |
| Q100393339 | Isolated Optic Neuritis after Pembrolizumab Administration for Non-Small-Cell Lung Carcinoma |
| Q80337267 | Isolated bilateral anterior optic neuritis following chickenpox in an immunocompetent adult |
| Q79327994 | Isolated bilateral optic neuritis in acute disseminated encephalomyelitis |
| Q53249251 | Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up. |
| Q48897984 | Isolated optic neuritis and its prognosis for multiple sclerosis: a clinical and paraclinical study with evoked potentials. CSF examination and brain MRI. |
| Q39189155 | Isolated optic neuritis associated with Mycoplasma pneumoniae infection: report of two cases and literature review |
| Q40243161 | Isolated optic neuritis from an identified Gnathostoma spinigerum. |
| Q84123202 | Isolated optic neuritis secondary to presumed tuberculosis in an immunocompetent child |
| Q57024818 | Isolated optic neuritis with a concurrent abnormal trigeminal nucleus on imaging: case report of a rare complication of herpes zoster ophthalmicus |
| Q41964168 | Isolated palatal weakness without optic neuritis as the presenting manifestation of multiple sclerosis and its diagnostic dilemma with acute disseminated encephalomyelitis in a young boy. |
| Q71911262 | Isolated unilateral optic neuritis revealing a voluminous chromophobic adenoma of the hypophysis |
| Q34580597 | Isolation & characterization of Bartonella sp. from optic neuritis patients. |
| Q74566034 | Isoniazid as a cause of optic neuritis and atrophy |
| Q50670120 | Ivermectin and onchocercal optic neuritis: short-term effects. |
| Q84976547 | Juvenile xanthogranuloma with bilateral optic neuritis |
| Q37722566 | LEBER'S HEREDITARY OPTIC NEURITIS THROUGH SIX GENERATIONS-A STERILIZATION PROBLEM. |
| Q76551587 | LYMPHOMATOUS OPTIC NEURITIS |
| Q30790629 | Lack of restriction of T cell receptor beta variable gene usage in cerebrospinal fluid lymphocytes in acute optic neuritis |
| Q48207843 | Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient with AML. |
| Q67312964 | Later course and prognosis of optic neuritis |
| Q53787643 | Leber's hereditary optic neuritis |
| Q95313842 | Leber's hereditary optic neuropathy following unilateral painful optic neuritis: a case report |
| Q45323348 | Leber's hereditary optic neuropathy masquerading as optic neuritis with spontaneous visual recovery |
| Q90641113 | Leber's hereditary optic neuropathy misdiagnosed as optic neuritis and Lyme disease in a patient with multiple sclerosis |
| Q93651395 | Leber's optic neuritis |
| Q66838135 | Leber's optic neuritis and visual evoked potentials (apropos of a study method) |
| Q58911442 | Leber′s Hereditary Optic Neuropathy (LHON)-Related Mitochondrial DNA Sequence Changes in Italian Patients Presenting with Sporadic Bilateral Optic Neuritis |
| Q70771935 | Left rhinogenic retrobular optic neuritis caused by right sphenoid sinusitis |
| Q35815017 | Lesion Activity on Brain MRI in a Chinese Population with Unilateral Optic Neuritis |
| Q62601727 | Lesion discrimination in optic neuritis using high-resolution fat-suppressed fast spin-echo MRI |
| Q71340843 | Lesion discrimination in optic neuritis using high-resolution fat-suppressed fast spin-echo MRI |
| Q39859856 | Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica. |
| Q67313801 | Letter: Aetiology of optic neuritis |
| Q47833490 | Letter: Measles-associated optic neuritis in man and canine distemper |
| Q42235190 | Letter: Optic neuritis caused by ethambutol |
| Q71443682 | Long echo time STIR sequence MRI of optic nerves in optic neuritis |
| Q71352357 | Long time echo STIR sequence magnetic resonance imaging of optic nerves in optic neuritis |
| Q71845775 | Long time echo stir sequence magnetic resonance imaging of optic nerves in optic neuritis |
| Q74100081 | Long- and short-term variability of automated perimetry results in patients with optic neuritis and healthy subjects |
| Q80847142 | Long-term brain magnetic resonance imaging changes after optic neuritis in patients without clinically definite multiple sclerosis |
| Q48088205 | Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests |
| Q73093754 | Long-term recovery and fellow eye deterioration after optic neuritis, determined by serial visual evoked potentials |
| Q48975018 | Long-term remyelination after optic neuritis: A 2-year visual evoked potential and psychophysical serial study. |
| Q41484449 | Long-term structural retinal changes in patients with optic neuritis related to multiple sclerosis |
| Q45873386 | Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy |
| Q37439937 | Longitudinal Changes in Retinal Nerve Fibre Layer Thickness after an Isolated Unilateral Retrobulbar Optic Neuritis: 1-Year Results |
| Q83741528 | Longitudinal extensive transverse myelitis and optic neuritis: the elements for the diagnosis of neuromyelitis optica |
| Q40097426 | Longitudinally Extensive Transverse Myelitis and Optic Neuropathy Associated with Syphilitic Meningomyelitis and Human Immunodeficiency Virus Infection: A Case Report and Review of the Literature |
| Q28647496 | Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis |
| Q50644701 | Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder. |
| Q46429691 | Longitudinally extensive optic neuritis in pediatric patients |
| Q37548624 | Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis |
| Q68742140 | Loss of P retinal ganglion cell function in resolved optic neuritis |
| Q104795561 | Low Contrast Visual Acuity Might Help to Detect Previous Optic Neuritis |
| Q51811187 | Low conversion rate to multiple sclerosis in idiopathic optic neuritis patients in Taiwan. |
| Q67997478 | Lupus optic neuritis with negative serology |
| Q79214975 | Lyme disease and optic neuritis: Long-term follow-up of seropositive patients |
| Q73106825 | Lyme disease and optic neuritis: long-term follow-up of seropositive patients |
| Q70989269 | Lymphocyte populations in the cerebrospinal fluid and peripheral blood of patients with multiple sclerosis and optic neuritis |
| Q71400635 | Lymphocyte proliferation response to S antigen in patients with uveitis and optic neuritis |
| Q72079648 | Lymphocyte subpopulations in peripheral blood and cerebrospinal fluid from patients with acute optic neuritis |
| Q67944522 | Lymphocytes subclasses and function in patients with optic neuritis in childhood with special reference to multiple sclerosis |
| Q84630225 | Lymphocytic hypophysitis in a patient presenting with sequential episodes of optic neuritis |
| Q64896344 | MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study. |
| Q85950155 | MMP-2 -1575G/A polymorphism modifies the onset of optic neuritis as a first presenting symptom in MS? |
| Q90444210 | MOG Antibody-Associated Disease with Recurrent Optic Neuritis and Multiple Cranial Neuropathies: A Rare Clinical Phenotype |
| Q47588480 | MOG antibody-associated optic neuritis in the setting of acute CMV infection |
| Q104140052 | MOG antibody-related disease with recurrent optic neuritis and sensory polyradiculoneuropathy: A case report |
| Q100737727 | MOG expressing teratoma followed by MOG-IgG-positive optic neuritis |
| Q90465441 | MOG-Ab prevalence in optic neuritis and clinical predictive factors for diagnosis |
| Q47373538 | MOG-IgG associated optic neuritis is not multiple sclerosis. |
| Q37383474 | MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients |
| Q104064926 | MOG-IgG- versus AQP4-IgG-Positive Optic Neuritis in Thailand: Clinical Characteristics and Long-Term Visual Outcomes Comparison |
| Q55221002 | MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder. |
| Q95943703 | MOG-associated optic neuritis masquerading as NAION in an elderly woman: a case report |
| Q37470690 | MONOCULAR OPTIC NEURITIS |
| Q33519664 | MR fat suppression combined with Gd-DTPA enhancement in optic neuritis and perineuritis |
| Q70273963 | MR imaging of optic neuritis using short T1 IR (inversion recovery) |
| Q104741342 | MRI Characteristics of NMO, MOG and MS Related Optic Neuritis |
| Q92950032 | MRI Histogram Texture Feature Analysis of the Optic Nerve in the Patients with Optic Neuritis |
| Q57744782 | MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study: Table 1 |
| Q69625621 | MRI in optic neuritis |
| Q92763617 | MRI of acute optic neuritis (ON) at the first episode: Can we predict the visual outcome and the development of multiple sclerosis (MS)? |
| Q40105560 | MRI of optic neuritis in a rat model. |
| Q33935794 | MRI texture heterogeneity in the optic nerve predicts visual recovery after acute optic neuritis |
| Q44102316 | MRI, VEP, SEP and biothesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis |
| Q35033339 | Macrophage-mediated optic neuritis induced by retrograde axonal transport of spike gene recombinant mouse hepatitis virus |
| Q64075118 | Macular ganglion cell complex parameters by optical coherence tomography in cases of multiple sclerosis without optic neuritis compared to healthy eyes |
| Q40374100 | Macular tuberculoma and optic neuritis: rare association with tuberculosis meningoencephalitis |
| Q48678510 | Magnetic resonance imaging at 3.0 tesla detects more lesions in acute optic neuritis than at 1.5 tesla. |
| Q68070579 | Magnetic resonance imaging in a case of mumps postinfectious encephalitis with asymptomatic optic neuritis |
| Q48438247 | Magnetic resonance imaging in acute optic neuritis in Singapore. |
| Q28173943 | Magnetic resonance imaging in optic neuritis due to giant cell arteritis |
| Q46949853 | Magnetic resonance imaging of optic neuritis in a patient with systemic lupus erythematosus |
| Q48485234 | Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis. |
| Q57025205 | Magnetic resonance imaging of the brain in patients with acute monosymptomatic optic neuritis |
| Q83455317 | Magnetisation transfer ratio in optic neuritis is associated with axonal loss, but not with demyelination |
| Q33734692 | Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: correlation with clinical findings and electrophysiology |
| Q59137326 | Malignant optic glioma masked by suspected optic neuritis and central retinal vein occlusion |
| Q74640154 | Malignant otitis externa with optic neuritis |
| Q34389308 | Management of acute optic neuritis: a survey of neurologists and ophthalmologists in Australia and New Zealand |
| Q46649757 | Management of isolated optic neuritis in France: survey of neurologists and ophthalmologists |
| Q35049583 | Management of optic neuritis |
| Q66844461 | Management of optic neuritis |
| Q46313093 | Management of optic neuritis and impact of clinical trials: an international survey |
| Q34457683 | Management of optic neuritis and multiple sclerosis |
| Q30570743 | Management of optic neuritis as a clinically first event of multiple sclerosis |
| Q34369920 | Management of optic neuritis in Canada: survey of ophthalmologists and neurologists. |
| Q52564349 | Management of optic neuritis in Ireland: a survey comparing the management practices of acute demyelinating optic neuritis amongst ophthalmologists and neurologists in Ireland. |
| Q46439229 | Management of optic neuritis in a developing African country. |
| Q104102212 | Markedly Elevated Serum Level of T-Helper Cell 17-Related Cytokines/Chemokines in Acute Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis |
| Q41814429 | Masquerading optic neuritis |
| Q50320858 | Measles-virus-specific IgG in optic neuritis and in multiple sclerosis after optic neuritis |
| Q43146627 | Measurement of retinal nerve fiber layer thickness in optic atrophy eyes of patients with optic neuritis using optical coherence tomography. |
| Q36318083 | Measurement of the retinal nerve fibre layer with scanning laser polarimetry in patients with previous demyelinating optic neuritis |
| Q73706668 | Mega dose intravenous methylprednisolone in bilateral simultaneous optic neuritis |
| Q67939642 | Megadose corticosteroids for optic neuritis |
| Q39089092 | Melatonin As A Therapeutic Resource For Inflammatory Visual Diseases |
| Q82980533 | Memantine for axonal loss of optic neuritis |
| Q40217189 | Meningoencephalitis-like onset of post-infectious AQP4-IgG-positive optic neuritis complicated by GM1-IgG-positive acute polyneuropathy. |
| Q89970333 | Metastatic Squamous Cell Lung Carcinoma to the Optic Nerve Sheath Mimicking Retrobulbar Optic Neuritis |
| Q102204289 | Microcytic abnormalities of the inner retina in a patient with myelin oligodendrocyte glycoprotein (MOG) antibody-associated optic neuritis |
| Q80844191 | Microfluorimetry defines early axonal damage in a rat model of optic neuritis: a novel method targeting early CNS autoimmunity |
| Q95940567 | Middle-aged Woman With Optic Neuritis and a Rapidly Progressing Retinal Vaso-occlusive Disease |
| Q73266471 | Miller fisher syndrome and optic neuritis: case report |
| Q42726961 | Mistaken diagnosis of optic neuritis and the possible role of phosphodiasterase-5 inhibitors (Sildenafil/Viagra). |
| Q33820029 | Mitochondrial Uncoupler Prodrug of 2,4-Dinitrophenol, MP201, Prevents Neuronal Damage and Preserves Vision in Experimental Optic Neuritis |
| Q81348416 | Mitochondrial changes in leukocytes of patients with optic neuritis |
| Q87629462 | Mitochondrial heat shock protein 70: new target for optic neuritis therapy |
| Q91818544 | Models and treatments for traumatic optic neuropathy and demyelinating optic neuritis |
| Q40028235 | Monocular Optic Neuritis, ? Neoplasm |
| Q57484886 | More than meets the eye: Point-of-care ultrasound diagnosis of acute optic neuritis in the emergency department |
| Q100518354 | Morphological Outer Retina Findings in Multiple Sclerosis Patients With or Without Optic Neuritis |
| Q70959959 | Motion-onset VEPs improve the diagnostics of multiple sclerosis and optic neuritis |
| Q34486982 | Movement phosphenes in optic neuritis: a new clinical sign |
| Q77788468 | Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG) |
| Q79771435 | Multicentric malignant glioma of adulthood masquerading as optic neuritis |
| Q30847634 | Multifocal VEP and OCT in optic neuritis: a topographical study of the structure-function relationship |
| Q86201188 | Multifocal VEP assessment of optic neuritis evolution |
| Q80152244 | Multifocal objective perimetry compared with Humphrey full-threshold perimetry in patients with optic neuritis |
| Q33771464 | Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy |
| Q39322562 | Multifocal visual evoked potentials in optic neuritis and multiple sclerosis: A review |
| Q93167965 | Multimodal imaging of secondary vitreoretinal lymphoma with optic neuritis and retinal vasculitis |
| Q74376397 | Multimodality visual evoked potentials in evaluating visual dysfunction in optic neuritis |
| Q85640262 | Multiphasic disseminated encephalomyelitis followed by optic neuritis in a child with gluten sensitivity |
| Q97517564 | Multiple sclerosis and neuromyelitis optica after optic neuritis: A nationwide cohort study in Taiwan |
| Q66701827 | Multiple sclerosis and optic neuritis |
| Q74446414 | Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid |
| Q33630193 | Multiple sclerosis following optic neuritis in Chile |
| Q45402826 | Multiple sclerosis in Tunisia. Clinical study |
| Q81441832 | Multiple sclerosis in childhood: presenting as bilateral optic neuritis |
| Q94669393 | Multiple sclerosis in ophthalmology: beyond optic neuritis |
| Q24650224 | Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up |
| Q69599373 | Myasthenia gravis and recurrent retrobulbar optic neuritis: an unusual combination of diseases |
| Q35260260 | Mycobacterium W administration for steroid resistant optic neuritis with long-term follow-up |
| Q89933263 | Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis Presenting as Idiopathic Orbital Inflammatory Syndrome |
| Q90585567 | Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome |
| Q96833388 | Myelin Oligodendrocyte Glycoprotein antibody-associated optic neuritis and myelitis in COVID-19 |
| Q68984450 | Myelin basic protein in the CSF of patients with multiple sclerosis, optic neuritis and various neurological diseases |
| Q99402125 | Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in Canada |
| Q90137495 | Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis mimicking pseudotumor cerebri: A case report |
| Q98775956 | Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis with considerable white blood cell elevation in cerebrospinal fluid |
| Q57024215 | Myelin oligodendrocyte glycoprotein-IgG-associated optic neuritis |
| Q89228123 | Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation |
| Q51327401 | Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. |
| Q36794719 | Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice |
| Q80907956 | Myelin/oligodendrocyte glycoprotein-specific T-cells induce severe optic neuritis in the C57BL/6 mouse |
| Q40642207 | Myelitis and optic neuritis caused by varicella |
| Q34023923 | Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis |
| Q34525476 | Myeloradiculitis with meningoencephalopathy and optic neuritis in a case of previous Chlamydia psittaci infection |
| Q81087691 | NMO antibody-positive recurrent optic neuritis without clear evidence of transverse myelitis |
| Q93331462 | Native ancestry is associated with optic neuritis and age of onset in hispanics with multiple sclerosis |
| Q85040547 | Neither retinal nor brain atrophy can be shown in patients with isolated unilateral optic neuritis at the time of presentation |
| Q71410546 | Nematode Optic Neuritis |
| Q33734757 | Nerve fiber layer and macular thinning measured with different imaging methods during the course of acute optic neuritis |
| Q37323492 | Neural network differentiation of optic neuritis and anterior ischaemic optic neuropathy |
| Q104792361 | Neuro-ophthalmologic manifestations of multiple sclerosis other than acute optic neuritis |
| Q100566728 | Neurofilament Results for the Phase II Neuroprotection Study of Phenytoin in Optic Neuritis |
| Q80557441 | Neurologic impairment 10 years after optic neuritis |
| Q30883922 | Neurological outcome and predictive factors of idiopathic optic neuritis in China |
| Q88689067 | Neuromyelitis Optica: Review and Utility of Testing Aquaporin-4 Antibody in Typical Optic Neuritis |
| Q45307861 | Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland |
| Q30649660 | Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography. |
| Q48831792 | Neuromyelitis optica and the Optic Neuritis Treatment Trial. |
| Q51528757 | Neuromyelitis optica antibodies in patients with severe optic neuritis in China. |
| Q82281620 | Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis |
| Q85179667 | Neuromyelitis optica-IgG+ optic neuritis associated with celiac disease and dysgammaglobulinemia: a role for tacrolimus? |
| Q69007804 | Neurophysiological and CSF immunological study of 19 patients affected by acute idiopatic optic neuritis |
| Q83073016 | Neuroplasticity predicts outcome of optic neuritis independent of tissue damage |
| Q48291974 | Neuroplasticity predicts outcome of optic neuritis independent of tissue damage. |
| Q39993334 | Neuroprotective effect of melatonin in experimental optic neuritis in rats |
| Q36362210 | Neurosyphilis with optic neuritis: an update |
| Q72798499 | Neurotropic viral infection and optic neuritis (Considerations on diagnosis and treatment) |
| Q90256629 | New actors in optic neuritis pathogenesis: An Editorial for "Influence of retinal NMDA receptor activity during autoimmune optic neuritis" on https://doi.org/10.1111/jnc.14980 |
| Q33702072 | New developments in the treatment of optic neuritis |
| Q36815400 | New directions in optic neuritis and multiple sclerosis |
| Q74145292 | New therapeutic perspectives for demyelinating retrobulbar optic neuritis |
| Q27015013 | New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C |
| Q79917920 | Nitric oxide in optic neuritis and multiple sclerosis |
| Q80929460 | No evidence for MSRV viraemia and glial cell death in acute optic neuritis |
| Q38627593 | No evidence of association between optic neuritis and secondary LHON mtDNA mutations in patients with multiple sclerosis |
| Q72605541 | Nonspecific stimulation therapy of optic neuritis |
| Q93180798 | Normal Visual Recovery after Optic Neuritis Despite Significant Loss of Retinal Ganglion Cells in Patients with Multiple Sclerosis |
| Q73157696 | Normal-appearing white matter in optic neuritis and multiple sclerosis: a comparative proton spectroscopy study |
| Q73370091 | Normalisation of visual evoked potentials after optic neuritis |
| Q93119404 | Note on a Case of Unilateral Acute Retrobulbar Optic Neuritis |
| Q83366827 | Notes on the use of HBO2 with optic neuritis |
| Q71871225 | Nursing care study: bilateral optic neuritis |
| Q72321159 | Nutritional tropical optic neuritis in West Africa |
| Q77070578 | OCCURRENCE OF OPTIC NEURITIS IN THE COURSE OF UNRECOGNIZED DISSEMINATED LUPUS ERYTHEMATOSUS. IMPORTANCE OF FAMILIAL INQUIRY |
| Q76727104 | ON A CASE OF OPTIC NEURITIS |
| Q76801160 | ON EARLY TREATMENT OF ACUTE RETROBULBAR OPTIC NEURITIS WITH STEROID HORMONES |
| Q84872078 | ON INTRACRANIAL THROMBOSIS AS THE CAUSE OF DOUBLE OPTIC NEURITIS IN CASES OF CHLOROSIS |
| Q84887609 | ON MUCOCELE OF THE NASAL SINUSES, AND ITS COMPLICATION BY OPTIC NEURITIS |
| Q30872401 | OPTIC NEURITIS ACCORDING TO DATA OF THE OPHTHALMOLOGIC CLINIC OF THE SCHOOL OF POSTGRADUATE MEDICAL EDUCATION IN 1954-1962 |
| Q77075751 | OPTIC NEURITIS AND MACULAR EDEMA AFTER CATARACT SURGERY |
| Q76733828 | OPTIC NEURITIS AND MACULAR EDEMA FOLLOWING CATARACT EXTRACTION |
| Q84887532 | OPTIC NEURITIS AND SUPPURATIVE OTITIS: A Further Investigation into the Frequency and Significance of Optic Neuritis and other Vascular Changes in the Retinae of Patients suffering from Purulent Disease of the Middle Ear |
| Q49451952 | OPTIC NEURITIS FOLLOWING SPHENOIDAL SINUSITIS LOCATED BY THE DIFFERENTIAL EXPLORATORY TEST |
| Q94269711 | OPTIC NEURITIS IN CHLOROSIS |
| Q76861642 | OPTIC NEURITIS IN CYSTIC FIBROSIS OF THE PANCREAS. ROLE OF CHLORAMPHENICOL THERAPY |
| Q37326467 | OPTIC NEURITIS IN MEASLES |
| Q37417115 | OPTIC NEURITIS IN SECOND EYE FOLLOWING PERFORATING WOUND AND EXCISION. |
| Q84907112 | OPTIC NEURITIS OF SPHENOIDAL SINUS ORIGIN: OPERATION: CURE |
| Q39730679 | OPTIC NEURITIS, PAPILLITIS, AND NEURONAL RETINOPATHY |
| Q36218541 | Occurrence of Asymptomatic Acute Neuromyelitis Optica Spectrum Disorder-Typical Brain Lesions during an Attack of Optic Neuritis or Myelitis |
| Q68681408 | Occurrence of MRI abnormalities in patients with isolated optic neuritis |
| Q40844041 | Occurrence of Optic Neuritis and Cervical Cord Schwannoma with Charcot-Marie-Tooth Type 4B1 Disease |
| Q78583033 | Ocular changes in pheochromocytoma, with a note on its mimicry of optic neuritis |
| Q90099922 | Odd O in NMO: isolated Horner syndrome without optic neuritis in a patient with neuromyelitis optica |
| Q83923115 | Oligoclonal band and multiple sclerosis risk in monosymptomatic optic neuritis patients: a retrospective study of 84 patients |
| Q37821146 | Oligoclonal bands predict multiple sclerosis after optic neuritis: a literature survey |
| Q55491731 | On the differential diagnosis of bilateral retrobular optic neuritis (author's transl) |
| Q100394311 | Ophthalmic manifestations of myelin oligodendrocyte glycoprotein-IgG-associated disorder other than optic neuritis: a systematic review |
| Q72541351 | Ophthalmology quiz #11. Arteritic ischemic optic neuritis |
| Q34021618 | Ophthalmology update for primary practitioners. Part I. Update on optic neuritis |
| Q36406023 | Ophthaproblem. Optic neuritis |
| Q36557936 | Optic Nerve Sheath Meningioma Masquerading as Optic Neuritis |
| Q93137158 | Optic Neuritis (Retrobulbar and Papillary) |
| Q104740516 | Optic Neuritis Associated With Tumor Necrosis Factor-Alpha Inhibitor Certolizumab |
| Q37118403 | Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease |
| Q33681462 | Optic Neuritis Associated with Adalimumab in the Treatment of Uveitis |
| Q53360559 | Optic Neuritis Associated with Myelodysplastic Syndrome Accompanied by Eosinophilic Crisis. |
| Q42727167 | Optic Neuritis Caused by Rathke's Cleft Cyst in Young Adult |
| Q62029316 | Optic Neuritis Diagnosed by Bedside Emergency Physician−Performed Ultrasound: A Case Report |
| Q94161507 | Optic Neuritis Due to Lead Poisoning |
| Q102133549 | Optic Neuritis During Lactation: A Case Series |
| Q91115823 | Optic Neuritis Possibly Induced by Anti-PD-L1 Antibody Treatment in a Patient with Non-Small Cell Lung Carcinoma |
| Q89656083 | Optic Neuritis Related to Atezolizumab Treatment in a Patient With Metastatic Non-Small-Cell Lung Cancer |
| Q91267024 | Optic Neuritis Related to Atezolizumab Treatment in a Patient With Metastatic Non-Small-Cell Lung Cancer |
| Q40010301 | Optic Neuritis and Chloramphenicol |
| Q59023696 | Optic Neuritis and Encephalomyelitis in Monkey produced with Human Optic Nerve |
| Q47121956 | Optic Neuritis and its Differential Diagnosis |
| Q48376558 | Optic Neuritis and the Visual Pathway: Evaluation of Neuromyelitis Optica Spectrum by Resting-State fMRI and Diffusion Tensor MRI. |
| Q93180761 | Optic Neuritis as First Manifestation of Bing-Neel Syndrome |
| Q35144169 | Optic Neuritis as a Complication of Carcinoma of the Breast |
| Q92246138 | Optic Neuritis as an Isolated Presentation of Kikuchi–Fujimoto Disease in a Pediatric Patient |
| Q40740000 | Optic Neuritis from Syphilitic Leptomeningitis |
| Q78791987 | Optic Neuritis in Children |
| Q55113725 | Optic Neuritis in Children: A Clinical Note. |
| Q58742284 | Optic Neuritis in Chlorosis |
| Q94113996 | Optic Neuritis in Chlorosis |
| Q94169005 | Optic Neuritis in Chlorosis |
| Q89906524 | Optic Neuritis in Guillain-Barre Syndrome |
| Q41578859 | Optic Neuritis in Korean Children: Low Risk of Subsequent Multiple Sclerosis |
| Q58787733 | Optic Neuritis in Typhoid Fever |
| Q42383228 | Optic Neuritis in a Patient with Bickerstaff's Brainstem Encephalitis |
| Q48154578 | Optic Neuritis in the Older Chinese Population: A 5-Year Follow-Up Study. |
| Q94285039 | Optic Neuritis in the Prognosis of Tumours of the Brain |
| Q41185168 | Optic Neuritis with Symmetrical Loss of the Lower Portion of the Field associated with Diabetes. |
| Q41680875 | Optic Neuritis, (?) due to X-rays. |
| Q36370956 | Optic Neuritis, A New Variant of Experimental Encephalomyelitis, A Durable Model for All Seasons, Now In Its Seventieth Year |
| Q69438727 | Optic Neuritis, Symptomology and Medical Management |
| Q49336386 | Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases. |
| Q90358406 | Optic Neuritis: A Rare Paraneoplastic Phenomenon of Hodgkin's Lymphoma |
| Q34550729 | Optic Neuritis: Another Dickensian Diagnosis |
| Q73403742 | Optic Neuritis: Clinical Analysis of 27 Cases |
| Q40243816 | Optic Neuritis: The Role of Disease-modifying Therapy in This Clinically Isolated Syndrome |
| Q64229406 | Optic Neuropathy with Features Suggestive of Optic Neuritis in Cerebrotendinous Xanthomatosis |
| Q46626397 | Optic disc cupping after optic neuritis evaluated with optic coherence tomography |
| Q46918956 | Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy |
| Q46217431 | Optic nerve demyelination induced by human serum: patients with multiple sclerosis or optic neuritis and normal subjects |
| Q83223064 | Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis |
| Q35080681 | Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes |
| Q70240128 | Optic nerve enlargement in acute optic neuritis |
| Q55471242 | Optic nerve glioma and optic neuritis mimicking one another: case report. |
| Q33206490 | Optic nerve head circulation in nonarteritic anterior ischemic optic neuropathy and optic neuritis |
| Q30583486 | Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomes. |
| Q61861950 | Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis |
| Q48588586 | Optic neuritis after Klebsiella pneumonitis and liver abscess. |
| Q30668704 | Optic neuritis after anthrax vaccination |
| Q52581466 | Optic neuritis after bee sting. |
| Q66845174 | Optic neuritis after digestive hemorrhage. Apropos of 3 cases |
| Q83133754 | Optic neuritis after infliximab therapy |
| Q73886058 | Optic neuritis after influenza vaccination |
| Q40879183 | Optic neuritis after injury or disease of the anterior half of the eyeball |
| Q52537359 | Optic neuritis after wasp sting |
| Q51720792 | Optic neuritis among National Health Insurance enrollees in Taiwan, 2000-2004. |
| Q40992516 | Optic neuritis and "Q" fever |
| Q41385762 | Optic neuritis and HIV-1 infection |
| Q71155666 | Optic neuritis and Jaccoud's syndrome in a patient with systemic lupus erythematosus |
| Q68511840 | Optic neuritis and MS |
| Q40360850 | Optic neuritis and acute anterior uveitis associated with influenza A infection: a case report |
| Q42837521 | Optic neuritis and anti tubercular therapy. |
| Q79435629 | Optic neuritis and bitemporal hemianopsia associated with isoniazid treatment in end-stage renal failure |
| Q46821740 | Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis |
| Q42174155 | Optic neuritis and compressive neuropathy associated with cat scratch disease |
| Q55490698 | Optic neuritis and computed tomography. |
| Q78983582 | Optic neuritis and corticotherapy |
| Q38340676 | Optic neuritis and cytokines: no relation to MRI abnormalities and oligoclonal bands |
| Q33572169 | Optic neuritis and demyelination. |
| Q39499681 | Optic neuritis and distribution of genetic markers of the HLA systems |
| Q72015614 | Optic neuritis and heart block in Kearns-Sayre syndrome |
| Q39617359 | Optic neuritis and human T-lymphotropic virus type 1-associated myelopathy: a case report |
| Q67908668 | Optic neuritis and ischemic neuropathy. What we thought we already knew |
| Q34770239 | Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles |
| Q54307745 | Optic neuritis and its relationship to disseminated sclerosis. |
| Q38790800 | Optic neuritis and its significance |
| Q30654054 | Optic neuritis and multiple sclerosis |
| Q66701092 | Optic neuritis and multiple sclerosis |
| Q71714678 | Optic neuritis and multiple sclerosis |
| Q73669805 | Optic neuritis and multiple sclerosis |
| Q80461060 | Optic neuritis and multiple sclerosis |
| Q93590394 | Optic neuritis and multiple sclerosis |
| Q93590399 | Optic neuritis and multiple sclerosis |
| Q93857539 | Optic neuritis and multiple sclerosis |
| Q44905516 | Optic neuritis and multiple sclerosis. An epidemiologic study |
| Q72611601 | Optic neuritis and multiple sclerosis. An immunological study |
| Q44079404 | Optic neuritis and multiple sclerosis. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides |
| Q71621317 | Optic neuritis and multiple sclerosis: anti-MBP and anti-MBP peptide antibody-secreting cells are accumulated in CSF |
| Q72511627 | Optic neuritis and multiple sclerosis: do factor B alleles influence progression of disease? |
| Q46378725 | Optic neuritis and multiple sclerosis: long-term prognostic considerations |
| Q41029401 | Optic neuritis and multiple sclerosis: the T cell repertoires to myelin proteins and MBP peptides change with time |
| Q69953457 | Optic neuritis and multiple sclerosis: what is the relationship? |
| Q59239032 | Optic neuritis and myelitis after booster tetanus toxoid vaccination |
| Q70422169 | Optic neuritis and myelitis following rubella vaccination |
| Q70292559 | Optic neuritis and myelopathy in systemic lupus erythematosus |
| Q71120771 | Optic neuritis and ophthalmoplegia caused by snake bite |
| Q71663814 | Optic neuritis and optic atrophy following chloramphenicol in cystic fibrosis patients |
| Q33530322 | Optic neuritis and orbital lesions: lipid-suppressed chemical shift MR imaging |
| Q48772226 | Optic neuritis and palatal dysarthria as presenting features of post-infectious GQ1b antibody syndrome. |
| Q67781026 | Optic neuritis and parasellar meningioma |
| Q28328194 | Optic neuritis and polyneuropathy after treatment with disulfiram (Antabus) |
| Q54083036 | Optic neuritis and polyneuropathy and disulfiram (Antabus) therapy |
| Q87283226 | Optic neuritis and rapidly progressive necrotizing retinitis as the initial signs of subacute sclerosing panencephalitis: a case report with clinical and histopathologic findings |
| Q31156123 | Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus |
| Q35151930 | Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis |
| Q44431353 | Optic neuritis and retinal vasculitis as primary manifestations of systemic lupus erythematosus |
| Q37405742 | Optic neuritis and risk of MS: differential diagnosis and management |
| Q66849796 | Optic neuritis and sarcoidosis (author's transl) |
| Q80283670 | Optic neuritis and sinusitis |
| Q45336764 | Optic neuritis and systemic lupus erythematosus |
| Q72074826 | Optic neuritis and systemic lymphoma |
| Q34896555 | Optic neuritis and the evaluation of visual impairment in multiple sclerosis |
| Q33285944 | Optic neuritis and the neuro-ophthalmology of multiple sclerosis |
| Q48933252 | Optic neuritis and the risk of multiple sclerosis--what can we learn from a brain MRI scan? |
| Q79325935 | Optic neuritis and uncontrolled diabetes mellitus in 14 patients |
| Q56527515 | Optic neuritis and uveitis in a case of benign tertian malaria |
| Q81590227 | Optic neuritis and vaccination investigation: failure to consider significant sex differences and multiple vaccine combinations |
| Q67542200 | Optic neuritis anti-myelin basic protein synthetic peptide specificity |
| Q73541946 | Optic neuritis as a clinical manifestation of neurobrucellosis |
| Q32064589 | Optic neuritis as a complication in preventive tetanus-diphtheria-poliomyelitis vaccination: a case report |
| Q42237395 | Optic neuritis as a complication to treatment of cystic fibrosis with chloramphenicol |
| Q48594440 | Optic neuritis as a feature of Wegener's granulomatosis. |
| Q38795657 | Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives |
| Q43734625 | Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome |
| Q98830471 | Optic neuritis as a presenting feature of Behçet's disease: case-based review |
| Q51523448 | Optic neuritis as a presenting symptom of Mycoplasma pneumoniae infection. |
| Q72084848 | Optic neuritis as a rare complication of epidemic protitis |
| Q36379520 | Optic neuritis as an early sign of multiple sclerosis |
| Q40926932 | Optic neuritis as an initial manifestation of human herpesvirus 6 reactivation after unrelated bone marrow transplantation. |
| Q43201677 | Optic neuritis as an initial presentation of Wegener's granulomatosis |
| Q39012087 | Optic neuritis as an initial presentation of primary Sjögren syndrome: A case report and literature review |
| Q71254483 | Optic neuritis as an initial symptom in multiple sclerosis |
| Q34428831 | Optic neuritis as first clinical manifestations the multiple sclerosis |
| Q27001030 | Optic neuritis as isolated manifestation of leptomeningeal carcinomatosis: a case report and systematic review of ocular manifestations of neoplastic meningitis |
| Q61457235 | Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey |
| Q90640453 | Optic neuritis as presenting primary hypoparathyroidism |
| Q81926065 | Optic neuritis as the first manifestation of rheumatoid arthritis |
| Q44104536 | Optic neuritis as the first sign of multiple sclerosis |
| Q59795718 | Optic neuritis as the initial clinical presentation of limbic encephalitis: a case report |
| Q52936386 | Optic neuritis associated to treatment with infliximab. |
| Q77185960 | Optic neuritis associated with Bornholm disease |
| Q37770319 | Optic neuritis associated with Q fever: case report and literature review. |
| Q94948088 | Optic neuritis associated with anti-NMDA receptor antibody in the remission phase of anti-NMDA receptor encephalitis |
| Q44851224 | Optic neuritis associated with chikungunya virus infection in South India |
| Q28322509 | Optic neuritis associated with dideoxyinosine |
| Q36417533 | Optic neuritis associated with etanercept therapy for juvenile arthritis |
| Q81239962 | Optic neuritis associated with etanercept therapy in two patients with extended oligoarticular juvenile idiopathic arthritis |
| Q40717090 | Optic neuritis associated with familial Mediterranean fever. |
| Q41704439 | Optic neuritis associated with influenza B virus meningoencephalitis. |
| Q99352323 | Optic neuritis associated with sunitinib |
| Q85468308 | Optic neuritis associated with tumor necrosis factor-alfa antagonists for the treatment of psoriasis |
| Q90369374 | Optic neuritis at disease onset predicts poor visual outcome in neuromyelitis optica spectrum disorders |
| Q43688173 | Optic neuritis caused by amoproxan |
| Q40941872 | Optic neuritis caused by arsenicals; treatment with B.A.L. |
| Q34682111 | Optic neuritis caused by canine distemper virus in a Jack Russell terrier |
| Q39846720 | Optic neuritis caused by clioquinol derivatives in children (apropos of 2 cases) |
| Q67817508 | Optic neuritis caused by contact with lead compounds |
| Q42235454 | Optic neuritis caused by ethambutol |
| Q42239686 | Optic neuritis caused by ethambutol (presentation of 2 clinical cases) |
| Q28331315 | Optic neuritis caused by ethembutol |
| Q70757031 | Optic neuritis caused by ethmoid-sphenoid sinusitis |
| Q82128597 | Optic neuritis caused by interferon-beta administration |
| Q46210212 | Optic neuritis caused by intraocular angiostrongyliasis. |
| Q72549140 | Optic neuritis caused by monoamine oxidase inhibitors |
| Q90722887 | Optic neuritis caused by the re-emerging great masquerader |
| Q69638565 | Optic neuritis caused by tobaccoism |
| Q39332064 | Optic neuritis caused by varicella infection in an immunocompetent child |
| Q85764939 | Optic neuritis combined with hepatitis B and neurosyphilis |
| Q43919793 | Optic neuritis complicating measles, mumps, and rubella vaccination |
| Q40565245 | Optic neuritis complicating west nile virus meningitis in a young adult |
| Q28335682 | Optic neuritis due to INH complicating tuberculous meningitis |
| Q69880314 | Optic neuritis due to acquired toxoplasmosis |
| Q67713383 | Optic neuritis due to demyelinating disease |
| Q42232836 | Optic neuritis due to ethambutol |
| Q37420739 | Optic neuritis due to immunobiologics: first Brazilian case report |
| Q81027887 | Optic neuritis due to solvent abuse |
| Q80046855 | Optic neuritis dueto multiple sclerosis |
| Q70072670 | Optic neuritis during lactation |
| Q68919803 | Optic neuritis during treatment with Esperal |
| Q45341732 | Optic neuritis following Epstein-Barr virus encephalitis in immunocompetent children: A case report |
| Q42204846 | Optic neuritis following Varicella zoster vaccination: report of two cases |
| Q71054620 | Optic neuritis following a spider bite. Report of a case |
| Q42537822 | Optic neuritis following albendazole therapy for orbital cysticercosis |
| Q93176373 | Optic neuritis following anti-rabies vaccine |
| Q44362950 | Optic neuritis following aseptic meningitis associated with modified measles: a case report |
| Q77116088 | Optic neuritis following cataract extraction |
| Q78534600 | Optic neuritis following cataract extraction |
| Q69550931 | Optic neuritis following chickenpox in adults |
| Q59349535 | Optic neuritis following diphtheria, tetanus, pertussis, and inactivated poliovirus combined vaccination: a case report |
| Q84964502 | Optic neuritis following hepatitis B vaccination in a 9-year-old girl |
| Q73760814 | Optic neuritis following isoniazid therapy |
| Q37325438 | Optic neuritis following measles/rubella vaccination in two 13-year-old children |
| Q71068961 | Optic neuritis following panophthalmitis in the other eye |
| Q74498118 | Optic neuritis following snake bite |
| Q70592867 | Optic neuritis following treatment with isoniazid in a hemodialyzed patient |
| Q80374191 | Optic neuritis from cold permanent wave |
| Q44267958 | Optic neuritis heralding varicella zoster virus retinitis in a patient with acquired immunodeficiency syndrome. |
| Q46821370 | Optic neuritis in African Americans |
| Q43892076 | Optic neuritis in Asian children |
| Q91797114 | Optic neuritis in German children: clinical findings and association with multiple sclerosis |
| Q43691209 | Optic neuritis in Hong Kong: a 1-year follow-up study |
| Q44163257 | Optic neuritis in Orientals and Caucasians |
| Q45770955 | Optic neuritis in Singapore. |
| Q74502330 | Optic neuritis in a case of poliomyelitis |
| Q41111855 | Optic neuritis in a child |
| Q69372685 | Optic neuritis in a child with Wilson's disease |
| Q37998016 | Optic neuritis in a child with biotinidase deficiency: case report and literature review |
| Q41664342 | Optic neuritis in a child with herpes zoster |
| Q70820845 | Optic neuritis in a dog |
| Q69941293 | Optic neuritis in a patient on ethambutol and isoniazid evaluated by visual evoked potentials: case report |
| Q83166513 | Optic neuritis in a patient with Miller-Fisher syndrome |
| Q88764681 | Optic neuritis in a patient with celiac disease |
| Q46816298 | Optic neuritis in a psoriatic arthritis patient treated by infliximab |
| Q40194213 | Optic neuritis in a traveler returning from Dominican Republic to Spain with dengue virus infection |
| Q35932269 | Optic neuritis in adults and children |
| Q41809949 | Optic neuritis in an adult patient with chickenpox. |
| Q37551707 | Optic neuritis in an ethnically diverse population: higher risk of atypical cases in patients of African or African-Caribbean heritage |
| Q64077284 | Optic neuritis in an immunocompetent 40-year-old female due to fungal sphenoidal sinusitis |
| Q39589198 | Optic neuritis in an urban black African community |
| Q43008304 | Optic neuritis in anti-GQ1b positive recurrent Miller Fisher syndrome |
| Q43638677 | Optic neuritis in cat scratch disease |
| Q46655774 | Optic neuritis in cat scratch disease |
| Q36880204 | Optic neuritis in cerebral toxocariasis |
| Q40420639 | Optic neuritis in childhood (author's transl) |
| Q40614707 | Optic neuritis in childhood. A pediatric series, literature review and treatment approach |
| Q73044303 | Optic neuritis in children |
| Q77881526 | Optic neuritis in children |
| Q79032396 | Optic neuritis in children |
| Q69808453 | Optic neuritis in children and adolescents |
| Q68466563 | Optic neuritis in children and its relationship to multiple sclerosis: a clinical study of 21 children |
| Q45187310 | Optic neuritis in children infectious mononucleosis as an etiology |
| Q46049625 | Optic neuritis in children with poor recovery of vision |
| Q75229870 | Optic neuritis in children--clinical and electrophysiological follow-up |
| Q48223711 | Optic neuritis in children: clinical features and visual outcome |
| Q71438473 | Optic neuritis in children: recurrence and subsequent development of multiple sclerosis |
| Q58456447 | Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: Demyelination and fast axonal transport changes in disease |
| Q48733087 | Optic neuritis in different strains of mice by a recombinant HSV-1 expressing murine interleukin-2. |
| Q68636197 | Optic neuritis in dogs |
| Q37094274 | Optic neuritis in dogs and cats |
| Q47190882 | Optic neuritis in dogs: 96 cases (1983-2016). |
| Q80843652 | Optic neuritis in evolution |
| Q70666592 | Optic neuritis in familial MS |
| Q73081673 | Optic neuritis in herpes zoster ophthalmicus |
| Q72815464 | Optic neuritis in inflammatory bowel disease |
| Q33187295 | Optic neuritis in multiple sclerosis |
| Q57911673 | Optic neuritis in multiple sclerosis |
| Q33429313 | Optic neuritis in multiple sclerosis: diagnosis and prognosis data |
| Q69616692 | Optic neuritis in multiple sclerosis: pathophysiologic considerations |
| Q30610471 | Optic neuritis in neuromyelitis optica |
| Q42009380 | Optic neuritis in non-Hodgkin's lymphoma |
| Q54258434 | Optic neuritis in paediatric patients: Experience over 27 years and a management protocol. |
| Q48340430 | Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France |
| Q38226963 | Optic neuritis in pediatric population: a review in current tendencies of diagnosis and management |
| Q88547359 | Optic neuritis in pregnancy after Tdap vaccination: Report of two cases |
| Q73454603 | Optic neuritis in relation to demyelinating diseases; a clinical study |
| Q39396093 | Optic neuritis in relation to multiple sclerosis |
| Q40346817 | Optic neuritis in systemic lupus erythematosus |
| Q70075528 | Optic neuritis in systemic lupus erythematosus |
| Q44518651 | Optic neuritis in systemic lupus erythematosus (personal case and review of the literature) |
| Q53703134 | Optic neuritis in systemic lupus erythematosus. |
| Q84977882 | Optic neuritis in systemic lupus erythematosus: report of 12 cases |
| Q33598880 | Optic neuritis in the Landry-Guillain-Barre-Strohl syndrome |
| Q72309365 | Optic neuritis in the diabetic |
| Q91011291 | Optic neuritis in the diagnosis of MS: More than meets the eye |
| Q67973246 | Optic neuritis in the elderly: prognosis for visual recovery and long-term follow-up |
| Q92698697 | Optic neuritis in the era of biomarkers |
| Q48730430 | Optic neuritis in the setting of NMDA receptor encephalitis. |
| Q69744718 | Optic neuritis in the two northernmost counties of Norway. A study of incidence and the prospect of later development of multiple sclerosis |
| Q33818633 | Optic neuritis incidence is increased in spring months in patients with asymptomatic demyelinating lesions. |
| Q91310456 | Optic neuritis induced by 5-fluorouracil chemotherapy: Case report and review of the literature |
| Q48393266 | Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations |
| Q34936918 | Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis |
| Q71607603 | Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-gamma, interleukin-4 and transforming growth factor-beta |
| Q79526703 | Optic neuritis is nothing to sneeze at |
| Q35954593 | Optic neuritis occurring with anti-tumour necrosis factor alpha therapy |
| Q44641951 | Optic neuritis of lactation |
| Q73993489 | Optic neuritis of unknown etiology |
| Q67568610 | Optic neuritis or anterior ischemic optic neuropathy? |
| Q93590396 | Optic neuritis or multiple sclerosis |
| Q48597468 | Optic neuritis or ophthalmic artery aneurysm? Case presentation with histopathologic documentation utilizing a new staining method |
| Q86103830 | Optic neuritis preceding progressive outer retinal necrosis in an immunocompromised patient after allogeneic stem cell transplantation |
| Q48468373 | Optic neuritis presenting with amaurosis fugax. |
| Q84500612 | Optic neuritis probably induced by isotretinoin |
| Q73130364 | Optic neuritis progressing to multiple sclerosis |
| Q53076584 | Optic neuritis revealing Kikuchi-Fujimoto disease. |
| Q87405400 | Optic neuritis revealing Kikuchi-Fujimoto's disease: clinical commentary |
| Q83966483 | Optic neuritis secondary to Angiostrongylus cantonensis infection |
| Q39063431 | Optic neuritis secondary to antiandrogen therapy |
| Q70701814 | Optic neuritis secondary to sinus disease |
| Q70927019 | Optic neuritis secondary to sphenoethmoiditis: surgical treatment |
| Q72238227 | Optic neuritis syndrome associated with meningioma of the tubercle of the sella turcica (apropos of 2 cases) |
| Q82388187 | Optic neuritis treated with histamine |
| Q71369753 | Optic neuritis treatment trial |
| Q72063920 | Optic neuritis treatment trial |
| Q72766497 | Optic neuritis treatment trial study |
| Q70763940 | Optic neuritis treatment trial. One-year follow-up results |
| Q80871680 | Optic neuritis treatment trial:10-year follow-up results |
| Q95371624 | Optic neuritis with TNF alpha antagonists |
| Q69534634 | Optic neuritis with an autoimmune disease (myasthenia gravis) |
| Q46786771 | Optic neuritis with concurrent etanercept and isoniazid therapy. |
| Q43008930 | Optic neuritis with marked distension of the optic nerve sheath due to local fluid congestion |
| Q39947398 | Optic neuritis with positive HLA-B27: Characteristic phenotype in the Chinese population |
| Q69981238 | Optic neuritis with prolonged use of chloramphenicol. Case report and relationship to fundus changes in cystic fibrosis |
| Q47967988 | Optic neuritis with radiological longitudinal spinal cord involvement and seronegative anti-aquaporin antibody: Evidence from a case study |
| Q77427018 | Optic neuritis with residual tunnel vision in perchloroethylene toxicity |
| Q77784970 | Optic neuritis with residual tunnel vision in perchloroethylene toxicity |
| Q69618638 | Optic neuritis with secondary retinal venous stasis |
| Q40452391 | Optic neuritis with secondary retinal venous stasis in a case of abdominal tuberculosis. |
| Q72308016 | Optic neuritis with silent cerebral lesions: availability of FLAIR sequences |
| Q38437561 | Optic neuritis with transient total blindness during lactation(1). |
| Q46968666 | Optic neuritis with visual field defect--possible Ibuprofen-related toxicity |
| Q71983220 | Optic neuritis, as the first symptom of a left sphenoidal meningioma reaching the orbit |
| Q42588074 | Optic neuritis, confirmed by visual evoked response, and the risk for multiple sclerosis: a prospective survey |
| Q40159769 | Optic neuritis, diabetes mellitus and multiple sclerosis: a three-way association |
| Q92939311 | Optic neuritis, encephalitis and leptomeningeal enhancement in a patient with anti-MOG antibodies: A case study |
| Q34377982 | Optic neuritis, its differential diagnosis and management |
| Q28299499 | Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow-up study |
| Q43058285 | Optic neuritis, multiple sclerosis-related or not: structural and functional study |
| Q36294049 | Optic neuritis, the most common initial presenting manifestation of multiple sclerosis in northern Iran |
| Q71009900 | Optic neuritis, transverse myelitis, and anti-DNA antibodies nine years after thymectomy for myasthenia gravis |
| Q54202964 | Optic neuritis. A case of optic neuritis which appeared during treatment with a new antiepileptic drug |
| Q84229882 | Optic neuritis: A mechanistic view |
| Q22306170 | Optic neuritis: A population-based study in Olrnsted County, Minnesota |
| Q91383510 | Optic neuritis: Both eyes improve after corticotropin |
| Q40283809 | Optic neuritis: Local synthesis in the central nervous system of oligoclonal antibodies to measles, mumps, rubella, and herpes simplex viruses |
| Q32153935 | Optic neuritis: MR imaging with combined fat- and water-suppression techniques. |
| Q46424608 | Optic neuritis: Observation and experience at a tertiary care hospital in Qassim region, Saudi Arabia |
| Q50900378 | Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages. |
| Q85387863 | Optic neuritis: a blurry issue |
| Q48773543 | Optic neuritis: a novel presentation of Schilder's disease. |
| Q68798360 | Optic neuritis: a prospective study |
| Q73255430 | Optic neuritis: a rare complication of primary varicella infection |
| Q74421110 | Optic neuritis: a rare manifestation of nasopharyngeal carcinoma |
| Q53634861 | Optic neuritis: a rare manifestation of nasopharyngeal carcinoma. |
| Q33514153 | Optic neuritis: a review |
| Q44447634 | Optic neuritis: characteristics and visual outcome |
| Q35592401 | Optic neuritis: chemokine receptor CXCR3 and its ligands. |
| Q35199041 | Optic neuritis: correlation of pain and magnetic resonance imaging |
| Q40925117 | Optic neuritis: diagnosis, treatment and clinical implications |
| Q81021196 | Optic neuritis: diagnostic criteria application in clinical practice |
| Q34496238 | Optic neuritis: differential diagnosis |
| Q44300363 | Optic neuritis: evaluation with orbital Doppler sonography |
| Q85387873 | Optic neuritis: experience from a south Indian demyelinating disease registry |
| Q48134815 | Optic neuritis: findings on MRI, CSF examination and HLA class II typing in 60 patients and results of a short-term follow-up |
| Q37561050 | Optic neuritis: from magnocellular to cognitive residual dysfunction |
| Q40525319 | Optic neuritis: guidelines. |
| Q53460405 | Optic neuritis: historical aspects. |
| Q73930611 | Optic neuritis: imaging with magnetization transfer |
| Q71678405 | Optic neuritis: mechanism of induction by dual antigen complex |
| Q41445578 | Optic neuritis: oligoclonal bands increase the risk of multiple sclerosis |
| Q70805192 | Optic neuritis: post epidemic keratoconjunctivitis |
| Q38338959 | Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings |
| Q66963765 | Optic neuritis: studies on the cerebrospinal fluid in relation to clinical course in 61 patients |
| Q73130480 | Optic neuritis: swelling and atrophy |
| Q39025824 | Optic neuritis: the eye as a window to the brain |
| Q79213615 | Optic neuritis: treatment by ACTH and cortisone |
| Q44914075 | Optic neuritis: variations in temporal modulation sensitivity with retinal eccentricity |
| Q75928026 | Optic neuritis; a 15 year study |
| Q78916389 | Optic neuritis; evaluation of treatment with retrobulbar hydrocortisone |
| Q73318717 | Optic neuropathy in multiple sclerosis; optic neuritis |
| Q48925435 | Optic radiation changes after optic neuritis detected by tractography-based group mapping. |
| Q92504055 | Optical Coherence Tomography Angiography of a Pale Optic Disc in Demyelinating Optic Neuritis and Ischemic Optic Neuropathy |
| Q104690198 | Optical Coherence Tomography and Optical Coherence Tomography Angiography Findings After Optic Neuritis in Multiple Sclerosis |
| Q40101567 | Optical Coherence Tomography for the Detection of Remote Optic Neuritis in Multiple Sclerosis. |
| Q38977857 | Optical Coherence Tomography in Patients with Relapsing-Remitting Multiple Sclerosis without Optic Neuritis: A 20-Month Longitudinal Study |
| Q30497714 | Optical coherence tomography (OCT) in optic neuritis and multiple sclerosis |
| Q89671941 | Optical coherence tomography angiography findings of multiple sclerosis with or without optic neuritis |
| Q91185649 | Optical coherence tomography for diagnosing optic neuritis: Are we there yet? |
| Q64122844 | Optical coherence tomography in acute optic neuritis: A population-based study |
| Q58597236 | Optical coherence tomography in central nervous system demyelinating diseases related optic neuritis |
| Q79470409 | Optical coherence tomography in optic neuritis |
| Q36895990 | Optical coherence tomography in optic neuritis and multiple sclerosis: a review |
| Q33971679 | Optical coherence tomography in the diagnosis and management of optic neuritis and multiple sclerosis |
| Q35762462 | Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis |
| Q79327985 | Optical coherence tomography versus automated perimetry for follow-up of optic neuritis |
| Q89858962 | Optimization of spectral domain optical coherence tomography and visual evoked potentials to identify unilateral optic neuritis |
| Q61248573 | Oral Levofloxacin-Induced Optic Neuritis Progressing in Loss of Vision |
| Q64948748 | Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial. |
| Q70741484 | Otorhinolaryngological pathology in patients with optic neuritis |
| Q58805146 | Outcome of Acute Monosymptomatic Optic Neuritis in Northern Sardinia, Italy |
| Q39675636 | Outcomes of toll-like receptors' antagonism in steroid-resistant optic neuritis; a pilot study |
| Q73037898 | Overlap of optic neuritis and anterior ischemic optic neuropathy |
| Q68259099 | Oxygen therapy of toxic optic neuritis of persons working in contact with nitroderivatives of toluol |
| Q81257237 | PAPILLEDEMA WITHOUT INTRACRANIAL PRESSURE (OPTIC NEURITIS) |
| Q73822048 | PCR typing of two short tandem repeat (STR) structures upstreams of the human myelin basic protein (MBP) gene; the genetic susceptibility in multiple sclerosis and monosymptomatic idiopathic optic neuritis in Danes |
| Q55539132 | PReS-FINAL-2027: Cerebral demyelination and optic neuritis during treatment with eternacept and methotrexate. |
| Q78210681 | Pachymeningitis and optic neuritis in rheumatoid arthritis: MRI findings |
| Q41919736 | Pachymeningitis and optic neuritis in rheumatoid arthritis: successful treatment with cyclophosphamide |
| Q49024934 | Paediatric ADEM followed by optic neuritis: disease course, treatment response and outcome. |
| Q40042645 | Paediatric optic neuritis: factors leading to unfavourable outcome and relapses. |
| Q53323398 | Pansinusitis causing bilateral optic neuritis in a 9-year-old child. |
| Q98880422 | Panuveitis and Optic Neuritis as a Possible Initial Presentation of the Novel Coronavirus Disease 2019 (COVID-19) |
| Q43409458 | Papilledema, optic neuritis, and pseudopapilledema. The use of fluorescein angiography in differential diagnosis |
| Q35020148 | Papilloedema and Optic Neuritis |
| Q95642563 | Papulonecrotic tuberculid with optic neuritis |
| Q100951551 | Para-neoplastic optic neuritis presenting in a child with fusion positive localised para-testicular alveolar rhabdomyosarcoma |
| Q33463579 | Paraclinical tests in acute-onset optic neuritis: basal data and results of a short follow-up |
| Q52037860 | Parainfectious optic neuritis and encephalomyelitis. A report of two cases with thalamic involvement. |
| Q90260969 | Parainfectious optic neuritis followed by microcystic macular oedema |
| Q42222269 | Parainfectious optic neuritis: manifestations in children vs adults |
| Q48499857 | Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumor. |
| Q68265509 | Paraneoplastic optic neuritis and encephalomyelitis. Report of a case |
| Q43508874 | Paraneoplastic optic neuritis and external ophthalmoplegia |
| Q45182187 | Paraneoplastic optic neuritis and external ophthalmoplegia |
| Q35052547 | Paraneoplastic optic neuritis as the first manifestation of periampullary carcinoma |
| Q39432495 | Parent and medical professional willingness to enroll children in a hypothetical pediatric optic neuritis treatment trial |
| Q41973941 | Partial closure of the central artery and vein of the retina in retrobulbar optic neuritis (author's transl) |
| Q33543414 | Patients' knowledge and perception on optic neuritis management before and after an information session |
| Q81575991 | Pattern VEP alterations in psoriatic patients may indicate a sub clinic optic neuritis |
| Q70500298 | Pattern VEP in two immunochemical subtypes of optic neuritis |
| Q92537494 | Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody |
| Q68212984 | Pattern electroretinogram as a function of spatial frequency after retrobulbar optic neuritis |
| Q44912171 | Pattern electroretinogram in neuromyelitis optica and multiple sclerosis with or without optic neuritis and its correlation with FD-OCT and perimetry |
| Q68583099 | Pattern electroretinograms in optic neuritis during the acute stage and after remission |
| Q67261763 | Pattern shift visual evoked responses. Two hundred patients with optic neuritis and/or multiple sclerosis |
| Q39875230 | Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients |
| Q94142718 | Pediatric Optic Neuritis Prospective Outcomes Study |
| Q91616056 | Pediatric Optic Neuritis and Other Demyelinating Optic Neuropathies |
| Q44434614 | Pediatric Optic Neuritis: What Is New. |
| Q30248247 | Pediatric optic neuritis |
| Q77379600 | Pediatric optic neuritis |
| Q81511782 | Pediatric optic neuritis |
| Q84299669 | Pediatric optic neuritis |
| Q90871072 | Pediatric optic neuritis |
| Q92376359 | Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients |
| Q48872163 | Pediatric optic neuritis and multiple sclerosis: who is at risk for progression? |
| Q34080426 | Pediatric optic neuritis and risk of multiple sclerosis: meta-analysis of observational studies |
| Q47109553 | Pediatric optic neuritis: Points to ponder! |
| Q48710893 | Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis. |
| Q87650413 | Pediatric optic neuritis: does a prolonged course of steroids reduce relapses? A preliminary study |
| Q71628822 | Peptide specificity of anti-myelin basic protein antibodies in patients with acute optic neuritis and the HLA system |
| Q101040155 | Peripapillary and macular choroidal thickness in both eyes of patients with acute unilateral retrobulbar optic neuritis |
| Q98653414 | Peripapillary and parafoveal microvascular changes in eyes with optic neuritis and their fellow eyes measured by optical coherence tomography angiography: an Exploratory Study |
| Q28330791 | Peripheral and optic neuritis in a patient with hemoglobin SC disease during treatment of salmonella osteomyelitis with chloramphenicol |
| Q42697207 | Perivascular Enhancement in a Patient with Neuromyelitis Optica Spectrum Disease during an Optic Neuritis Attack |
| Q28265269 | Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis |
| Q92997324 | Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis |
| Q87416512 | Persistent presence of the anti-myelin oligodendrocyte glycoprotein autoantibody in a pediatric case of acute disseminated encephalomyelitis followed by optic neuritis |
| Q39377591 | Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial. |
| Q40813534 | Phenytoin in acute optic neuritis: neuroprotective or not? |
| Q92300161 | Photoreceptor outer nuclear layer thickness changes in optic neuritis follow up |
| Q67327237 | Picture of the macula following retrobulbar optic neuritis |
| Q30392850 | Pituitary apoplexy presented with optic neuritis |
| Q79937594 | Pituitary tumors with central scotomas simulating retrobulbar optic neuritis |
| Q35903461 | Plasma exchange for severe optic neuritis: treatment of 10 patients |
| Q86300364 | Plasma exchange is effective in a 13-year-old girl with steroid-resistant bilateral optic neuritis |
| Q92064466 | Plasma exchange: an effective add-on treatment of optic neuritis in neuromyelitis optica spectrum disorders |
| Q41349853 | Polio-encephalo-myelitis associated with Optic Neuritis, Nephritis, and Myocarditis. |
| Q86925086 | Poppers toxic maculopathy misdiagnosed as atypical optic neuritis |
| Q97686665 | Population based incidence of optic neuritis in the era of aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies |
| Q91301336 | Population-based Incidence of Pediatric and Adult Optic Neuritis and the Risk of Multiple Sclerosis |
| Q55010646 | Possible Combined Central and Peripheral Demyelination Presenting as Optic Neuritis, Cervical Myelitis, and Demyelinating Polyneuropathy with Marked Nerve Hypertrophy. |
| Q81723267 | Possible link between infliximab and optic neuritis |
| Q67781025 | Possible role of a metal deficiency in the pathogenesis of various forms of toxic and nutritional optic neuritis |
| Q40647322 | Possible role of corticosteroids in nervous system plasticity: improvement in amblyopia after optic neuritis in the fellow eye treated with steroids |
| Q35401299 | Post-Plasmodium vivax malaria cerebellar ataxia and optic neuritis: A new form of delayed cerebellar ataxia or cerebellar variant of acute disseminated encephalomyelitis? |
| Q40042836 | Postinfectious Anti-Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis and Myelitis |
| Q104799357 | Postinfectious Optic Neuritis After Hand-Foot-Mouth Disease |
| Q72335249 | Postinfectious hepatitis B optic neuritis |
| Q80628201 | Postpartum optic neuritis due to multiple sclerosis |
| Q73933296 | Postpartum optic neuritis: etiologic and pathophysiologic considerations |
| Q48328354 | Predicting multiple sclerosis at optic neuritis onset |
| Q45399652 | Predicting multiple sclerosis following isolated optic neuritis in children |
| Q60729976 | Predicting the Outcome of Optic Neuritis |
| Q80523105 | Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria |
| Q96164422 | Predictive value of optical coherence tomography, multifocal visual evoked potentials, and full-field visual evoked potentials of the fellow, non-symptomatic eye for subsequent multiple sclerosis development in patients with acute optic neuritis |
| Q90258358 | Predictors of Visual Acuity and Usefulness of a Treatment Algorithm in Rhinogenous Optic Neuritis |
| Q57823883 | Predictors of response to opicinumab in acute optic neuritis |
| Q41478333 | Prefoveal floaters as a differential diagnosis to optic neuritis: "mouches dormantes". |
| Q50077959 | Prefoveal floaters as a differential diagnosis to optic neuritis: ''mouches dormantes''. |
| Q72425295 | Prepublication blackout in the Optic Neuritis Treatment Trial |
| Q90748255 | Presumed Primary Bacterial Rhinosinusitis-Associated Optic Neuritis in a Cat |
| Q82553360 | Presumed cytomegalovirus-associated retrobulbar optic neuritis in a patient after allogeneic stem cell transplantation |
| Q100317949 | Presumed optic neuritis of non-infectious origin in dogs treated with immunosuppressive medication: 28 dogs (2000-2015) |
| Q86393691 | Presumed tuberculous retrobulbar optic neuritis: a diagnosis challenge |
| Q50140683 | Prevalence and Incidence of Optic Neuritis in Patients with Different Types of Uveitis. |
| Q87849852 | Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial |
| Q84733166 | Prevalence of systemic lupus erythematosus-associated optic neuritis |
| Q45019593 | Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial |
| Q77823272 | Primary Sjögren's syndrome initially manifested by optic neuritis: MRI findings |
| Q86022291 | Primary angiitis of the central nervous system presenting as unilateral optic neuritis |
| Q83158472 | Primary antiphospholipid antibody syndrome with optic neuritis |
| Q74273838 | Primary idiopathic optic neuritis in U.S. Air Force Aviators |
| Q72369435 | Primary optic neuritis evolved in multiple sclerosis: an epidemiological study |
| Q89730729 | Prodromal headache in MOG-antibody positive optic neuritis |
| Q70943973 | Profile of optic neuritis in Chandigarh and surrounding areas |
| Q70069216 | Prognosis in optic neuritis related to age |
| Q80825015 | Prognosis of Taiwanese patients with isolated optic neuritis after intravenous methylprednisolone pulse therapy |
| Q66908168 | Prognosis of optic neuritis |
| Q43645878 | Prognosis of optic neuritis with special reference to cerebrospinal fluid immunoglobulins and measles virus antibodies |
| Q91872320 | Prognostic Factors for Recovery of Vision in Canine Optic Neuritis of Unknown Etiology: 26 Dogs (2003-2018) |
| Q104282441 | Prognostic Factors for Visual Outcomes Following the First Episode of NMOSD-Related Optic Neuritis in Affected Eyes |
| Q70391457 | Prognostic indicators in optic neuritis |
| Q41323083 | Prognostic value of cerebrospinal fluid electrophoresis in optic neuritis and suspected multiple sclerosis |
| Q71832984 | Prognostic value of magnetic resonance imaging in monosymptomatic optic neuritis |
| Q36937186 | Progression of optic neuritis to multiple sclerosis in the County of Split-Dalmatia, Croatia |
| Q43947886 | Progression of optic neuritis to multiple sclerosis: a prospective study in an Italian population |
| Q73120480 | Progression of optic neuritis to multiple sclerosis: an 8-year follow-up study |
| Q74043027 | Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis |
| Q97679000 | Promising recovery biomarkers after first event acute demyelinating optic neuritis |
| Q91322671 | Prophylactic Treatment with Intravenous Immunoglobulin Attenuates Experimental Optic Neuritis in Mice |
| Q91952516 | Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis |
| Q42363769 | Pseudo-subarachnoid hemorrhage and optic neuritis in an 18-year-old girl with sodium valproate overdose |
| Q67386883 | Pulfrich pendulum phenomenon in patients with a history of acute optic neuritis |
| Q44642633 | Pulse therapy in the treatment of optic neuritis in multiple sclerosis |
| Q67337804 | Pupil cycle time in optic neuritis |
| Q77574755 | Putative role of calpain in the pathophysiology of experimental optic neuritis |
| Q40769866 | Q fever meningoencephalitis associated with bilateral abducens nerve paralysis, bilateral optic neuritis and abnormal cerebrospinal fluid findings |
| Q41083095 | Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT). |
| Q35762430 | Quantification of optic nerve head topography in optic neuritis: a pilot study. |
| Q84142130 | Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography |
| Q53621556 | Quantifying axonal loss after optic neuritis with optical coherence tomography. |
| Q37020917 | Quantitative evaluation of signal intensity of magnetic resonance images in optic neuritis |
| Q43121362 | Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis |
| Q55018865 | Questioning the Diagnosis of Recurrent Optic Neuritis Associated with Neuro-Behçet's Disease. |
| Q76801172 | RECENT RESEARCH ON RETROBULBAR OPTIC NEURITIS IN OUR CLINIC |
| Q92861321 | RECURRENT ATYPICAL OPTIC NEURITIS AS THE LEADING SIGN OF FABRY DISEASE |
| Q76861341 | RETROBULBAR OPTIC NEURITIS AND DISORDERS OF GASTRIC CHEMISTRY |
| Q51049340 | RNFL thickness in MS-associated acute optic neuritis using SD-OCT: critical interpretation and limitations. |
| Q33899862 | Radial diffusivity in remote optic neuritis discriminates visual outcomes. |
| Q37299525 | Radiation-induced optic neuritis after pituitary adenoma radiosurgery in a patient with multiple sclerosis: case report |
| Q52152221 | Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. |
| Q81238244 | Radiology case of the month. Unilateral vision loss with ipsilateral eye and head pain. Optic neuritis |
| Q91726532 | Radiomics Analysis of DTI Data to Assess Vision Outcome After Intravenous Methylprednisolone Therapy in Neuromyelitis Optic Neuritis |
| Q90130233 | Randomized control trial of evaluation of Clemastine effects on visual evoked potential, nerve fiber layer and ganglion cell layer complex in patients with optic neuritis |
| Q100435631 | Rapid Administration of High-Dose Intravenous Methylprednisolone Improves Visual Outcomes After Optic Neuritis in Patients With AQP4-IgG-Positive NMOSD |
| Q68054315 | Rapid response of syphilitic optic neuritis to posterior sub-tenon's steroid injection |
| Q46657116 | Rapidly developing optic neuritis secondary to ethambutol: possible mechanism of injury. |
| Q42405532 | Rare combination of bilateral putaminal necrosis, optic neuritis, and polyneuropathy in a case of acute methanol intoxication among patients met with hooch tragedy in Gujarat, India |
| Q30865447 | Re-evaluating the treatment of acute optic neuritis |
| Q98186595 | Re: Francis et al.: Immune checkpoint inhibitor associated optic neuritis (Ophthalmology. 2020 May 8 [Epub ahead of print]) |
| Q87396253 | Re: Leber's hereditary optic neuropathy masquerading as optic neuritis with spontaneous visual recovery |
| Q80771674 | Re: Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome |
| Q92334877 | Reader response: Optical coherence tomography for diagnosing optic neuritis: Are we there yet? |
| Q60937619 | Rebound of relapses after discontinuation of rituximab in a patient with MOG-IgG1 positive highly relapsing optic neuritis: a case report |
| Q37864375 | Recent advances in optic neuritis related to multiple sclerosis |
| Q77714867 | Recommendations of the Optic Neuritis Study Group |
| Q60678676 | Recovering optic neuritis during systemic cisplatin and carboplatin chemotherapy |
| Q33630733 | Recovery after optic neuritis in childhood |
| Q38898911 | Recovery from optic neuritis attack in neuromyelitis optica spectrum disorder and multiple sclerosis |
| Q35456378 | Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study |
| Q72998823 | Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study. Werring DJ, bullmore ET, toosy AT, miller DH, barker GJ, MacManus DG, brammer MJ, |
| Q48181935 | Recovery from optic neuritis: an ROI-based analysis of LGN and visual cortical areas |
| Q70596140 | Recovery from severe visual loss in optic neuritis |
| Q80842377 | Recovery of vision and pupil responses in optic neuritis and multiple sclerosis |
| Q70309203 | Recovery of visual evoked potentials in optic neuritis |
| Q67769759 | Recovery of visual field defects in ischemic optic neuropathy and idiopathic optic neuritis |
| Q41704529 | Recovery of visual field function in the optic neuritis treatment trial |
| Q92010737 | Recurrent Bilateral Myelin Oligodendrocyte Glycoprotein Antibody Optic Neuritis in a Leber Hereditary Optic Neuropathy Carrier |
| Q96299652 | Recurrent MOG-IgG optic neuritis initially attributed to Sjögren's syndrome |
| Q40226509 | Recurrent Optic Neuritis Associated With MOG Antibody Seropositivity |
| Q55428098 | Recurrent Optic Neuritis as the Initial Symptom in Demyelinating Diseases. |
| Q86515148 | Recurrent Optic Neuritis in Children |
| Q88053754 | Recurrent idiopathic neuroretinitis as a spectrum of atypical optic neuritis: a case report and literature review |
| Q47138508 | Recurrent isolated optic neuritis: A study on 22 patients |
| Q80404584 | Recurrent myelitis and optic neuritis in a 29-year-old woman |
| Q87827237 | Recurrent myelopathy and optic neuritis associated with systemic lupus erythematosus |
| Q91869277 | Recurrent optic neuritis - Different patterns in multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody disease |
| Q89123803 | Recurrent optic neuritis and neuromyelitis optica-IgG following first and second human papillomavirus vaccinations |
| Q57458341 | Recurrent optic neuritis as the only manifestation of chronic hepatitis B virus flare: a case report |
| Q36152662 | Recurrent optic neuritis as the presenting manifestation of primary hypereosinophilic syndrome: a report of two cases |
| Q37861658 | Recurrent optic neuritis associated with Chlamydia pneumoniae infection of the central nervous system |
| Q101408272 | Recurrent optic neuritis in a patient with Sjogren syndrome and neuromyelitis optica spectrum disorder: A case report |
| Q33702083 | Recurrent optic neuritis: clues from a long-term follow up study of recurrent and bilateral optic neuritis patients. |
| Q84943628 | Reduced retinal nerve fiber layer and macular thickness in patients with multiple sclerosis with no history of optic neuritis identified by the use of spectral domain high-definition optical coherence tomography |
| Q60984211 | Reduced visual evoked responses in multiple sclerosis patients with optic neuritis: Comparison of functional magnetic resonance imaging and visual evoked potentials |
| Q78008127 | Reduced visual evoked responses in multiple sclerosis patients with optic neuritis: comparison of functional magnetic resonance imaging and visual evoked potentials |
| Q68984585 | Regional threshold contrast sensitivity within the central visual field in optic neuritis |
| Q96953489 | Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation |
| Q87899110 | Relapsed Acute Lymphoblastic Leukemia Presenting as Optic Neuritis |
| Q88780918 | Relapsing acute disseminated encephalomyelitis followed by optic neuritis in children; a clinical entity associated with anti-MOG antibody |
| Q81343567 | Relapsing inflammatory optic neuritis: is it neuromyelitis optica? |
| Q33693049 | Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India |
| Q64059652 | Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome |
| Q42242264 | Relapsing optic neuritis: a multicentre study of 62 patients. |
| Q40350564 | Relapsing uveitis and optic neuritis due to chronic Q fever |
| Q79032398 | Relation of optic neuritis to multiple sclerosis in children |
| Q28255095 | Relationship between NMO-antibody and anti-MOG antibody in optic neuritis |
| Q35015106 | Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis |
| Q70654406 | Relationship of optic neuritis to disease of the paranasal sinuses |
| Q70992819 | Relative Afferent Pupillary Defects in Optic Neuritis |
| Q71614482 | Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid |
| Q41228008 | Remote clinic/patient monitoring for multicenter trials. Optic Neuritis Study Group |
| Q47136341 | Reply to Pediatric optic neuritis: Points to ponder |
| Q48295053 | Reply to the letter by Jasmin Zvorničanin on the article Prefoveal floaters as a differential diagnosis to optic neuritis: "mouches dormantes". |
| Q98384325 | Reply: Bilateral optic neuritis as a complication of successive Flaviviridae virus infections |
| Q35219562 | Repository corticotropin injection in a patient presenting with focal segmental glomerulosclerosis, rheumatoid arthritis, and optic neuritis: a case report |
| Q26767135 | Research Advances in Biomarkers for Demyelinating Optic Neuritis |
| Q98775957 | Resolution of myelin oligodendrocyte glycoprotein (MOG)-IgG optic neuritis without treatment |
| Q54402438 | Response to Letter to the Editor 'Simvastatin improves final visual outcome in acute optic neuritis, a randomized study'. |
| Q89699377 | Response to: Optic neuritis induced by 5-fluorouracil chemotherapy: case report and review of the literature |
| Q90204606 | Response to: Transorbital ultrasonography in acute optic neuritis: Can it be a supportive diagnostic tool? |
| Q42618809 | Response variability in the visual field: comparison of optic neuritis, glaucoma, ocular hypertension, and normal eyes. |
| Q43808217 | Results of treatment of optic neuritis (author's transl) |
| Q90931059 | Retinal Degeneration After First-Ever Optic Neuritis Helps Differentiate Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder |
| Q36261569 | Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study. |
| Q91378147 | Retinal Nerve Fiber Layer Thickness and Higher Relapse Frequency May Predict Poor Recovery after Optic Neuritis in MS Patients |
| Q71168786 | Retinal and cortical evoked responses to chromatic contrast stimuli. Specific losses in both eyes of patients with multiple sclerosis and unilateral optic neuritis |
| Q68669701 | Retinal arteriolar occlusion and optic neuritis |
| Q39342993 | Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis |
| Q52836605 | Retinal ganglion cell and axonal loss in optic neuritis: risk factors and visual functions. |
| Q89455044 | Retinal ganglion cell function in recovered optic neuritis: Faster is not better |
| Q79331999 | Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis |
| Q91803697 | Retinal haemorrhage in a child with optic neuritis and acute disseminated encephalomyelitis |
| Q96773442 | Retinal microvasculature alterations in neuromyelitis optica spectrum disorders before optic neuritis |
| Q49540276 | Retinal nerve fiber layer and ganglion cell layer changes on optical coherence tomography in early multiple sclerosis and optic neuritis cases. |
| Q52980539 | Retinal nerve fiber layer thickness by Stratus and Cirrus OCT in retrobulbar optic neuritis and nonarteritic ischemic optic neuropathy. |
| Q33823769 | Retinal nerve fiber layer thickness changes following optic neuritis caused by multiple sclerosis |
| Q57068400 | Retinal nerve fiber layer thickness in optic neuritis with MOG antibodies: A systematic review and meta-analysis |
| Q57466598 | Retinal nerve fibre layer evaluation in multiple sclerosis patients with and without optic neuritis |
| Q34525419 | Retinal nerve fibre layer thinning in patients with clinically isolated optic neuritis and early treatment with interferon-beta |
| Q88326785 | Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome |
| Q91965056 | Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis |
| Q51213963 | Retinal segmented layers with strong aquaporin-4 expression suffered more injuries in neuromyelitis optica spectrum disorders compared with optic neuritis with aquaporin-4 antibody seronegativity detected by optical coherence tomography. |
| Q40443280 | Retinitis Pigmentosa and Bilateral Idiopathic Demyelinating Optic Neuritis in a 6-Year-Old Boy with OFD1 Gene Mutation |
| Q37771845 | Retinitis and optic neuritis in a child with chickenpox: case report and review of literature |
| Q104279410 | Retraction notice to Retinal microvasculature alterations in neuromyelitis optica spectrum disorders before optic neuritis [Multiple sclerosis and related disorders 44 (2020) 102277] |
| Q80766603 | Retrobulbar acute optic neuritis |
| Q44444810 | Retrobulbar chiasmatic optic neuritis during curable lymphocytic meningitis; relation to poliomyelitis |
| Q79580175 | Retrobulbar decadron in optic neuritis |
| Q67318843 | Retrobulbar optic neuritis |
| Q77394118 | Retrobulbar optic neuritis |
| Q43281020 | Retrobulbar optic neuritis after Hepatitis A vaccination in a HIV-infected patient |
| Q42549844 | Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria |
| Q45719038 | Retrobulbar optic neuritis and live attenuated influenza vaccine |
| Q46522753 | Retrobulbar optic neuritis and meningoencephalitis following progressive outer retinal necrosis due to CMV in a patient with AIDS. |
| Q69582636 | Retrobulbar optic neuritis and polyneuritis due to prolonged chloramphenicol therapy |
| Q30847365 | Retrobulbar optic neuritis and rhegmatogenous retinal detachment in a fourteen-year-old girl with retinitis pigmentosa sine pigmento |
| Q47735771 | Retrobulbar optic neuritis associated with infliximab in a patient with Crohn disease |
| Q82963550 | Retrobulbar optic neuritis associated with infliximab in a patient with Crohn's disease |
| Q44049764 | Retrobulbar optic neuritis associated with infliximab. |
| Q43807339 | Retrobulbar optic neuritis caused by Herxheimer's reaction |
| Q73193734 | Retrobulbar optic neuritis caused by toxicity from digitalis preparations |
| Q84792258 | Retrobulbar optic neuritis in a bevacizumab-treated patient with metastatic breast cancer |
| Q58378002 | Retrobulbar optic neuritis in a patient with acute type B hepatitis |
| Q43515968 | Retrobulbar optic neuritis in a two-year-old boy. |
| Q44539588 | Retrobulbar optic neuritis in the course of epidemic parotitis |
| Q43970500 | Retrobulbar optic neuritis in the course of methimazole therapy (a clinical case) |
| Q80258966 | Retrobulbar optic neuritis revealing primary anti-phospholipid antibody syndrome |
| Q42735806 | Retrobulbar optic neuritis: a complication of Lyme disease? |
| Q68695830 | Retrospective study of 117 patients with optic neuritis |
| Q42775176 | Reversible bilateral optic neuritis after Infliximab discontinuation in a patient with Crohn's disease |
| Q41664378 | Reversible blindness in optic neuritis associated with influenza vaccination |
| Q69677671 | Reversible optic neuritis secondary to paranasal sinusitis |
| Q58724635 | Rhinogenic Optic Neuritis Caused by Sphenoid Mucocele with Sinusitis |
| Q72420736 | Rhinogenous optic neuritis with drastic diurnal variation of visual function |
| Q91368458 | Rhinogenous optic neuritis with full recovery of vision - The role of endoscopic optic nerve decompression and a review of literature |
| Q34257416 | Risk factors for idiopathic optic neuritis recurrence |
| Q79297503 | Risk of Multiple Sclerosis After Optic Neuritis |
| Q68261498 | Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study |
| Q43420675 | Risk of multiple sclerosis after idiopathic optic neuritis in a Pakistani population. |
| Q39315140 | Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI. |
| Q52584863 | Rituximab was effective for acute disseminated encephalomyelitis followed by recurrent optic neuritis with anti-myelin oligodendrocyte glycoprotein antibodies. |
| Q102325904 | Rodent Models of Optic Neuritis |
| Q92656172 | Role of Diffusional Kurtosis Imaging in Differentiating Neuromyelitis Optica-Related and Multiple Sclerosis-Related Acute Optic Neuritis: Comparison With Diffusion-Weighted Imaging |
| Q82618962 | Role of NMO-IgG in distinguishing the type of optic neuritis |
| Q91378352 | Role of Plasma Exchange in the Management of Pediatric Optic Neuritis With Antibodies Against Myelin Oligodendrocyte Glycoprotein |
| Q88384636 | Role of coronal high-resolution diffusion-weighted imaging in acute optic neuritis: a comparison with axial orientation |
| Q68472541 | Role of nuclear magnetic resonance imaging in the diagnosis of monosymptomatic optic neuritis |
| Q85032790 | SECTIONS OF OPHTHALMOLOGY AND LARYNGOLOGY, JOINT DISCUSSION No. 6: DISCUSSION ON OPTIC NEURITIS IN ITS RELATION TO SINUSITIS |
| Q35971418 | SIRT1 activation confers neuroprotection in experimental optic neuritis |
| Q38946774 | Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial |
| Q97558621 | Safety and efficacy of plasma exchange for the treatment of optic neuritis in neuromyelitis optica spectrum disorders: A protocol for systematic review and meta-analysis |
| Q33597613 | Scanning laser polarimetry quantification of retinal nerve fiber layer thinning following optic neuritis |
| Q73145561 | Screening for Leber's hereditary optic neuropathy associated mitochondrial DNA mutations in patients with prominent optic neuritis |
| Q77446604 | Screening for mt-DNA mutations in optic neuritis of unknown cause |
| Q44926963 | Seasonal occurrence of optic neuritis |
| Q81506077 | Seasonal pattern of births in patients with optic neuritis |
| Q52926831 | Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis. |
| Q83748177 | Seeing optic neuritis through myopic eyes |
| Q44005568 | Segmental optic neuritis and ischemia of the optic nerve |
| Q100301824 | Selective plasma exchange for multiple sclerosis with optic neuritis |
| Q90958850 | Sensitive Assessment of Acute Optic Neuritis by a New, Digital Flicker Test |
| Q93036664 | Sensitivity of orbital magnetic resonance imaging in acute demyelinating optic neuritis |
| Q33997467 | Sensitivity to encephalitogenic protein in optic neuritis |
| Q92703712 | Sequential Optic Neuritis: A Neuromyelitis Optica Spectrum Disorder |
| Q48665414 | Serial Gadolinium-enhanced MRI in untreated patients with acute optic neuritis: implications for natural history. |
| Q49029308 | Serial MRI, VEP, SEP and biotesiometry in acute optic neuritis: value of baseline results to predict the development of new lesions at one year follow up. |
| Q79589017 | Serial fundus photographs of choroiditis, optic neuritis and papilloedema |
| Q43875468 | Serial quantitative MR assessment of optic neuritis in a case of neuromyelitis optica, using Gadolinium- "enhanced" STIR imaging |
| Q73148555 | Serial visual evoked potentials in 90 untreated patients with acute optic neuritis |
| Q92134336 | Serum Level of the Angiotensin-Converting Enzyme in Patients with Idiopathic Acute Optic Neuritis: A Case-Control Study |
| Q91946264 | Seven-year nationwide incidence of optic neuritis requiring intravenous methylprednisolone injection in Korean adults |
| Q67444548 | Severe "idiopathic" optic neuritis in a young patient |
| Q102977303 | Severe Bilateral Optic Neuritis: A Rare Presentation of Clinically Isolated Syndrome |
| Q44875428 | Severe bilateral optic neuritis associated with prolonged linezolid therapy |
| Q45341483 | Severe bilateral optic neuritis post hepatitis A virus (HAV) and typhoid fever vaccination |
| Q74130917 | Severe irreversible optic neuritis following Mantoux tuberculin skin test in a child with multiple sclerosis--a case report |
| Q42232119 | Severe myelopathy, peripheral neuropathy and optic neuritis appearing during treatment with chloroiodoquin (clioquinol) |
| Q36499017 | Severe optic neuritis in a patient with combined neuromyelitis optica spectrum disease and primary Sjögren's syndrome: a case report |
| Q68305862 | Severe optic neuritis in infectious mononucleosis |
| Q75945293 | Severe optic neuritis in infectious mononucleosis; report of a case |
| Q96773063 | Severe visual loss after one episode of anti-MOG optic neuritis |
| Q79664150 | Shift of temporal responsivity curve of pattern reversal visually evoked potentials to lower frequencies in patients after recovery from optic neuritis |
| Q88868491 | Short-term effect of additional apheresis on visual acuity changes in patients with steroid-resistant optic neuritis in neuromyelitis optica spectrum disorders |
| Q67471208 | Short-term effect of megadose steroid therapy in optic neuritis |
| Q82602518 | Should most patients with optic neuritis be tested for neuromyelitis optica antibodies and should this affect their treatment? |
| Q30993431 | Should patients with optic neuritis be treated with steroids? |
| Q44613669 | Side effects during treatment with Solu-Medrol for optic neuritis in the course of MS |
| Q48871173 | Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial. |
| Q64959250 | Simultaneous Bilateral Optic Neuritis Following Human Papillomavirus Vaccination in a Young Child. |
| Q90997019 | Simultaneous bilateral optic neuritis in China: clinical, serological and prognostic characteristics |
| Q48896378 | Simvastatin improves final visual outcome in acute optic neuritis: a randomized study. |
| Q84578151 | Simvastatin in acute optic neuritis |
| Q90806945 | Sjögren Disease and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis |
| Q92739509 | Sleep disturbance and cognitive decline in multiple sclerosis patients with isolated optic neuritis as the first demyelinating event |
| Q36810935 | Smoking and optic neuritis |
| Q33366345 | Some remarks on the clinical and genetic puzzle of Leber's optic neuritis |
| Q85952678 | Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history |
| Q83481838 | Sphenoid sinus carcinoma mimicking retrobulbar optic neuritis |
| Q64978627 | Sphenoid sinus mucocele masquerading as retrobulbar optic neuritis: a case report. |
| Q44801833 | Spontaneously curable forms of Leber's optic neuritis |
| Q51069347 | Statistical analysis of visual evoked potentials in optic neuritis and ischemic optic neuropathy subjects. |
| Q74562368 | Steady-state PVECP is superior to transient PVECP in the diagnosis of optic neuritis |
| Q51535841 | Stellate ganglion block improved loss of visual acuity caused by retrobulbar optic neuritis after herpes zoster. |
| Q84510863 | Stereoacuity testing discloses abnormalities in multiple sclerosis without optic neuritis |
| Q85343648 | Steroid responsive rhombencephalitis and optic neuritis with autoimmune thyroid disease |
| Q33912538 | Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials |
| Q75847147 | Streptomycin causing retrobulbar optic neuritis; case report |
| Q36059954 | Structural Alterations of Segmented Macular Inner Layers in Aquaporin4-Antibody-Positive Optic Neuritis Patients in a Chinese Population |
| Q89138153 | Structural and visual functional deficits in a rat model of neuromyelitis optica spectrum disorders related optic neuritis |
| Q72931346 | Studies on humoral immunity and HLA antigens in multiple sclerosis, optic neuritis and hereditary optic atrophy |
| Q39396086 | Studies on the geographic clustering of multiple sclerosis and optic neuritis in Finland |
| Q72827907 | Studies on the natural history of multiple sclerosis. 2. The progression of optic neuritis to multiple sclerosis |
| Q71625486 | Sub-tenon steroid injection for optic neuritis |
| Q42231649 | Subacute neuromyelitis with optic neuritis following chloroiodoquine. A new case |
| Q73988913 | Subacute sclerosing panencephalitis presenting as optic neuritis |
| Q43505294 | Subclinical optic neuritis in neuromyelitis optica |
| Q39221487 | Subtle disturbances of vision after optic neuritis elicited by studying contrast sensitivity |
| Q104136673 | Successful oral treatment of third cranial nerve palsy and optic neuritis from neglected herpes zoster in an immunocompetent patient |
| Q45307526 | Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis |
| Q46341702 | Successful resolution of cryptococcal meningitis and optic neuritis in an adult horse with oral fluconazole |
| Q72079384 | Sudden blindness. Report of a case due to bilateral optic neuritis in a four year old child |
| Q33538725 | Sudomotor dysfunction in patients with optic neuritis |
| Q24294447 | Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis |
| Q70487501 | Supraliminal contrast sensitivity functions in recovered optic neuritis |
| Q40337794 | Suspecting optic neuritis, diagnosing Bartonella cat scratch disease |
| Q84353395 | Sustained motion perception deficit following optic neuritis: Behavioral and cortical evidence |
| Q68591025 | Symptomatic optic neuritis (etiological factors in acute optic neuritis) |
| Q71211131 | Symptomatology of optic neuritis |
| Q67312962 | Symptoms, signs and early course of optic neuritis |
| Q38383570 | Syphilitic uveitis and optic neuritis in Sydney, Australia |
| Q37573333 | Systemic Sclerosis Presenting with Simultaneous Retinal Vasculitis in One Eye and Optic Neuritis in the other along with Severe Immune Haemolytic Anaemia |
| Q81655442 | Systemic T-cell activation in acute clinically isolated optic neuritis |
| Q67364257 | Systemic lupus erythematosus presenting as optic neuritis |
| Q37174824 | Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review |
| Q48329817 | T cells recognizing multiple peptides of myelin basic protein are found in blood and enriched in cerebrospinal fluid in optic neuritis and multiple sclerosis |
| Q69373451 | T-lymphocyte subpopulations in acute unilateral optic neuritis |
| Q94329941 | THE POSSIBLE FUNCTIONS OF THE CEREBRO-SPINAL FLUID AND OPTIC NEURITIS |
| Q37015317 | Takayasu arteritis associated with ulcerative colitis and optic neuritis: first case in Korea |
| Q39167264 | Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis. |
| Q37942092 | Tau protein: a possible prognostic factor in optic neuritis and multiple sclerosis |
| Q97535418 | Teaching NeuroImages: Bilateral optic neuritis: When to suspect anti-MOG antibodies |
| Q99364212 | Teaching NeuroImages: Central serous chorioretinopathy after corticosteroid treatment for optic neuritis |
| Q59100321 | Temporal and spatial response properties of optic neuritis patients manifesting statokinetic dissociation |
| Q71162022 | Temporal contrast sensitivity in optic neuritis and amblyopia |
| Q48456058 | Temporal frequency discrimination in optic neuritis and multiple sclerosis. |
| Q72684929 | Temporal modulation transfer function of vision by pattern visual evoked potentials in patients with optic neuritis |
| Q69599366 | The 'flicker test' according to Aulhorn in the diagnosis of acute optic neuritis |
| Q77441720 | The 5-year risk of MS after optic neuritis |
| Q93913029 | The 5-year risk of MS after optic neuritis |
| Q93913033 | The 5-year risk of MS after optic neuritis |
| Q48579290 | The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. |
| Q28208059 | The 5-year risk of MS after optic neuritis: experience of the optic neuritis treatment trial. 1997 |
| Q71626567 | The Aetiology of Optic Neuritis |
| Q34227268 | The Association of Optic Neuritis, Facial Paralysis, and Facial Hemiatrophy |
| Q67997534 | The Aulhorn flicker test: possibilities and limits. Its use in optic neuritis for diagnosis, differential diagnosis, monitoring the course of the disease, and assessing the effect of oral prednisolone |
| Q35640735 | The Correlation between Aquaporin-4 Antibody and the Visual Function of Patients with Demyelinating Optic Neuritis at Onset |
| Q90572937 | The Course of Visual Recovery after Optic Neuritis: Experience of the Optic Neuritis Treatment Trial |
| Q30995944 | The Diagnosis and Treatment of Optic Neuritis |
| Q90637884 | The Most/Common Eye Manifestation in Multiple Sclerosis: Optic Neuritis |
| Q73640346 | The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial |
| Q99402682 | The Oldest Japanese Case of Combined Central and Peripheral Demyelination, which Developed Nine Years After the First Instance of Optic Neuritis |
| Q70194929 | The Optic Neuritis Treatment Trial |
| Q90572933 | The Optic Neuritis Treatment Trial |
| Q70932495 | The Optic Neuritis Treatment Trial. Putting the results in perspective. The Optic Neuritis Study Group |
| Q43672100 | The SKILL Card test in optic neuritis: experience of the Optic Neuritis Treatment Trial. Smith-Kettlewell Institute Low Luminance. Optic Neuritis Study Group |
| Q72600297 | The Tübingen Study on Optic Neuritis Treatment--a prospective, randomized and controlled trial |
| Q54858593 | The Value of Optic Neuritis in Medical Diagnosis. |
| Q69434327 | The aetiology of optic neuritis |
| Q90211473 | The application of RNFL thickness detection in early differential diagnosis among various types of idiopathic optic neuritis |
| Q91776567 | The astrocyte transcriptome in EAE optic neuritis shows complement activation and reveals a sex difference in astrocytic C3 expression |
| Q70081384 | The blink reflex and somatosensory evoked potential in optic neuritis in south India |
| Q72530923 | The changing role of MR imaging in the evaluation of acute optic neuritis |
| Q71741685 | The clinical and paraclinical profile of optic neuritis: a prospective study |
| Q33861485 | The clinical characteristics of optic neuritis in Korean children |
| Q48463712 | The clinical features, MRI findings, and outcome of optic neuritis in children. |
| Q34084313 | The clinical profile of childhood optic neuritis |
| Q67908670 | The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group |
| Q92546298 | The clinical spectrum and prognosis of idiopathic acute optic neuritis: A longitudinal study in Southern Finland |
| Q84353367 | The consequences of optic neuritis: more than meets the eye |
| Q72357289 | The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial |
| Q41206310 | The dyschromatopsia of optic neuritis is determined in part by the foveal/perifoveal distribution of visual field damage |
| Q34211288 | The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial |
| Q33630430 | The early risk of multiple sclerosis after optic neuritis |
| Q81727328 | The effect of contrast reduction on pattern-reversal VEPs in suspected multiple sclerosis and optic neuritis |
| Q34344201 | The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group |
| Q43266633 | The effect of interferon beta-1a on optic neuritis relapse in patients with multiple sclerosis |
| Q60029282 | The effect of oral prednisolone on visual evoked potential latencies in acute optic neuritis monitored in a prospective, randomized, controlled study |
| Q33713762 | The electrophysiological examination in acute optic neuritis and during their recovery. |
| Q50540092 | The epidemiology of optic neuritis in Finland |
| Q81806573 | The etiology of optic neuritis in Asian population |
| Q104740197 | The eyes have it: CNS leukemia presenting as optic neuritis |
| Q44799068 | The first rapid onset optic neuritis after measles-rubella vaccination: case report |
| Q68416117 | The germline repertoire of T-cell receptor beta chain genes in patients with relapsing/remitting multiple sclerosis or optic neuritis |
| Q73204125 | The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists |
| Q50587407 | The incidence of optic neuritis and its prognosis for multiple sclerosis. |
| Q50754653 | The incidence of optic neuritis in Split-Dalmatia county, Croatia. |
| Q38227109 | The investigation of acute optic neuritis: a review and proposed protocol |
| Q37849770 | The limited demyelinating diseases: the voyage of optic neuritis and transverse myelitis to multiple sclerosis and neuromyelitis |
| Q72361197 | The naso-sinusal factor in optic neuritis |
| Q30958657 | The natural history of recurrent optic neuritis |
| Q52147517 | The number of optic neuritis attacks is a potential confounder when comparing patients with NMO vs. controls by voxel-based neuroimaging analysis. |
| Q68068472 | The optic neuritis treatment trial. Implications for clinical practice. Optic Neuritis Study Group |
| Q46484735 | The optic neuritis treatment trial: a definitive answer and profound impact with unexpected results |
| Q33571547 | The optic neuritis treatment trial: implications for clinicians |
| Q72566220 | The optic neuritis treatment trial: three-year follow-up results |
| Q69420913 | The outcome of optic neuritis |
| Q34469161 | The pathogenesis of optic neuritis caused by Angiostrongylus cantonensis in BALB/c mice |
| Q39377524 | The pattern electroretinogram: N95 amplitudes in normal subjects and optic neuritis patients |
| Q66880601 | The pattern evoked responses (VER) in optic neuritis |
| Q48390404 | The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis. Optic Neuritis Study Group |
| Q43807076 | The presentation, aetiology, management and outcome of optic neuritis in an Asian population |
| Q90310158 | The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis |
| Q73843052 | The probability of developing multiple sclerosis following an episode of optic neuritis |
| Q53959271 | The problem of optic neuritis in an African with cerebrospinal fluid oligoclonal bands: a case report. |
| Q73505717 | The prognosis of idiopathic optic neuritis |
| Q38585660 | The putative acceleration of optic neuritis when combined with chronic hepatitis B. |
| Q36025920 | The relationship between HLA-DRB1 alleles and optic neuritis in Irish patients and the risk of developing multiple sclerosis |
| Q85194876 | The relatively benign course of patients initially presenting with unilateral optic neuritis |
| Q44285332 | The retinal nerve fiber layer of patients with neuromyelitis optica and chronic relapsing optic neuritis is more severely damaged than patients with multiple sclerosis |
| Q58552722 | The retinoprotective role of phenytoin |
| Q37141903 | The risk of multiple sclerosis developing in patients with isolated idiopathic optic neuritis in Brazil |
| Q33546518 | The risk of multiple sclerosis development in patients with idiopathic optic neuritis: prognosis and other problems |
| Q42144082 | The role of infection and vaccination in the genesis of optic neuritis and multiple sclerosis in children |
| Q33860213 | The role of magnetic resonance imaging and visual evoked potential in management of optic neuritis |
| Q53872318 | The role of optical coherence tomography (OCT) in optic neuritis (ON). |
| Q72361193 | The role of sinusitis in the etiology of retrobulbar optic neuritis |
| Q84500668 | The role of visual evoked potentials in the differential diagnosis of functional visual loss and optic neuritis in children |
| Q44020131 | The socioeconomic consequences of optic neuritis with and without multiple sclerosis: a controlled national study |
| Q68642860 | The treatment of optic neuritis |
| Q34005484 | The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis |
| Q73143845 | The value of neurophysiological and MRI assessment in demyelinating optic neuritis (DON) |
| Q87851452 | The value of tests evaluating visual functions in detecting overt or subclinical optic neuritis in multiple sclerosis |
| Q69420996 | The visual evoked potential contrast response function in recovering optic neuritis |
| Q70955795 | The visual-evoked cortical potential to colour stimuli in multiple sclerosis and optic neuritis |
| Q67837764 | The visually evoked cortical potentials (VECPs) in optic neuritis (author's transl) |
| Q72430364 | Therapeutic problems in optic neuritis of sinus origin |
| Q71396093 | Therapy of optic neuritis |
| Q48281065 | Thickness of macular inner retinal layers and peripapillary retinal nerve fibre layer in neuromyelitis optica spectrum optic neuritis and isolated optic neuritis with one episode |
| Q84431356 | Thirty-one episodes of myelitis and optic neuritis in a woman with neuromyelitis optica and systemic lupus erythematosus |
| Q34351429 | Three-dimensional geometries representing the retinal nerve fiber layer in multiple sclerosis, optic neuritis, and healthy eyes. |
| Q48006469 | Three-way ROC validation of rs-fMRI visual information propagation transfer functions used to differentiate between RRMS and CIS optic neuritis patients. |
| Q42985703 | Tick-borne encephalitis virus as a possible cause of optic neuritis in a dog. |
| Q92244050 | Time is tissue in optic neuritis |
| Q60433376 | Time to steroid treatment in severe acute optic neuritis |
| Q33845112 | Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis |
| Q81386101 | To test or not to test: NMO-IgG and optic neuritis |
| Q92510806 | Tocilizumab treatment in severe recurrent anti-MOG-associated optic neuritis |
| Q72556602 | Toxic optic neuritis due to IMAO |
| Q42215933 | Toxic optic neuritis induced by ethambutol: a reality |
| Q67357659 | Toxic optic neuritis: amblyopia caused by tobacco and alcohol (author's transl) |
| Q68608256 | Toxoplasma gondii retinochoroiditis and optic neuritis in acquired immune deficiency syndrome. Report of a case |
| Q46523193 | Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography |
| Q49051471 | Tracking the recovery of local optic nerve function after optic neuritis: a multifocal VEP study. |
| Q92968761 | Trans-orbital sonography versus visual evoked potentials in acute demyelinating optic neuritis |
| Q41545569 | Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis |
| Q89713033 | Transbulbar B-mode sonography in multiple sclerosis without optic neuritis; clinical relevance |
| Q41593328 | Transient optic neuritis following tetramisole |
| Q39282409 | Transient visually evoked potentials to sinusoidal gratings in optic neuritis |
| Q56781012 | Transorbital Sonography and Visual Outcome for the Diagnosis and Monitoring of Optic Neuritis |
| Q56781098 | Transorbital Sonography in Acute Optic Neuritis: A Case-Control Study |
| Q92713572 | Transorbital ultrasonography in acute optic neuritis: Can it be a supportive diagnostic tool? |
| Q49203745 | Transverse myelitis and bilateral optic neuritis in a patient with systemic lupus erythematosus. |
| Q69267479 | Transverse myelitis and optic neuritis in systemic lupus erythematosus: a case report with magnetic resonance imaging findings |
| Q66881406 | Treatmenf of optic neuritis by retrobulbar injection of triamcinolone |
| Q89260795 | Treatment Choices in Optic Neuritis: Corticosteroids, Intravenous Immunoglobulin, Plasma Exchange, or Other? |
| Q40094670 | Treatment and prognosis of toxic optic neuritis caused by methyl alcohol |
| Q30974206 | Treatment of acute demyelinating optic neuritis |
| Q38268540 | Treatment of acute optic neuritis and vision complaints in multiple sclerosis |
| Q46484740 | Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial |
| Q42595540 | Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin |
| Q42206055 | Treatment of cytomegalovirus optic neuritis with dihydroxy propoxymethyl guanine. |
| Q30891403 | Treatment of optic neuritis |
| Q70211947 | Treatment of optic neuritis |
| Q72414093 | Treatment of optic neuritis |
| Q72643616 | Treatment of optic neuritis |
| Q84551125 | Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica |
| Q36670604 | Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol |
| Q68270424 | Treatment of optic neuritis with intravenous megadose corticosteroids. A consecutive series |
| Q70017331 | Treatment of optic neuritis with megadose corticosteroids |
| Q28335884 | Treatment of severe optic neuritis caused by ethambutol |
| Q50996129 | Treatment of steroid-unresponsive optic neuritis with plasma exchange. |
| Q72797484 | Treatment of toxocaral optic neuritis |
| Q38275636 | Treatment options for atypical optic neuritis |
| Q95522376 | Treatment with atacicept enhances neuronal cell death in a rat model of optic neuritis |
| Q100444096 | Trends in Optic Neuritis Incidence and Prevalence in the UK and Association With Systemic and Neurologic Disease |
| Q79532878 | Tryparsamide optic neuritis treated by 2,3 dimercaptopropanol (BAL) |
| Q79037337 | Tuberculous Allergy as the Cause of Retrobulbar Optic Neuritis in Japan |
| Q43046024 | Tuberculous meningitis-related optic neuritis: recovery of vision with thalidomide in 4 consecutive cases |
| Q44893483 | Tuberculous optic neuritis histologically resembling leprous neuritis |
| Q87030831 | Tuberculous optic neuritis: A case report |
| Q33193367 | Tuberculous osteomyelitis and optic neuritis |
| Q82961174 | Tularemia induced bilateral optic neuritis |
| Q92026577 | Tumefactive Demyelination Associated with Bilateral Optic Neuritis in Neuromyelitis Optica Spectrum Disorders |
| Q68085185 | Tumor necrosis factor alpha gene polymorphism in multiple sclerosis and optic neuritis |
| Q41680642 | Two Cases of Optic Neuritis (? Cerebral Tumour). |
| Q93107396 | Two Cases of Optic Neuritis of Intracranial Origin |
| Q53988177 | Two cases of recurrent optic neuritis (OPN) and acute transverse myelopathy (ATM) with associated anticardiolipin antibodies |
| Q70074424 | Two cases of the diagnosis of optic neuritis leading to the diagnosis of multiple sclerosis |
| Q93652047 | Two common neuro-ophthalmic problems. Optic neuritis and transient visual disturbances |
| Q73248498 | Two ultraviolet radiation-induced episodes of optic neuritis in a patient with antinuclear antibody |
| Q40090090 | UNILATERAL OPTIC NEURITIS AND CENTRAL RETINAL VASCULITIS DUE TO OCULAR SYPHILIS. |
| Q42017253 | Uhthoff's symptom in optic neuritis: relationship to magnetic resonance imaging and development of multiple sclerosis |
| Q28067223 | Uhthoff`s phenomenon 125 years later - what do we know today? |
| Q88332177 | Ultrasonic Elastography Evaluation in Optic Neuritis |
| Q71584182 | Ultrasonographic investigation of optic neuritis |
| Q42018376 | Ultrasonography in distinguishing optic neuritis from nonarteritic anterior ischemic optic neuropathy |
| Q91465050 | Ultrasound and optic neuritis |
| Q91227712 | Ultrasound optic nerve sheath diameter measurement in optic neuritis |
| Q93113859 | Ultrasound-Assisted Diagnosis of Optic Neuritis in the Emergency Department: A Case Report |
| Q59273716 | Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Optic Neuritis |
| Q33757445 | Unilateral Measles-Associated Retrobulbar Optic Neuritis without Encephalitis: A Case Report and Literature Review |
| Q41244781 | Unilateral Optic Neuritis and Complete Ophthalmoplegia Externa resulting from Acute Sphenoidal Sinusitis. |
| Q96635257 | Unilateral Optic Neuritis in Children: Experience of a Tertiary Centre |
| Q36861056 | Unilateral Optic Neuritis: A Rare Complication after Measles-Mumps-Rubella Vaccination in a 30-Year-Old Woman |
| Q104581270 | Unilateral optic disc drusen mis-diagnosed as optic neuritis: Diagnostic and therapeutic implications |
| Q43916287 | Unilateral optic neuritis and Miller Fisher syndrome |
| Q42081948 | Unilateral optic neuritis as a presentation of neurobrucellosis |
| Q45399375 | Unilateral optic neuritis as the presenting symptom of human immunodeficiency virus toxoplasmosis infection |
| Q70991528 | Unilateral optic neuritis caused by Histoplasma capsulatum in a patient with the acquired immunodeficiency syndrome |
| Q43919560 | Unilateral optic neuritis in a Chinese population in three centers |
| Q42250576 | Unilateral optic neuritis, scleritis and exudative retinal detachment due to recurrent orbital pseudotumor |
| Q46983318 | Unilateral papilledema: a case of optic neuritis diagnosed with bedside ocular sonography |
| Q36171445 | Unilateral retrobulbar optic neuritis due to varicella zoster virus in a patient with AIDS: a case report and review of the literature |
| Q43902500 | Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion |
| Q38505710 | Unusual case of bilateral optic neuritis in Lyme neuroborreliosis |
| Q88923071 | Unusual case of cerebral demyelination and bilateral optic neuritis in an infant with suppurative BCG lymphadenitis |
| Q36077577 | Unusual intranuclear filaments in the circulating lymphocytes of patients with multiple sclerosis and optic neuritis |
| Q89986439 | Update on Pediatric Optic Neuritis |
| Q92746911 | Update on pediatric optic neuritis |
| Q41784430 | Updated recommendations from the Optic Neuritis Treatment Trial. |
| Q35592042 | Use of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid dependent optic neuritis not associated with demyelinating disease. |
| Q74710748 | Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy |
| Q71662412 | Use of pattern electroretinography to differentiate acute optic neuritis from acute anterior ischemic optic neuropathy |
| Q37197191 | Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders. |
| Q90365092 | Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis |
| Q66863062 | Uveitis and optic neuritis as an expression of autoimmune disease |
| Q78614708 | Uveitis, glaucoma, and optic neuritis |
| Q96136709 | Uveitis, optic neuritis and MOG |
| Q89518162 | VENOUS STASIS RETINOPATHY SECONDARY TO MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-POSITIVE OPTIC NEURITIS |
| Q60283895 | VISUAL LOSS IN MULTIPLE SCLEROSIS AND ITS RELATION TO PREVIOUS OPTIC NEURITIS, DISEASE DURATION AND CLINICAL CLASSIFICATION |
| Q85652800 | Vaccination-induced bilateral optic neuritis: rare but existing |
| Q98186063 | Validation of inter-eye difference thresholds in optical coherence tomography for identification of optic neuritis in multiple sclerosis |
| Q51224359 | Valproic acid and ASK1 deficiency ameliorate optic neuritis and neurodegeneration in an animal model of multiple sclerosis. |
| Q92996867 | Varicella Zoster Meningitis, Optic Neuritis Preceding the Development of Posterior Outer Retinal Necrosis, and Central Retinal Artery Occlusion in a HIV Patient |
| Q68278638 | Varicella optic neuritis |
| Q44441091 | Varicella zoster virus retrobulbar optic neuritis preceding retinitis in patients with acquired immune deficiency syndrome |
| Q45767395 | Varicella-zoster virus retrobulbar optic neuritis in a patient with human immunodeficiency virus |
| Q69935747 | Various stages of optic neuritis assessed by subjective brightness of flicker |
| Q41677192 | Vascular hypoperfusion in acute optic neuritis is a potentially new neurovascular model for demyelinating diseases |
| Q94214719 | Vasodilatator therapy with monoethanol amine nicotinate of post-hemorrhagic acute optic neuritis |
| Q44810269 | Vasodilator treatment by repeated retrobulbar injections of alcohol-nicotine-induced optic neuritis |
| Q37074784 | Vasopressin test in cases of optic atrophy and optic neuritis |
| Q99636285 | Vestibulo ocular reflex in multiple sclerosis patients without any optic neuritis |
| Q43625053 | Virus antibodies in patients of optic neuritis (author's transl) |
| Q39930644 | Virus antibody levels in serum specimens from patients with optic neuritis and from matched controls; |
| Q90570063 | Vision Loss from Atypical Optic Neuritis: Patient and Physician Perspectives |
| Q69653872 | Vision disturbances in optic neuritis |
| Q99350766 | Vision improvement in severe acute isolated optic neuritis after plasma exchange treatment in Chinese population: a prospective case series study |
| Q90939646 | Visual Evoked Potentials as a Biomarker in Multiple Sclerosis and Associated Optic Neuritis |
| Q54253513 | Visual Outcomes and Clinical Manifestations of Pediatric Optic Neuritis in Indian Population: An Institutional Study. |
| Q90979605 | Visual Outcomes of Adding Erythropoietin to Methylprednisolone for Treatment of Retrobulbar Optic Neuritis |
| Q92616042 | Visual Outcomes of Plasma Exchange Treatment of Steroid-Refractory Optic Neuritis: A Retrospective Monocentric Analysis |
| Q66939868 | Visual Parameters Associated with Recovered Retrobulbar Optic Neuritis |
| Q40854645 | Visual activation patterns in patients with optic neuritis: an fMRI pilot study. |
| Q92516974 | Visual but not verbal working memory interferes with balance in patients after optic neuritis suggestive of multiple sclerosis |
| Q38223035 | Visual electrophysiology in the clinical evaluation of optic neuritis, chiasmal tumours, achiasmia, and ocular albinism: an overview |
| Q68540171 | Visual evoked blink reflex in optic neuritis |
| Q67769729 | Visual evoked potential and relative afferent pupillary defect in patients with unilateral optic neuritis |
| Q42133681 | Visual evoked potentials in chessboard pattern reversion in children with optic neuritis |
| Q32067617 | Visual evoked responses in ethambutol induced optic neuritis |
| Q33643151 | Visual fatigue phenomenon and prescribing tinted lenses in patients with optic neuritis |
| Q73318709 | Visual field changes in optic neuritis |
| Q74442657 | Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features |
| Q73217988 | Visual field defects in the optic neuritis treatment trial: central vs peripheral, focal vs global |
| Q33611158 | Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis |
| Q97434075 | Visual field loss and structure-function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody |
| Q46149388 | Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial |
| Q33938131 | Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years |
| Q72546439 | Visual fields in optic neuritis |
| Q53171007 | Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. |
| Q73945208 | Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group |
| Q70135474 | Visual function after optic neuritis: a preliminary study |
| Q89563662 | Visual function and inner retinal structure correlations in aquaporin-4 antibody-positive optic neuritis |
| Q33645785 | Visual function and pattern visual evoked response in optic neuritis |
| Q40186381 | Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome |
| Q70939822 | Visual function in patients with optic neuritis associated with acute transverse myelopathy in multiple sclerosis |
| Q53360219 | Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. |
| Q45298102 | Visual functions in optic neuritis |
| Q67769763 | Visual functions of optic neuritis in children caused by demyelinating disease |
| Q48920669 | Visual loss in multiple sclerosis and its relation to previous optic neuritis, disease duration and clinical classification. |
| Q64930079 | Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: a clinical case series. |
| Q38041953 | Visual outcome following optic neuritis: a 5-year review |
| Q58795812 | Visual outcome is similar in optic neuritis patients treated with oral and i.v. high-dose methylprednisolone: a retrospective study on 56 patients |
| Q58920776 | Visual outcomes in pediatric optic neuritis |
| Q90920432 | Visual prognosis in seronegative idiopathic optic neuritis finally elucidated: as bad as that in anti-AQP4 antibody-positive optic neuritis |
| Q61861990 | Visual recovery following acute optic neuritis |
| Q68192470 | Visual recovery in patients with optic neuritis and visual loss to no light perception |
| Q53602824 | Visual symptoms after optic neuritis. Results from the Optic Neuritis Treatment Trial. |
| Q53580188 | Visual symptoms after optic neuritis: results from the Optic Neuritis Treatment Trial. |
| Q67401687 | Visual-evoked response differentiation of ischemic optic neuritis from the optic neuritis of multiple sclerosis |
| Q28325126 | Visually evoked cortical potentials for early detection of optic neuritis in ethambutol therapy |
| Q72910110 | Vogt-Koyanagi syndrome with optic neuritis |
| Q34279673 | West Nile virus-associated optic neuritis and chorioretinitis |
| Q72816143 | What have the optic neuritis treatment trial and the longitudinal optic neuritis study shown us? |
| Q43662997 | What have we learned from the multicenter study on optic neuritis corticosteroid treatment? |
| Q68022048 | What to tell the patient with optic neuritis about multiple sclerosis |
| Q28307319 | What we have learned from the Optic Neuritis Treatment Trial |
| Q70998556 | What we have learned from the optic neuritis treatment trial |
| Q36776885 | White and Gray Matter Volume Changes and Correlation with Visual Evoked Potential in Patients with Optic Neuritis: A Voxel-Based Morphometry Study |
| Q91967742 | Whole exome sequencing in a child with acute disseminated encephalomyelitis, optic neuritis, and periodic fever syndrome: a case report |
| Q89164615 | Why Therapeutic Compliance in Optic Neuritis Deserves to Be More Than Just a Footnote: Response |
| Q89101269 | Why Therapeutic Compliance in Optic Neuritis Deserves to be More Than Just a Footnote |
| Q83010840 | Why we should treat idiopathic optic neuritis with high-dose and long-term corticosteroids in China |
| Q48129982 | Words: Perception, "-Omics" Another Epidemic? Vaccine Optic Neuritis; An Amblyopia Symposium; Strasbismus surgery anesthesia |
| Q86198932 | You're the Flight Surgeon: optic neuritis |
| Q46046687 | Zolendronic acid-induced retrobulbar optic neuritis: a case report |
| Q94945822 | [A 25-year-old woman with primary Sjögren syndrome who developed optic neuritis and encephalomyelitis associated with an anti-aquaporin 4 antibody] |
| Q84858848 | [A case of Charles Bonnet syndrome following syphilitic optic neuritis] |
| Q69728159 | [A case of Graves-Basedow optic neuritis treated by orbital decompression using Ogura's technic] |
| Q73037557 | [A case of Leber's idiopathic stellate retinitis and optic neuritis] |
| Q73308856 | [A case of acute transverse myelopathy and bilateral optic neuritis associated with anticardiolipin antibodies, lupus anticoagulant and perinuclear antineutrophil cytoplasmic antibodies] |
| Q57065651 | [A case of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-N-methyl-D-aspartate (NMDA) receptor antibody-positive encephalitis with optic neuritis] |
| Q71823178 | [A case of bilateral optic neuritis and polyneuritis associated with Mycoplasma pneumoniae infection] |
| Q73819360 | [A case of bilateral optic neuritis of sinusoid origin treated by an operation after de Lima] |
| Q68109319 | [A case of bilateralized stunning retrobulbar optic neuritis in multiple sclerosis] |
| Q72026818 | [A case of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated with acute bilateral optic neuritis with normal findings on pattern-reversal visual evoked potential study] |
| Q89140409 | [A case of early systemic lupus erythematosus complicated with optic neuritis] |
| Q73033174 | [A case of optic neuritis as the only symptom in lead poisoning] |
| Q79967716 | [A case of optic neuritis associated with Crohn's disease] |
| Q83569694 | [A case of optic neuritis associated with lymphocytic hypophysitis revealed by pattern-reversal VEP] |
| Q70478602 | [A case of optic neuritis following rubella encephalitis] |
| Q68666172 | [A case of optic neuritis in a child with systemic lupus erythematosus] |
| Q78746334 | [A case of retrobulbar optic neuritis associated with Sjögren syndrome which remitted spontaneously] |
| Q74675990 | [A case of retrobulbar optic neuritis with cervical herpes zoster] |
| Q69767641 | [A comparison of central visual field measurement by automated perimetry in optic neuritis due to multiple sclerosis and of unknown etiology] |
| Q69153226 | [A differential diagnostic test for optic neuritis] |
| Q73223240 | [A further case of acute edematous optic neuritis] |
| Q78447642 | [A new treatment of optic neuritis caused by alcohol and tobacco; vitamin B6 in massive doses] |
| Q77706847 | [A risk of developing multiple sclerosis following an outbreak of optic neuritis during a mean follow-up of 4.5 years] |
| Q77057116 | [A variant form of septo-optic-pituitary dysplasia (SOPD) complicated with acute optic neuritis] |
| Q76246120 | [Acute bilateral optic neuritis following ethmoiditis] |
| Q75478846 | [Acute edematous optic neuritis and cervical discopathy; recovery of vision and disappearance of edema by extension of the neck] |
| Q73354418 | [Acute optic neuritis and general treatment by cortisone] |
| Q73590539 | [Acute optic neuritis in children: clinical features and treatment. A study of 28 eyes in 20 children] |
| Q78028804 | [Acute optic neuritis: clinical and MRI prognostic factors. Study of fifty patients] |
| Q69736495 | [Acute optic neuritis] |
| Q75507637 | [Acute papilledema and cervical disk disorder recovery of vision and disappearance of edema by extension of the neck; optic neuritis and acroparesthesia syndrome.] |
| Q71348486 | [Acute retrobulbar optic neuritis and adrenaline] |
| Q54757394 | [Acute retrobulbar optic neuritis of tuberculous origin]. |
| Q77140680 | [Acute retrobulbar optic neuritis; rapid recovery with tetracycline & prednisone therapy] |
| Q74442743 | [Adaptometric, campimetric & electrophysiological research; findings in 2 cases of retrobulbar optic neuritis] |
| Q74140318 | [Advances in the treatment of optic neuritis] |
| Q83415419 | [Analysis of optical coherence tomography in early stage of optic neuritis in multiple sclerosis patients] |
| Q69031325 | [Anomalies of the pupils and pupillary reflexes in patients with multiple sclerosis and optic neuritis] |
| Q73704379 | [Anterior optic neuritis do to ulcerative colitis] |
| Q85929539 | [Anti-MOG antibody in different types of immune-mediated optic neuritis] |
| Q92625033 | [Anti-NMDAR encephalitis associated with relapsing optic neuritis: a case report and differential diagnosis] |
| Q97552455 | [Anti-NMDAR encephalitis associated with relapsing optic neuritis] |
| Q79166820 | [Apparently primary optic neuritis caused by mumps. Its diagnosis.] |
| Q72869264 | [Apropos of a further case of optic neuritis due to disulfiram] |
| Q72361200 | [Apropos of the role of the otorhinolaryngologist in optic neuritis] |
| Q102136405 | [Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis: Diagnosis and Treatment] |
| Q68064032 | [Atypical forms of optic neuritis of multiple sclerosis] |
| Q64389496 | [Atypical optic neuritis in systemic lupus erythematosus (SLE)] |
| Q97683330 | [Atypical optic neuritis: the importance of a comprehensive diagnostic work-up] |
| Q78443746 | [Bilateral axial optic neuritis during treatment with D860] |
| Q74382869 | [Bilateral edematous optic neuritis recurring after 2 years; results of neurosurgical treatment] |
| Q77811484 | [Bilateral optic neuritis and ponto-mesencephalic involvement shown by MRI in Miller-Fisher syndrome] |
| Q72419544 | [Bilateral optic neuritis and transverse myelitis associated with anticardiolipin antibodies] |
| Q73201351 | [Bilateral optic neuritis caused by chloramphenicol] |
| Q69793295 | [Bilateral optic neuritis following a 3-month period of Bisecurin therapy] |
| Q73938281 | [Bilateral optic neuritis; case report] |
| Q72648239 | [Bilateral posterior ischemic optic neuritis in an adolescent with diabetes mellitus with decompensated blood glucose homeostasis] |
| Q69455589 | [Bilateral progressive optic neuritis of unknown origin] |
| Q73978029 | [Bilateral retrobulbar optic neuritis caused by cancerous metastases into the arachnoid sheaths] |
| Q76240448 | [Bipolar arachnoiditis, edematous optic neuritis, and arachnoiditis of the pontocerebellar angle] |
| Q69756767 | [Borrelia burgdorferi infection with bilateral optic neuritis and intracerebral demyelinization lesions] |
| Q81643277 | [Brucellosis with multiple pulmonary nodules and optic neuritis] |
| Q71826469 | [CSF examinations in patients with optic neuritis] |
| Q80353878 | [Case of acute zonal occult outer retinopathy (AZOOR): a 15 years' mislabeling as retrobulbar optic neuritis] |
| Q75756916 | [Case of bilateral optic neuritis due to acute post-hemorrhagic anemia.] |
| Q46004291 | [Case of optic neuritis associated with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL)]. |
| Q72562784 | [Cellular immunoreaction to S-antigen in patients with uveitis and optic neuritis] |
| Q73037453 | [Central visual field in patients with multiple sclerosis without symptoms of optic neuritis] |
| Q54794751 | [Certain characteristics of the course of toxic optic neuritis caused by methyl alcohol poisoning] |
| Q74100251 | [Cervico-carotid sympathectomy in optic neuritis toxic and infectious optic neuritis; analysis of 10 cases] |
| Q73698319 | [Cervico-carotid sympathectomy in therapy of optic neuritis] |
| Q71895156 | [Changes in contrast sensitivity in children with optic neuritis] |
| Q67267406 | [Changes in contrast sensitivity in patients with multiple sclerosis with or without retrobulbar optic neuritis] |
| Q74109243 | [Chiasmatic syndrome: frequency of its non-pituitary origin; need for an early diagnosis with retrobulbular optic neuritis] |
| Q53860312 | [Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated with acute optic neuritis] |
| Q89168324 | [Clinical and immunological characteristics and predicted factors of vision outcome in patients with acute severe bilateral optic neuritis] |
| Q72433796 | [Clinical and morphological picture of retrobulbar optic neuritis] |
| Q78341607 | [Clinical association of optic neuritis with gastric hypo-or achlorhydria] |
| Q54591374 | [Clinical characteristic of optic neuritis and its relevancy with human leukocyte antigen]. |
| Q92174310 | [Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-positive optic neuritis] |
| Q90432315 | [Clinical characteristics, treatment and prognosis of myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in children] |
| Q80876247 | [Clinical peculiarities of optic neuritis and alterations of local immune response in patients with multiple sclerosis] |
| Q84896124 | [Clinical study of optic neuritis combined with viral hepatitis] |
| Q69460962 | [Color vision in multiple sclerosis with optic neuritis] |
| Q72576997 | [Comments on the editorial by G. Kommerell "Treatment of optic neuritis with corticosteroids"] |
| Q71884619 | [Comparative treatment of acute optic neuritis with "boluses" of intravenous methylprednisolone or oral prednisone] |
| Q68010062 | [Comparison of color vision and pattern VECP in optic neuritis] |
| Q73081486 | [Considerations on campimetric deficiency in optic neuritis] |
| Q74055686 | [Corticosteroids in the treatment of multiple sclerosis and optic neuritis] |
| Q87550401 | [Current recommendations on optic neuritis] |
| Q95622835 | [Current status and progress in diagnosis and treatments of pediatric optic neuritis] |
| Q71012616 | [Dental focal infections and optic neuritis] |
| Q74135839 | [Devic disease: a rare cause of retrobulbar optic neuritis: a case report] |
| Q75837799 | [Devic's disease; ascending myelitis with optic neuritis during measles] |
| Q79756759 | [Devic's neuromyelitis optica: diagnosis after 10 years of bilateral severe relapsing optic neuritis] |
| Q72806182 | [Diabetic optic neuritis] |
| Q69865803 | [Diagnosis and therapy of optic neuritis] |
| Q68052184 | [Diagnostic and treatment problems in optic neuritis] |
| Q87459098 | [Diagnostic clues for giant cell arteritis: beyond headache and ischemic optic neuritis] |
| Q50531812 | [Diagnostic studies of optic neuritis in children and adolescents]. |
| Q86051020 | [Differential diagnosis of optic neuritis (review] |
| Q69737517 | [Does optic neuritis due to cimetidine exist? An analysis of 3 cases] |
| Q71914574 | [Early and retrospective diagnosis of optic neuritis in multiple sclerosis] |
| Q73223293 | [Edematous optic neuritis during multiple sclerosis] |
| Q76125835 | [Edematous, acute optic neuritis] |
| Q73094755 | [Effect of vaccination programs on the incidence of idiopathic optic neuritis] |
| Q90268576 | [Effects of different treatment and prevention regimens on myelin oligodendrocyte glycoprotein antibody-related optic neuritis] |
| Q92174315 | [Effects of intravenous methylprednisolone pulse therapy on optic neuritis associated with AQP4 antibody seropositive neuromyelitis optica] |
| Q98723030 | [Effects of intravenous methylprednisolone pulse therapy on recurrent optic neuritis associated with aquaporin 4 antibody seropositive neuromyelitis optica] |
| Q72100980 | [Electrophysiological methods in assessing the risk for the development of multiple sclerosis in adolescents with monosymptomatic optic neuritis] |
| Q83420780 | [Encephalopathy coincide with optic neuritis in a child due to lead exposure] |
| Q50882065 | [Etiological and clinical characteristics of infectious optic neuritis] |
| Q68685383 | [Evaluation of the central visual field measured by automated perimeter octopus and pattern VECP in optic neuritis] |
| Q70650390 | [Experimental allergic optic neuritis in albino rabbits --light microscopic observations in the optic nerves-- (author's transl)] |
| Q71322123 | [Experimental allergic optic neuritis in albino rabbits. II. Electron microscopic observations in the optic nerves (author's transl)] |
| Q75716033 | [Familial retrobulbar optic neuritis (Leber's disease).] |
| Q75738518 | [Familial retrobulbar optic neuritis (Leber's disease).] |
| Q54391559 | [Familial retrobulbar optic neuritis (Leber's disease)]. |
| Q74516165 | [Follow-up studies of optic neuritis with lymphocytic adenohypophysitis] |
| Q67978996 | [Fourier analysis of pattern visual evoked potentials and changes of the harmonic component in longstanding optic neuritis] |
| Q68496642 | [Functional exploration of alcohol-tobacco induced optic neuritis] |
| Q69722748 | [Genetic and electroencephalographic study of a family with Leber's hereditary optic neuritis] |
| Q71998595 | [Glucocorticoid treatment of acute optic neuritis and multiple sclerosis risk] |
| Q92871741 | [Herpesviral infection as an etiological factor of acute idiopathic optic neuritis] |
| Q80660368 | [High-dose intravenous immunoglobulins for treatment of optic neuritis in Guillain-Barré syndrome] |
| Q71089928 | [Histopathological studies of chronic experimental optic neuritis] |
| Q78730615 | [Immunogenetics of optic neuritis in children with multiple sclerosis] |
| Q71124929 | [In the presence of optic neuritis, when can one eliminate multiple sclerosis?] |
| Q50598963 | [Incidence of acute idiopathic optic neuritis and its therapy in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG)]. |
| Q68698995 | [Induction of localized optic neuritis with lysophosphatidylcholine] |
| Q68530973 | [Inflammatory optic neuritis] |
| Q84530669 | [Inflammatory optic neuritis] |
| Q50211655 | [Investigation of color vision in acute unilateral optic neuritis using a web-based color vision test]. |
| Q83451617 | [Is it efficacy for the treatment of idiopathic optic neuritis with glucocorticosteroid] |
| Q80174006 | [Leber hereditary optic neuropathy and optic neuritis: similarities and differences of clinical characteristics] |
| Q73698819 | [Leber's atrophy and optic neuritis] |
| Q71196398 | [Leber's optic neuritis and micro-computers] |
| Q72122905 | [Long-term prolongation of direct pupillary light reflex latency and P100 latency of pattern visual evoked potential in unilateral optic neuritis] |
| Q68572581 | [MRI lesions of the optic nerves in optic neuritis] |
| Q69713997 | [Magnetic resonance imaging (MRI) in the diagnosis of optic neuritis and neuropathy] |
| Q77616210 | [Magnetic resonance imaging in 40 cases of optic neuritis] |
| Q54752625 | [Maxillary and sphenoid sinusitis complicated by acute inflammatory optic neuritis in a 12-year-old patient] |
| Q70111105 | [Meningoencephalitis in a primary cytomegalovirus infection. Localization to the brain stem with bilateral subclinical optic neuritis] |
| Q82181735 | [Multifocal chorioretinitis, papillitis, and recurrent optic neuritis in cat-scratch disease] |
| Q81219415 | [Multifocal visually evoked responses in two children with optic neuritis] |
| Q78268790 | [Mumps causing retrobulbar optic neuritis & corticotherapy] |
| Q84689375 | [Myasthenia gravis complicated with optic neuritis showing anti-aquaporin 4 antibody: a case report] |
| Q85796478 | [National clinical investigation of anti-aquaporin-4 seropositive optic neuritis] |
| Q104694354 | [Natural history and optic neuritis in multiple sclerosis] |
| Q71101619 | [Neuro-ophthalmologic control in patients following optic neuritis with inflammatory cerebrospinal fluid changes] |
| Q87447444 | [New aspects in the therapy of multiple sclerosis and optic neuritis] |
| Q73345082 | [New observation on acute intracanalicular edematous optic neuritis] |
| Q75665063 | [New series of optic neuritis cases operated on by endo-nasal route.] |
| Q76861338 | [OPTIC NEURITIS DURING PREGNANCY AND LACTATION.] |
| Q79065156 | [Optic neuritis (visual decline) caused by neoformation of the anterior and median level of the base of the cranium] |
| Q52759135 | [Optic neuritis after a bee sting]. |
| Q87166966 | [Optic neuritis after influenza vaccination in a patient after stem cell transplantation] |
| Q80168317 | [Optic neuritis after meningococcal vaccination] |
| Q79298702 | [Optic neuritis after tonsillectomy.] |
| Q34253804 | [Optic neuritis after treatment with Catran.] |
| Q78396472 | [Optic neuritis after varicella] |
| Q68493866 | [Optic neuritis and clioquinol] |
| Q69134002 | [Optic neuritis and ethambutol. 6 new cases] |
| Q81219737 | [Optic neuritis and infliximab] |
| Q69639927 | [Optic neuritis and its differential diagnosis] |
| Q73225640 | [Optic neuritis and measles infection] |
| Q77706842 | [Optic neuritis and multiple sclerosis] |
| Q70035360 | [Optic neuritis and myasthenia] |
| Q85343770 | [Optic neuritis and optic ischemic neuropathy: the problem of differential diagnosis] |
| Q73309974 | [Optic neuritis and sinus diseases] |
| Q74762133 | [Optic neuritis and the risk of development of multiple sclerosis] |
| Q79085737 | [Optic neuritis and tonsillopathies.] |
| Q71125942 | [Optic neuritis and vitamin C] |
| Q72873374 | [Optic neuritis appearing during treatment with clomiphene] |
| Q80598532 | [Optic neuritis as first manifestation of systemic lupus erythemathosus] |
| Q70805714 | [Optic neuritis as the 1st symptom of alcoholic neuropathy] |
| Q70718692 | [Optic neuritis as the first sign of multiple myeloma] |
| Q74135806 | [Optic neuritis as the initial manifestation of multiple sclerosis] |
| Q81685681 | [Optic neuritis associated with infliximab] |
| Q79938876 | [Optic neuritis attributable to Mycoplasma pneumoniae] |
| Q71597807 | [Optic neuritis caused by disulfiram] |
| Q68800720 | [Optic neuritis caused by herpes zoster ophthalmicus. Case report and review of the literature] |
| Q67267473 | [Optic neuritis caused by manioc] |
| Q69689073 | [Optic neuritis due to iodo-quinoleins. Apropos of a case of acrodermatitis enteropathica] |
| Q73099655 | [Optic neuritis due to massive exposure to soot] |
| Q73344561 | [Optic neuritis during lactation] |
| Q74522555 | [Optic neuritis during measles encephalitis] |
| Q54230567 | [Optic neuritis erroneously diagnosed as due to alcoholism or tobaccoism]. |
| Q70508488 | [Optic neuritis from lithium?] |
| Q78496636 | [Optic neuritis in childhood] |
| Q71979528 | [Optic neuritis in children and adolescents] |
| Q71030009 | [Optic neuritis in children. Clinical aspects and evolution in 14 patients (author's transl)] |
| Q71634073 | [Optic neuritis in children: analysis of 58 cases] |
| Q67908265 | [Optic neuritis in children] |
| Q86089501 | [Optic neuritis in juvenile idiopathic arthritis patient] |
| Q85163483 | [Optic neuritis in multiple sclerosis] |
| Q70397379 | [Optic neuritis in patients with multiple sclerosis (author's transl)] |
| Q69588500 | [Optic neuritis in primary Sjögren's syndrome] |
| Q70402126 | [Optic neuritis in young diabetics] |
| Q73327273 | [Optic neuritis masked in the initial stage by ophthalmoscopic signs of obliteration of the central artery of the retina] |
| Q77224244 | [Optic neuritis of arteriosclerotic pathogenesis] |
| Q57602135 | [Optic neuritis, brain stem syndromes and myelitis: rapid conversion to multiple sclerosis] |
| Q69548104 | [Optic neuritis, myelitis, and lupus. apropos of two cases] |
| Q85564756 | [Optic neuritis: Rare manifestation of neurobrucellosis] |
| Q80761049 | [Optic neuritis; sudden improvement following encephalography.] |
| Q84223124 | [Orbital inflammatory pseudotumor with optic neuritis in Behçet's disease] |
| Q73744360 | [Overview of the etiology of optic neuritis] |
| Q40461027 | [Parainfectious optic neuritis with macular infiltrate in Neisseria meningitidis B meningitis]. |
| Q94608448 | [Paraneoplastic optic neuritis in an unknown small cell lung carcinoma defined by CRMP-5-IgG] |
| Q71019483 | [Pathological changes of subarachnoid space in experimental allergic optic neuritis with special reference to phagocytosis] |
| Q70625039 | [Pattern ERG and VECP following optic neuritis in childhood] |
| Q69103709 | [Pattern VECPs in optic neuritis caused by multiple sclerosis] |
| Q70373533 | [Pattern reversal VEP and computer perimetry of the partner eye in optic neuritis] |
| Q64963024 | [Peculiarities of the course of toxic optic neuritis caused by methyl alcohol poisoning] |
| Q83313183 | [Penicillin in a case of luetic optic neuritis] |
| Q69096011 | [Pituitary apoplexy, a difficult diagnosis. Sinusitis, optic neuritis or subarachnoid hemorrhage?] |
| Q73046421 | [Post-spinal anesthetic external oculomotor paralysis and retrobulbar optic neuritis] |
| Q83084367 | [Preliminary report of contrast sensitivity in idiopathic optic neuritis patients after recovery] |
| Q68461677 | [Procedure to follow in acute optic neuritis] |
| Q98723042 | [Progress in the treatment of neuromyelitis optica spectrum disorders related optic neuritis] |
| Q71826465 | [Progress of optic neuritis with and without corticosteroid treatment. Findings in a long-term investigation with static perimetry] |
| Q50099073 | [Progression of nerve fiber layer defects in retrobulbar optic neuritis by the macular ganglion cell complex]. |
| Q67987830 | [Psychogenic malnutrition occurring in Gayet-Wernicke encephalopathy with retrobulbar optic neuritis in a deficient schizophrenic patient] |
| Q78741266 | [Puerperal optic neuritis treated by ACTH drips] |
| Q76908662 | [RETROBULBAR OPTIC NEURITIS CAUSED BY INHALATION OF WOOD ALCOHOL] |
| Q78811005 | [Radiotherapeutic cure of a bilateral optic neuritis in the course of malignant edematous exophthalmos.] |
| Q83451656 | [Recent progress on genetics of optic neuritis] |
| Q68478455 | [Recessive optic neuritis during lucitis due to Mederel] |
| Q82711995 | [Recurrent inflammatory optic neuritis and neuromyelitis optica] |
| Q55462076 | [Recurring neuromyelitis without optic neuritis: a case report]. |
| Q71806324 | [Relation of optic neuritis to multiple sclerosis] |
| Q69800843 | [Relationship between central visual field and pattern VECP in optic neuritis] |
| Q95553226 | [Relationship between the levels and variation of CXCL12, PDGF, CXCL14 in cerebrospinal fluid of optic neuritis and neuromyelitis optica] |
| Q73174820 | [Report of a case of retrobulbar optic neuritis treated with cortisone] |
| Q88630129 | [Research progression of animal models of idiopathic optic neuritis] |
| Q77951192 | [Response to high dose corticosteroids in a girl with bilateral optic neuritis] |
| Q64896475 | [Results of static perimetry in subclinical optic neuritis in multiple sclerosis]. |
| Q74353405 | [Retrobulbar bilateral subacute optic neuritis; etiologic problem] |
| Q79752678 | [Retrobulbar optic neuritis and multiple sclerosis] |
| Q75520804 | [Retrobulbar optic neuritis and osteoma of the frontal sinus] |
| Q74444633 | [Retrobulbar optic neuritis as an allergic disorder] |
| Q54260819 | [Retrobulbar optic neuritis as an initial symptom of multiple sclerosis. Results of a prospective study] |
| Q80607141 | [Retrobulbar optic neuritis as first sign of HIV infection] |
| Q79832699 | [Retrobulbar optic neuritis associated with Infliximab] |
| Q70923455 | [Retrobulbar optic neuritis caused by disulfiram (Espéral): a case] |
| Q76126065 | [Retrobulbar optic neuritis caused by methyl chloride] |
| Q81012892 | [Retrobulbar optic neuritis during infliximab treatment for ulcerative colitis] |
| Q91854490 | [Retrobulbar optic neuritis in a 15-year-old boy] |
| Q74470691 | [Retrobulbar optic neuritis. III. Retrobulbar optic neuritis during neuraxitis degenerative disorders] |
| Q74470694 | [Retrobulbar optic neuritis. IV. Retrobulbar optic neuritis of cervical sympathetic origin] |
| Q74470712 | [Retrobulbar optic neuritis. IX. Unexplained results of otorhinolaryngological surgery in retrobulbar optic neuritis] |
| Q74470700 | [Retrobulbar optic neuritis. VI. Retrobulbar optic neuritis and compression by tumors] |
| Q74470705 | [Retrobulbar optic neuritis. VII. Optic neuritis, initially retrobulbar, and craniopharyngiomas] |
| Q74470709 | [Retrobulbar optic neuritis. VIII. Exploration of the opto-chiasmatic region and anatomical verifications of acute optic neuritis] |
| Q74470716 | [Retrobulbar optic neuritis. X. Cervico-carotid sympathectomy for toxi-infectious optic neuritis; results in ten cases] |
| Q81548061 | [Reversible retrobulbar optic neuritis due to sphenoidal sinus disorders: two case studies] |
| Q72829143 | [Rhinogenous retrobulbar optic neuritis: a case report] |
| Q77641158 | [Role of ultrasonic B-scanning in differential diagnosis and prognosis of the course of optic neuritis] |
| Q76501831 | [SOME CASES OF OPTIC NEURITIS AS AN ACCOMPANYING SYMPTOM OF EPIDEMIC KERATOCONJUNCTIVITIS] |
| Q76819853 | [STATISTICAL OBSERVATIONS ON OPTIC NEURITIS OF NASAL ORIGIN DURING THE PAST 3 YEARS IN OUR CLINIC.] |
| Q76880866 | [STUDY ON RETROBULBAR OPTIC NEURITIS] |
| Q54117759 | [Sensory neuropathy and optic neuritis after prolonged absorption of chloroidoquinone] |
| Q70745614 | [Significance of optic neuritis at the onset of multiple sclerosis] |
| Q68030171 | [Significance of the Tübingen flicker test in the differential diagnosis of optic neuritis] |
| Q78551549 | [Significance of the cerebrospinal fluid in the establishment of etiologic relationship between optic neuritis and multiple sclerosis] |
| Q71970004 | [Some considerations on the histopathogenesis of keratoconus: apropos of a possible association of disseminated leukoencephalomyelitis, retrobulbar optic neuritis and keratoconus] |
| Q50537832 | [Spatial contrast sensitivity in the differential diagnosis of optic neuritis] |
| Q72925125 | [Statistical and analytical study of 164 cases of alcohol-tobacco optic neuritis] |
| Q73920442 | [Streptomycin therapy of optic neuritis] |
| Q83142701 | [Study on the association between IL-2R and IL-7R gene polymorphism and idiopathic demyelinating optic neuritis] |
| Q70622538 | [Supraliminal contrast sensitivity functions to square-wave gratings in patients with optic neuritis] |
| Q72366163 | [Syphilitic optic neuritis in 2 patients with HIV infection] |
| Q71680119 | [Systematic neuroradiological examination and neurosurgical exploration in optic neuritis] |
| Q68029328 | [Tapetoretinal degeneration: apropos of a case associated with bilateral optic neuritis] |
| Q68057513 | [Tapetoretinal degeneration: apropos of a case associated with bilateral optic neuritis] |
| Q75665070 | [The anatomic correlation between the optic canal and sphenoid sinus as a factor predisposing to optic neuritis of sinusal origin] |
| Q85929534 | [The clinical outcomes of idiopathic optic neuritis with no light perception in 21 eyes] |
| Q67910679 | [The color vision in patients with optic neuritis and chronic open-angle glaucoma] |
| Q76428090 | [The different forms of optic neuritis in Iran.] |
| Q72693431 | [The multi-channel VEPs topography in optic neuritis] |
| Q92174349 | [The progress of research on the immune pathogenesis and biomarkers in optic neuritis related to neuromyelitis optica] |
| Q68010019 | [The study of the components of pattern ERG--2. Longstanding optic neuritis] |
| Q93574403 | [The temporal transfer properties of the visual system in patients with optic neuritis] |
| Q86093009 | [The usefulness of 3T magnetic resonance in the differential diagnosis of ischemic optic neuropathy and inflammatory optic neuritis] |
| Q78493996 | [Therapy of retrobulbar optic neuritis; therapeutic stages] |
| Q83084353 | [To improve understanding of etiology of optic neuritis in China] |
| Q68057896 | [Toxic optic neuritis with ethambutol] |
| Q70946535 | [Toxic optic neuritis: sometimes wrongly attributed to antituberculosis treatment (author's transl)] |
| Q71623639 | [Toxic retrobulbar optic neuritis caused by nitrogen oxides] |
| Q79323164 | [Transverse optic neuritis in the course of a subacute encephalomyelitis.] |
| Q73915284 | [Treatment of acute optic neuritis with high dose of prednisone] |
| Q71998906 | [Treatment of acute optic neuritis with large doses of corticosteroids] |
| Q79275289 | [Treatment of optic neuritis and papilledema with prednisone, gonadotrophin and ACTH.] |
| Q79335726 | [Treatment of optic neuritis by corticoids.] |
| Q72898142 | [Treatment of optic neuritis with corticosteroids. Discussion at the 10th Meeting of the International Neuro-ophthalmological Society (Freiburg 5 to 9 June 1994)] |
| Q73020173 | [Treatment of optic neuritis with cortisone] |
| Q80127487 | [Treatment of optic neuritis] |
| Q73404270 | [Treatment of retrobulbar optic neuritis by milk hypoglycemic shocks; preliminary communication] |
| Q54306749 | [Two cases of optic neuritis in children with rapid thinning of the ganglion cell complex]. |
| Q71385681 | [Two early-childhood cases of optic neuritis] |
| Q69606158 | [Uhthoff's sign associated with postmeningitic bilateral optic neuritis] |
| Q79313360 | [Unilateral exophthalmos accompanying the acute optic neuritis syndrome.] |
| Q68786268 | [Unilateral optic neuritis in a patient treated with ethambutol] |
| Q74414284 | [Unusual combinations of pathological ocular manifestations: neuroretinal lesions caused by Vaquez disease and retrobulbar optic neuritis with oculomotor paralysis caused by herpes zoster ophthalmicus] |
| Q72782968 | [Uveomeningitis and optic neuritis disclosing sarcoidosis] |
| Q68057894 | [VEP in the follow up of patients with optic neuritis] |
| Q73972523 | [Value of sympathetic interventions in the treatment of optic neuritis] |
| Q72325983 | [Varicella and optic neuritis] |
| Q73005535 | [Vasodilatator therapy with monoethanol amine nicotinate of post-hemorrhagic acute optic neuritis] |
| Q71471362 | [Visual evoked potentials in the early diagnosis of alcohol-tobacco optic neuritis (comparison of 2 methods of stimulation , checker-board and flash)] |
| Q72418978 | [Visual function in patients with optic neuritis associated with acute transverse myelopathy in multiple sclerosis] |
| Q73869692 | [Voluminous myxochondroma of the pterygomaxillary junction with reduced symptomatology (retrobulbar optic neuritis)] |
| Q78692304 | [delta-Cortisone therapy of 11 cases of acute retro-bulbar optic neuritis; discussion of their viral origin] |
| Q77421708 | mtDNA haplogroup J: a contributing factor of optic neuritis |
| Q417222 | methylprednisolone | medical condition treated | P2175 |
| Q21174940 | naphthalene exposure | symptoms and signs | P780 |
| Q26737757 | central scotoma | has cause | P828 |
| Category:Optic neuritis | wikimedia | |
| Arabic (ar / Q13955) | التهاب العصب البصري | wikipedia |
| az | Optik nevrit | wikipedia |
| Catalan (ca / Q7026) | Neuritis òptica | wikipedia |
| Optická neuritida | wikipedia | |
| Neuritis nervi optici | wikipedia | |
| Optic neuritis | wikipedia | |
| Neuritis óptica | wikipedia | |
| Basque language (eu / Q8752) | Neuritis optiko | wikipedia |
| Persian (fa / Q9168) | التهاب عصب بینایی | wikipedia |
| Névrite optique | wikipedia | |
| דלקת עצב הראייה | wikipedia | |
| Optički neuritis | wikipedia | |
| Neurite ottica | wikipedia | |
| 視神経炎 | wikipedia | |
| 시신경염 | wikipedia | |
| Neuritis optica | wikipedia | |
| Zapalenie nerwu wzrokowego | wikipedia | |
| Neurite óptica | wikipedia | |
| Неврит зрительного нерва | wikipedia | |
| Запаљење оптичког живца | wikipedia | |
| Optik nörit | wikipedia | |
| Tatar language (tt / Q25285) | Күрү нервы невриты | wikipedia |
| uz | Optik nevrit | wikipedia |
| Viêm dây thần kinh thị giác | wikipedia |
Search more.